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In recent years, fluorescence imaging has become an indispensable tool for the exploration 
of biological processes, demonstrating both molecular specificity and high spatial and 
temporal resolution. Despite the significant progress made in this field, a number of 
challenges still exist which, if addressed could potentially result in the transformative 
development of fluorescent imaging for a plethora of biological applications. This may 
include the development of new fluorescent probes for the detection of unknown analytes, 
or the improvement of existing probes in order to enhance their properties. In this research, 
a fluorescent probe for the detection of hydrogen sulphide was repurposed for use as a ‘first 
of its kind’ fluorescent probe for the detection of hydroxylamine. In addition, the known 
peroxynitrite-mediated oxidation of boronic acid to phenol has been exploited for the 
development of a range of reaction based fluorescent probes. Initially non-fluorescent, each 
probe is ‘turned on’ in the presence of peroxynitrite, resulting in the formation of a highly 
fluorescent phenol derivatives. Such probes have been successfully evaluated during cell 
imaging experiments; demonstrating clear potential in the field of medical diagnostics. 
Specific applications may include ‘oxidative stress’, neurodegenerative disease and the 
evaluation of drug efficacy in the treatment of Alzheimer’s disease. 
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1.1 Fluorescence  
Luminescence is defined as the emission of light from any substance, which occurs from an 
electronically excited state. This process can exist in two forms – fluorescence and 
phosphorescence.1 Fluorescence is the emission of light when an electron in a singlet excited 
state relaxes back to the ground state, whereas phosphorescence is the emission of light when 
the electron in its triplet excited state returns to the ground state. The major difference 
between fluorescence and phosphorescence is their emission rates: fluorescence – fast (108 
s-1), phosphorescence – slow (103 s-1). 
The overall process of luminescence involves the absorption and emission of light, which is 
often depicted using a Jablonski diagram shown in Figure 1. The absorption of light from a 
fluorophore, results in its excitation to a higher vibrational level, either S1 or S2. In the case 
of fluorescence, all of the excited vibrational states quickly relax to the lowest vibrational 
level of S1 (10
-12 s), which is known as internal conversion (IC). The electron in the excited 
orbital is paired to the second electron (with an opposite spin) in the ground state orbital 
therefore the subsequent transition to the ground state is spin allowed and the emission of 
light is fast. However, molecules in the S1 can undergo a spin conversion to the first triplet 
state T1 (intersystem crossing). This transition from T1 to the singlet ground state is 
forbidden, therefore the emission (phosphorescence) is at a longer wavelength (lower 
energy) and the emission rate is considerably slower than for fluorescence. In this thesis, we 
will be solely focusing on fluorescence as a method to detect specific analytes and their 




Figure 1 – A typical Jablonski diagram.1 S0 is the electronic ground state. S1 and S2 are the singlet excited states amd T1 
is the first excited triplet state. IC is internal conversion and ISC is intersystem crossing. 
1.1.1 Why use Fluorescence? 
Fluorescence spectroscopy has been extensively used as a method for the detection of a range 
of different chemical species using small molecule fluorescent probes.2 This technique 
transforms the act of binding to a target analyte into a readable optical signal at the molecular 
level. Therefore, the use of fluorescence offers a non-invasive approach to study living 
biological samples i.e. live cells and animals. The distinct advantage of fluorescence over 
the traditional detection methods such as electrochemistry, GC-MS, HPLC and 
spectrophotometry is that it offers the ability to observe living biological samples in real 
time without the sample being destroyed. Further to this, fluorescent probes can be designed 
to have a high sensitivity and specificity towards a target analyte allowing them to interact 
selectively with a single target, within a complex biological environment. Therefore, 
fluorescence imaging can provide high spatial and temporal resolution thus providing a 
detailed image of a whole sample. In summary, the versatility of fluorescence allows it to be 
used to study molecular interactions in a range of different media and interfaces, making it 
an ideal method for biological investigations. Consequently, fluorescent probes have been 
used for a broad range of applications including clinical diagnostics and for the detection of 




1.2 The Design of a Fluorescent Probe 
 
In the design of a fluorescent probe, it is important to use specific host-guest interactions, or 
a specific chemical reaction to invoke a change in the fluorescent properties of the system. 
If the binding between the host and guest is non-covalent and reversible, the fluorescent 
probe is referred to as a chemosensor. If the interaction between the host and guest produces 
an irreversible chemical reaction, then the fluorescent probe is referred to as a 
chemidosimeter (reaction based).2 Over the years, these two definitions, as well as the term 
‘fluorescent probe’, have been used interchangeably and ambiguously, therefore in this 
thesis they will both be referred to only as fluorescent probes. 
The first step in the design of a fluorescent probe requires the choice of a suitable reporter 
(fluorophore). There are many factors to consider when choosing a suitable fluorophore.  
Firstly, the fluorophore should be non-toxic at the concentration used, whilst the choice of 
the excitation/ emission wavelength profile should be in the visible or near-infrared (NIR) 
region. The development of long wavelength/ NIR fluorescent probes are of particular 
interest as they provide a non-invasive method for in vivo visualisation of mammalian tissues 
with minimal photodamage to the biological sample, minimal interference from background 
auto fluorescence, and acceptable penetration through biological tissues.4 A balance of 
hydrophobicity and hydrophilicity needs to be considered, so that the probe exhibits suitable 
cell membrane permeability, water solubility and cellular retention properties. Lastly, high 
optical brightness is important to minimalize the amount of fluorescent probe needed, which 
avoids interference from the biological sample. 
Each fluorophore can be arranged by their structure and colour (emission) as shown in 
Figure 2 – (Anthracene 1, Coumarin 2, Bodipy 3, Napthalimide 4, Fluoroscein 5, Rhodamine 
6, Cyanine 7). Each fluorophore shown below, has been widely used as reporter molecule 




Figure 2 – A representative set of common organic dyes that can be transformed into fluorescent probes5 
 
The next step in the design of a fluorescent probe is the choice of receptor. The receptor is 
usually covalently linked to the reporter directly, or linked by a spacer to make up a whole 
sensing unit. The aim of the receptor is to interact with the target in a chemoselective manner, 
which then relays a response to the reporter that provides the signal that is observed by the 
fluorimeter. If the receptor is a chemically reactive trigger, the reaction must proceed with 
reasonable kinetics in aqueous solution and under complex biological conditions (pH, high 
salt content and large concentration of reactive nucleophilic thiols). Furthermore, the 
fluorescent probe should be biorthogonal with any by-products being inert and non-toxic. 
The current challenges in this area is to identify new specific biorthogonal chemical reactions 
that allow us to interrogate a specific analytes role in its biological environment. 
A model example of a chemoselective reaction based probe is shown below in Scheme 1. C. 
Chang et al. developed a highly selective fluorescent probe for the detection of hydrogen 
sulphide (H2S). This fluorescent probe exploited the reactivity of an azide towards H2S, 
resulting in it being reduced to its corresponding amine to produce a fluorescent response. 
This chemical reactivity has been employed in many organic reactions for the synthesis of 
new molecules. The azide fluorescent probe was found to be non-fluorescent, however, its 
14 
 
reduction with H2S resulted in the formation of a highly fluorescent rhodamine derivative. 
This fluorescent probe was shown to be able to detect H2S in cell imaging experiments.
9, 10  
 
 
Scheme 1 – An example of a hydrogen sulphide fluorescent probe 62 
 
In addition to the design of a fluorescent probe, the change in the fluorescence emission 
intensity needs to be considered. It is preferred that upon binding to the target analyte, an 
increase in fluorescence emission intensity (‘turn on’) is observed, rather than a decrease in 
fluorescence emission intensity (‘turn off). This is because it is much easier to visualise a 
bright signal against a dark background, which can provide better resolution of the target 
analyte throughout a whole biological sample. Another desired feature for a fluorescent 
probe is a shift in the excitation/emission maxima, which allows for ratiometric imaging. 
Therefore, a ratiometric fluorescence response provides a method for internal calibration 




1.3 Fluorescence Mechanisms 
There are three classic fluorescence mechanisms that can be used to generate a fluorescent 
response, these are PET (Photoinduced Electron Transfer), FRET (Förster Resonance 
Energy Transfer) and ICT (Internal Charge Transfer).  
1.3.1 Photoinduced Electron Transfer (PET)  
Photoinduced electron transfer (PET) has been widely used for the design of molecular logic 
and small molecule fluorescent probes. This method either results in the quenching, or an 
increase in fluorescence intensity.11-14 The important requirements for a PET system are the 
closeness in space of the receptor and reporter and matching of their energy levels. PET 
occurs when excitation of a fluorescent probe results in electron transfer from the HOMO 
orbital of the receptor to the HOMO of the fluorophore. This results in a fluorescence 
quenching taking place due to the excited electron returning to the ground state via a non-
radiative pathway. However, when the receptor binds/reacts with the target analyte, the 
receptor HOMO energy becomes lower than the fluorophore system blocking the PET 
process thus resulting in the emission of light (Figure 3).11 
 
 
Figure 3 – A schematic diagram of the PET process14 
 
A number of PET fluorescent probes have been developed for the sensing of a range of 
analytes. A seminal example of a fluorescent PET sensor for the detection of saccharides is 
16 
 
shown below in Scheme 2.15 Shinkai et al. demonstrated the ability of this fluorescent probe 
to detect saccharides over a large pH range in aqueous media.  
 
 
Scheme 2 - A schematic diagram of a PET based fluorescent probe for the detection of saccharides 
 
More recently, Kim et al. developed a fluorescent PET probe that was used for the 
quantitative measurement of mitochondrial pH changes.16 The probe consisted of a cationic 
triphenylphosphonium group for mitochondrial targeting, a piperazine-linked naphthalimide 
unit as the fluorophore and a reactive benzyl chloride subunit for mitochondrial fixation. 
This sensor was shown to operate in the mitochondria of whole live cells, where it displayed 








1.3.2 Förster Resonance Energy Transfer (FRET)  
Förster resonance energy transfer (FRET) is a non-radiative process in which two or more 
fluorophores with similar excited state energies can exchange their energy due to long range 
dipole-dipole resonance interactions. However, this process depends strongly on the 
proximity between the fluorophores, with the distance having to be within 1 – 10 nm. The 
FRET process also requires that the absorption spectrum of the acceptor fluorophore should 
overlap with the emission spectrum of the donor fluorophore.3 The requirements for FRET 
are illustrated below in Figure 4. FRET and intramolecular charged transfer (ICT) systems 
are the most commonly exploited systems for the design of ratiometric fluorescent probes, 
with a number of reviews available on FRET based fluorescent probes.17, 18 
 
 
Figure 4 – Requirements for the FRET process to take place19 
 
Lin et al. developed a FRET based ratiometric fluorescent probe for the detection of 
endogenous nitric oxide (NO) (Scheme 4),20 which consists of a coumarin-rhodamine FRET 
pair linked together via a piperazine moiety. An o-phenylenediamine fragment was used as 
the receptor moiety for NO, which resulted in rhodamine being kept in its ‘closed’ form. 
Rhodamine in its closed form is non-fluorescent, therefore the excitation energy from the 
coumarin donor cannot be transferred to the rhodamine acceptor. This resulted in only the 
coumarin emission being observed. However, the presence of NO results in its reaction with 
the o-phenylenediamine receptor, which induced ring opening of rhodamine. Because of 
this, FRET is turned on and a 420-fold ratiometric response was observed (I583/I473) upon 
19 
 
excitation at the coumarin donor. This probe was used to produce ratiometric images of 




Scheme 4 – FRET based coumarin-rhodamine system for the detection of NO20 
 
Another example of a FRET system has been reported by Zhao and James et al, who joined 
two BODIPY molecules together to create a FRET fluorescent probe for the detection of 
homocysteine and cysteine (HCys/Cys).21 Initially, the fluorescent probe was weakly 
fluorescent at 566 nm. The relatively low fluorescence observed was due to the attached 
dinitrobenzenesulfonyl (DNBS) moiety. DNBS is known to react with thiols, therefore the 
presence of Cys/HCys resulted in cleavage of this moiety leading to a large fluorescence 
increase (> 20 fold) at 590 nm. Furthermore, the probe was shown to be able to detect cellular 





Scheme 5 – A BODIPY based FRET fluorescent probe for the detection of Cys/HCys 
 
1.3.3 Internal Charge Transfer (ICT) 
 
As discussed above, ICT is a common strategy employed for the design of ratiometric 
fluorescent probes. In the case of ICT, the reporter (fluorophore) is integrated with the 
receptor with a sufficient orbital overlap. An ICT system contains an electron donating group 
and an electron withdrawing group at each end, often referred to as a ‘push-pull’ system. 
The excitation of the ICT fluorophore results in redistribution of electron density, creating a 
substantial dipole. Therefore, the binding of a target species to the integrated receptor causes 
an interaction with the excited dipole, which results in a shift in the emission and excitation 
spectra to give a ratiometric response (Not observed in PET).12 ICT excited states are very 
sensitive to the presence of electric fields and therefore are affected by solvents, cations and 
hydrogen bonding.14  
21 
 
An example of an ICT fluorescent probe has been reported by Cho and Chang et al., in which 
they developed a two-photon ratiometric fluorescent probe for the detection of hydrogen 
peroxide (H2O2) using the ICT fluorophore 2-acetyl-6-aminonapthalene (AN1).
22 This probe 
was developed through attaching a boronate-based carbamate onto the amino functionality. 
This resulted in inhibition of the ICT process as the electron donating group was converted 
to an electron withdrawing group (amine to amide) creating a pull-pull system. However, 
the presence of H2O2 resulted in oxidative cleavage of the boronate carbamate protecting 
group to liberate an electron donating amino group (amine). This resulted in a ratiometric 




Scheme 6 – An ICT fluorescent probe for the detection of H2O2 
 
More recently, Wu and co-workers have developed a ratiometric naphthalimide ICT 
fluorescent probe for the detection of hydrazine (N2H4) in living cells and in vivo.
23 The 
presence of N2H4 resulted in removal of the acetate protecting group and led to the formation 
of an ICT push-pull system. As a result, a fast colorimetric and ratiometric ‘turn-on’ response 




Scheme 7 – An ICT fluorescent probe 72 for the detection of N2H4 
 
1.4 Reactive Oxygen/ Reactive Nitrogen Species (ROS/RNS) 
In recent years, there has been an explosion in interest in the role of oxygen-free radicals 
that are also known as reactive oxygen and reactive nitrogen species (ROS/RNS). These 
highly reactive species are continuously formed within the cell at low physiological 
concentrations (subtoxic). ROS/RNS are known to act as signalling molecules to regulate 
certain cellular processes, such as proliferation, cellular defence, differentiation and 
apoptosis.24, 25 However, excessive production of ROS/RNS can occur due to an imbalance 
between ROS/RNS and antioxidants, leading to the term ‘oxidative stress’. This 
overproduction of ROS/RNS can result in reversible and irreversible oxidative damage to a 
wide range of biomolecules such as nucleic acids, carbohydrates, lipids and proteins. This 
oxidative damage ultimately leads to a loss of molecular and cellular functions. As a 
consequence, oxidative stress has been shown to be involved in a number of pathological 
conditions such as Alzheimer’s disease, cancer, diabetes mellitus, cardiovascular disease and 
aging.26 These short-lived ROS/RNS species are known to exhibit both beneficial and 
harmful biological effects, and as a consequence a number of fluorescent probes have been 




1.4.1 Types of ROS/RNS and its sources 
ROS/RNS can be divided into two groups:  
(i) Radical compounds, which include superoxide (
-
O2), hydroxyl (HO•), nitric oxide (NO•), 
and peroxyl radical (ROO
.
)  
(ii) Non-radical compounds, which include hydrogen peroxide (H2O2), peroxynitrite 
(ONOO-), Ozone (O3),hypochlorite (ClO
-) and singlet oxygen (1O2).
24 
These species can be produced from both exogenous and endogenous pathways. External 
sources include: UV, air pollution, cigarette smoke, xenobiotics and ionising and non-
ionising radiation. Endogenously, there are three main sources: leakage of “activated” 
oxygen from within the mitochondria, monoamine oxidase (MAO) catalysed production of 
H2O2, and through oxygen-metabolising enzymatic reactions, such as those catalysed by 
xanthine oxidase (XO), cytochromes P450, NADPH oxidases, dual oxidases, 
myeloperoxidase (MPO) and nitric oxide synthases (NOSs).24 
 
1.4.2 Sensors for the detection of Reactive Oxygen and Reactive Nitrogen 
Species (ROS/RNS) 
1.4.2.1 Fluorescent probes for the detection of Superoxide (-O2) 
 
The production of superoxide (-O2) mostly occurs within the mitochondria. This is due to 
the leakage of electrons to molecular oxygen from the electron transport chain. -O2 is known 
as the “primary” ROS as it interacts with a range of molecules to produce other ROS/RNS. 
Due to its high reactivity, -O2 has a short half-life and has been shown to be involved in a 
range of pathological processes such as inflammation, aging, and ischemia-reperfusion.27-30 
The most commonly used system for the detection of -O2 is a hydroethidine based fluorescent 
probe 20. The addition of -O2 results in the oxidation of hydroethidine to form the highly 
fluorescent 2-hydroxyethidium species 21 shown in Scheme 8. This oxidation reaction has 





Scheme 8 – Oxidation of the fluorescent probe hydroethidine 20 with superoxide 
 
More recently, Murthy and co-workers exploited the unique reactivity of -O2 to develop a 
range of hydrocyanine fluorescent probes for the detection of -O2 (Scheme 9).
32 Each 
fluorescent probe was synthesised through the NaBH4 reduction of the corresponding 
cyanine dye. These hydrocyanine probes were shown to have a range of emission 
wavelengths between 560 – 830 nm, excellent stability towards autoxidation, and have the 
ability to detect nanomolar levels of -O2. These probes were shown to image 
-O2 in cell 
cultures, tissue explants and within animals for the first time. 
 
 
Scheme 9 – Hydrocyanine fluorescent probes for the detection of superoxide 
Alternative strategies have been employed for the design of reaction based fluorescent 
probes for the detection of -O2. These include those based on the ability of 
-O2  to reduce 
nitroxides into hydroxylamines33 and the ability of -O2 to act as a nucleophile to deprotect 




1.4.2.2 Fluorescent probes for the detection of Hydrogen Peroxide (H2O2) 
 
Hydrogen peroxide (H2O2) in its uncharged form is a weak oxidant and weak nucleophile, 
which enables H2O2 to diffuse within cells and across cell membranes. The diffusion of H2O2 
into the cytoplasm induces specific physiological processes such as cell proliferation, 
differentiation and apoptosis and it can be used as a secondary messenger in cell signalling. 
The accumulation of H2O2 has been implicated in a number of pathological conditions, 
including cancer and neurodegenerative diseases.26, 36 Due to these reasons, there has been 
an increasing demand for the development of fluorescent probes for the selective detection 
and quantification of H2O2 in biological systems.  
The well-known H2O2-mediated conversion of arylboronates to phenols is the most 
commonly employed strategy for the detection of H2O2. H2O2 is a potent nucleophile, which 
attacks the boron centre to form a tetra-substituted ‘ate’ intermediate, which then undergoes 
a C-O boronate migration reaction to form a labile borate species that readily hydrolyses to 
give the desired phenol that produces a fluorescent response (Scheme 10).5 
 
 
Scheme 10 - H2O2-mediated conversion of arylboronates to phenols 
 
Chang and co-workers designed a family of xanthene diboronate fluorescent probes for the 
detection of H2O2.
22, 37-42 All of these diboronate fluorescent probes are originally non-
fluorescent, however, their reaction with H2O2 results in an immediate fluorescence 
response. All of these fluorescent probes demonstrated excellent selectivity over other 
ROS/RNS and were able to detect H2O2 at micromolar concentrations in living cells. A few 








Other fluorescent strategies that have been employed for the detection of H2O2 include H2O2-
mediated hydrolysis of sulfonic esters,43 H2O2-mediated transformation of benzyl groups to 
benzoic acid,44 and H2O2-oxidation of triphenylphosphine groups to their corresponding 
phosphine oxides (Scheme 11).2, 45  
 
 




1.4.2.3 Fluorescent probes for the detection of Hypochlorite (HOCl/ClO-)  
 
Hypochlorous acid (HOCl) is a weak acid, which partially dissociates to form its 
hypochlorite anion (ClO-) under physiological pH conditions. Myeloperoxidase (MPO), is 
an enzyme found in leukocytes (neutrophils, macrophages and monocytes) that catalyses the 
reaction of H2O2 and chloride to produce HOCl/ClO
-. HOCl/ClO- is an important ROS, that 
plays a vital role in immune defence systems due to its microbiocidal properties. However, 
excessive production of HOCl/ClO- can lead to damage to a number of known biological 
targets, which include amino acids, proteins, carbohydrates, lipids and antioxidants.46 
Therefore, abnormal production levels of HOCl/ClO- has been associated with a range of 
diseases associated with cell and tissue damage.47-49 Consequently, a number of fluorescent 
probes have been developed for the detection of HOCl/ClO- to further understand the role of 
MPO and HOCl/ClO- in biological systems.  
Yang et al. developed a BODIPY based fluorescent probe 37 for the detection of HOCl/ClO-
based on HOCl/ClO- specific reactivity with p-methoxyphenol to form a benzoquinone.50 
This p-methoxyphenol moiety was attached to a BODIPY unit, resulting in quenching of its 
fluorescence via a PET process. The HOCl/ClO- mediated oxidation of p-methoxyphenol to 
benzoquinone inhibited the PET process, resulting in an immediate fluorescence response 
being observed. The requirement of HOCl/ClO- for the reaction to take place results in this 
probe having an excellent selectivity profile over other ROS/RNS. 37 was shown to have a 
high sensitivity towards HOCl/ClO-, with the ability to detect micromolar concentrations of 
HOCl/ClO-. The probe’s ability was further demonstrated through its use in an MPO assay 
(MPO/H2O2/Cl
- system) where it was able to detect HOCl/ClO- in live cells. 
 
Scheme 12 – Fluorescence detection of HOCl/ClO- via the oxidation of p-methoxyphenol to benzoquinone 
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There are a range of fluorescence strategies used to detect HOCl/ClO-.2 A commonly used 
strategy involves spirolactam ring opening and oxidation of xanthene fluorescent probes.For 
example, Xu and co-workers developed a rhodamine B thiospirolactone 39, which 
underwent a chlorination reaction and thio-spiro ring opening in the presence of 
HOCl/ClO.51 The probe displayed high sensitivity and selectivity towards HOCl/ClO-, and 
could detect HOCl/ClO-  in living human neutrophil cells.  
 
 
Scheme 13 - HOCl/ClO- induced spirolactam ring opening  
 
1.4.2.4 Fluorescent probes for the detection of Hydroxyl radical (HO.) 
Under oxidative stress, -O2 interacts with [4Fe-S] cluster containing enzymes resulting in the 
release of free Fe(II). Fe(II) is then able to participate in a non-enzymatic Fenton reaction 
with H2O2 to produce the highly reactive hydroxyl radical (HO•) (Scheme 14).26 
 
 




The high reactivity of HO• means that it has a short half-life in aqueous solution of less than 
1 ns. This short half-life localises its damage, however, the radical can react with any 
biological molecules present in its near vicinity. This ROS is therefore known to be 
responsible for oxidative damage towards DNA, proteins and lipids.  
Nitroxides have well-known antioxidant properties with the ability to interact with radicals, 
where that can act to degrade superoxide, peroxide and inhibit the Fenton reaction.52 Tang 
and co-workers have developed a fluorescent probe for the detection of HO
.
 by attaching a 
stable nitroxide moiety directly to a BODIPY fluorophore 41.53 The presence of the nitroxide 
group resulted in the quenching of the fluorescence through an electron-exchange 
mechanism. However, addition of a carbon centred radical.CH3 led to the reduction of the 
nitroxide and the formation of a hydroxylamine. This eliminated the intramolecular 
fluorescence quenching pathway leading to a fluorescence response. 41 was shown to be cell 
permeable and have the ability to detect intracellular. HO
•
. This was achieved by adding 
DMSO which reacts with any HO
.
 present to generate •CH3 that then reacts with the 
fluorescent probe to enable indirect measurement of HO
•
 concentration (Scheme 15). 
 
 










cleavage of a DNA strand54 , C-H abstraction55 and HO
•
 induced aromatic hydroxylation.56 
 
Scheme 16 – Ratiometric detection of .OH via C-H abstraction55 
 
1.4.2.5 Fluorescent probes for the detection of Singlet Oxygen (1O2) 
 
Molecular oxygen in its excited state is known as singlet oxygen (1O2), which is a highly 
reactive ROS that results in  damage to a range of biological molecules such as DNA, protein 
and lipids.57 Currently, there is very little understanding of the role of 1O2 as a signalling 
molecule in biological systems due to the lack of suitable fluorescent probes. The current 
sensing strategies for 1O2 are based on its reactivity to form endoperoxides via cycloaddition 
reactions with dienes. Anthracene and 9, 10-diphenylanthracene (DPA) are well-known 1O2 
traps that react with 1O2 to form stable endoperoxides (Scheme 17).  
 
 
Scheme 17 – Formation of a stable endoperoxide, (R = H or CH3)  
 
A number of groups including Nagano et al. have developed fluorescent probes that exploit 
this unique reactivity of anthracene with 1O2 , as shown in Scheme 18.
58, 59 Fluorescent probe 
47 combined anthracene and fluorescein into a single molecule, which resulted in quenching 
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of fluorescence due to a PET process. However, the addition of 1O2 rapidly led to the 
formation of the stable endoperoxide and the inhibition of the PET process leading to an 
increase in fluorescence intensity. 
 
 
Scheme 18 – Anthracene-fluoroscein probe for the detection of 1O2 
 
More recently, Tang and co-workers have developed a near-infrared fluorescent probe 49 
for the detection of intracellular 1O2.
60 This probe contained a histidine fragment, which had 
a known reactivity to undergo [4+2] cycloaddition reactions with 1O2. 49 is originally non-
fluorescent due to a PET process that is caused by the electron donating ability of histidine. 
However, the presence of 1O2, leads to the oxidation of the histidine moiety and inhibition 
of the PET process. As a result, 49 demonstrated a rapid and selective fluorescent response 
that could detect 1O2 in live cells (Scheme 19). 
 




1.4.2.6 Fluorescent probes for the detection of Ozone (O3) 
 
Ozone (O3) located in the stratosphere protects the earth from harmful UV light. However, 
in the lower troposphere, O3 is known to be toxic to mammals.
61 In addition, Wentworth and 
co-workers have discovered that antibodies can catalyse the production of previously 
unknown oxidant, dihydrogen trioxide (H2O3) and O3 from 
1O2 for the purpose of immune 
defense.62 For these reasons, the development of a fluorescent probe for the detection of O3 
is highly desirable for health and safety reasons and in order to gain a better understanding 
of its biological function.  
Ozonolysis is a well-known and commonly used organic transformation for the hydrolysis 
of an alkene to form two carbonyl products. Koide et al. utilised this knowledge to develop 
a fluorescent probe for the detection of O3 by attaching a homoallyl ether moiety to 
dichlorofluorescein (DCF) 51.63 Originally, 51 is non-fluorescent, however, the presence of 
O3 resulted in the ozonolysis of its terminal alkene. The resultant aldehyde subsequently 
undergoes a β-elimination reaction to release the DCF fluorophore and generate a fluorescent 
response. 51 was shown to be capable of detecting O3 in both biological (bronchial epithelial 
cells) and atmospheric samples (Scheme 20). 
 
 





More recently, Tang et al. developed the ‘first’ NIR fluorescent probe 53 for the detection 
of endogenous O3.
64 This fluorescent probe consisted of the fluorophore tricarbocyanine and 
L-tryptophan as the receptor to interact with O3. The presence of O3 led to its reaction with 
L-tryptophan and an increase in fluorescence intensity due to the inhibition of a twisted 
intramolecular charge transfer (TICT) mechanism. 53 displayed excellent selectivity and 
sensitivity towards O3 and it was able to detect endogenous O3 in macrophage cells 
stimulated by PMA (Scheme 21). 
 
 
Scheme 21 – NIR probe 107 for the detection of endogenous O3 
 
1.4.2.7 Fluorescent probes for the detection of Nitric Oxide (NO.) 
 
Nitric oxide (NO) is the smallest signalling molecule known and is generated via three 
different types of nitric oxide synthases (NOS).65 NO synthases catalyse the oxidative 
conversion of L-arginine to L-citrulline to produce NO. NO affects a large variety of 
physiological functions such as neurotransmission, blood pressure regulation, smooth 
muscle relaxation and immune regulation.24, 26 NO can lead to nitrosative stress, which has 
been implicated in many neurodegenerative diseases and ischemia-reperfusion.24 Therefore, 
the development of a fluorescent probe for the detection of NO is particularly attractive, as 
it provides a tool that would allow for direct and real-time monitoring of NO. 
The most common sensing strategy for NO is the use of o-phenylenediamine, which reacts 
with NO and cyclises to form a less electron donating benzotriazole, which inhibits the PET 
process. For example, Nagano et al. developed a NIR cyanine based fluorescent probe 55 
35 
 
containing an o-phenylenediamine used to detect NO. Originally, 55 is non-fluorescent due 
to a PET process, however, the presence of NO leads to the formation of the desired triazole 
and a fluorescence response (inhibition of the PET process).  
 
 
Scheme 22 – Cyanine based fluorescent probe for the detection of NO 
 
1.4.2.8 Fluorescent probes for the detection of Peroxynitrite (ONOO-) 
Peroxynitrite (ONOO-) is a highly reactive RNS with a very short half-life (~10-20 ms). It 
is formed via the diffusion controlled reaction of NO and -O2. ONOO
- has a wide range of 
biological targets including proteins, DNA and lipids.66 Therefore, ONOO- has been 
implicated in the pathogenesis of a number of diseases such as neurodegeneration, 
inflammation, ischemic-reperfusion and cancer.66 Therefore, the development of fluorescent 
probes to understand the processes of ONOO- in biological systems is vital.  
Sikora et al. compared the reactivity of ONOO-, H2O2 and ClO
- towards aliphatic and 
aromatic boronate compounds.67 In their research, it was found that 4-acetylphenylboronic 
acid reacts with ONOO- a million times faster (k = 1.6 x 106  M-1 s-1) than it does with H2O2 
(k = 2.2 M-1 s-1) and 200 times faster than ClO- (k = 6.2 x 103 M-1 s-1) to form the oxidised 
phenol product. Subsequently, a number of research groups have taken advantage of the 
difference in rates of reactivity to detect ONOO- over H2O2 and ClO
-.  
For example, Wang and co-workers developed a boronate based coumarin fluorescent probe 
for the detection of ONOO- in vitro and in vivo.68 The probe was shown to detect micromolar 
concentrations of ONOO- through a dual ratiometric and colorimetric response, being 





Scheme 23 – Boronate based fluorescent probe for the detection of ONOO- 
 
An alternative sensing mechanism was discovered by Olson et al., in which, ONOO- was 
found to  react with activated ketones to form a dioxirane, which subsequently oxidised the 
attached phenyl ring to afford a dienone product.69 Yang et al. used this chemistry to develop 
a BODIPY based fluorescent probe 59 containing an activated ketone that would react with 
ONOO-,70 which was successfully used to detect endogenous ONOO- in macrophage cells 
via PMA, LPS and IFN-γ stimulation (Scheme 24). 
 
 




1.5 Summary of Introduction 
In summary, the field of fluorescent probes has developed significantly over recent years, 
with this literature review highlighting representative examples where fluorescent probes 
have been used for the detection of ROS/RNS. On reading this review, the reader should 
appreciate the potential of fluorescence to detect biologically important analytes. The field 
of fluorescent probes is far from complete due to researchers constantly requiring new tools 
to detect yet unknown analytes and improve specificity for existing analytes in different 
biological scenarios. These unknown analytes could take the form of biomarkers for a 
particular disease, or trace pollutants present in water and air supplies. On the other hand, 
current fluorescent probes may work but may fall short on the required selectivity or 
sensitivity required for a specific application. Therefore, it is likely that there will always be 




2.0 Chapter One: A BODIPY fluorescent probe for the 
detection of hydroxylamine 
 
A previous research program in the Bull Group was focused on the synthesis of novel 
heterocyclic ring systems for pharmaceutical and sensing applications. Through this 
research, it was discovered that reaction of an aromatic aldehyde containing an ortho α,β-
unsaturated ester 61 with NH2OH.HCl, and base (NaOAc or NEt3) in water/EtOH at rt 
resulted in the clean formation of isoindole nitrone in 78 % yield (Scheme 25).  
 
 
Scheme 25 – Aza-conjugate addition of HA to a ortho α,β-unsaturated ester 61 
 
From this discovery, the conditions for the cyclisation reaction to form 62 were then 
optimised by screening different bases, solvents and different sources of hydroxylamine 
(HA). The optimal conditions were 1.1 equivalents of hydroxylamine (50% solution in 
water) in THF at -20 oC, which furnished 62 with a yield of 91 %. These conditions were 
then applied to the synthesis of more than 20 different examples providing excellent yields 




Scheme 26 – Proposed HA cyclisation mechanism 
 
2.1 Aim  
 
In this research, it was believed that the reactivity of HA with an aromatic aldehyde 
containing an adjacent ortho α,β-unsaturated ester could be used as a sensing strategy for the 
detection of HA. Therefore, the aim of this project was to develop a reaction based 
fluorescent probe for the detection of HA.  
 
2.2 Results and discussion 
At the start of this research program, there were no fluorescent probes for the detection of 
HA. HA is widely used in industrial and pharmaceutical processes72 and is widely known as 
a NO donor, that can participate in a wide range of biological processes.73-75 Therefore, a 
HA fluorescent probe would provide a useful tool for environmental (pollutant) and 
biological purposes.  
In cellular metabolism, it is believed that HA is an intermediate in the conversion of L-
arginine to NO.76, 77 As depicted in Scheme 27, the process involves the hydrolysis of the 
oxime of arginine to L-citruline and HA. HA is then converted by catalase to NO and 
superoxide (-O2 ) in the presence of H2O2.
78 It is also believed that non-enzymatic reaction 
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between HA and -O2 in inflammatory cells can take place to generate NO.
74, 79 HA has also 
shown to be a vasodilator in a dose-dependent manner in the blood vessels of rat kidneys80 
and as an inhibitor for the release of insulin and an activator of K+ channels (characteristic 
of NO production).74, 81 
 
Scheme 27 – Proposed pathway for the converision of L-arginine to NO82 
Despite HA being an intermediate in metabolism and a NO donor, it is also known to be 
moderately toxic to humans, animals and plants. The toxicity of HA only occurs at 
concentrations that are substantially greater than normal physiological concentration. 
Overexposure to HA has been shown to be hemotoxic, mutagenic and an inhibitor of 
enzymes and viruses.83 Therefore, this reinforces the need for the development of a 
fluorescent probe for the detection of HA, since this would enable the study of its biological 
activity in-vivo and provide a potential industrial and environmental monitoring system. 
Current reported analytical methods for HA are spectrophotometry, HPLC, GC, 
potientiometry, polarography, biamperometry and electrochemistry.84-91 
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Two BODIPY fluorescent probes containing an aromatic aldehyde and α,β-unsaturated ester 
ortho motif have been reported in the literature for the sensing of sulphide (H2S) in cells 
(Scheme 28).92, 93 
 
 
Scheme 28 – “Turn-on” fluorescent probes for the detection of sulphide 
 
63 was the chosen fluorescent probe that needed to be synthesised in 10 steps from O-TBS 
protected benzaldehyde 71. The first step involved acid-catalysed esterification of p-toluic 
acid using EtOH and H2SO4 to afford ester 65 that was then brominated at its benzyl position 
using a free radical reaction using N-bromosuccinimide (NBS), and benzoyl peroxide (BPO) 
in carbon tetrachloride (CCl4). Unfortunately, this bromination reaction resulted in formation 
of a mixture of mono-brominated 66 and dibrominated 67 products (Figure 6), which 




Figure 6 – Mono-brominated and dibrominated product 
 
Therefore, this mixture of mono- and dibrominated esters was taken onto the next step 
without purification. 66 was selectively hydrolysed using 4 equivalents of CaCO3 in 1:1 
dioxane/H2O at 100 
oC for 18 h to afford the desired alcohol 68 in relatively low yield. 
However, 68 could be purified by chromatography due to a large polarity difference with the 
unreacted dibromo side product. 68 was then protected using tert-butyldimethylsilylchloride 
(TBDMSCl) and imidazole in DMF to afford 69 in good yield. To access the desired 
aldehyde 71, 69 was then reduced with LiAlH4 (2.4 M in THF) and the resultant alcohol 
functionality 70 was oxidised using pyridinium chlorochromate (PCC) (Scheme 29). 
 
Scheme 29 – Synthesis of the desired aldehyde 
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Once isolated 71, it allowed us to use it as a substrate to construct the BODIPY fluorophore, 
which was carried out using a standard protocol involving treatment with 2,4-dimethyl-
pyrrole in the presence of DDQ and BF3.Et2O. This enabled 72 to be isolated in 41% yield 
after exhaustive purification, which was then used as a substrate to synthesise the final 
product (Scheme 30). With 72 in hand, the TBS protecting group was subsequently removed 
using TBAF, which provided 73 in modest yield (40 %). The alcohol functionality was then 
oxidised using PCC to produce 74 in a relatively low yield (35 %). A Heck reaction was then 
carried out with methyl acrylate to isolate the desired fluorescent probe 63 in a reasonable 
yield (55 %)  
 
 




Upon isolating 63, it was subjected to the optimised cyclisation conditions with HA, which 
underwent the desired aza-conjugate reaction to form 75 in quantitative yield (Scheme 31). 
The 1H NMR spectrum of the nitrone product is shown in Figure 8, with key diagnostic 




Scheme 31 – HA aza-conjugate addition with 63  
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Figure 8: NMR of nitrone 75 
 
Fluorescence experiments were then carried out in the same buffer solution used by Chuan 
and co-workers for their H2S fluorescence studies.
92 As shown in Figure 9, the time-curve 
experiments indicate that the reactivity of 63 with HA was concentration-dependent and not 
instantaneous. As illustrated in Figure 10 and Figure 11, the ability to detect HA was 
evaluated and the probe was shown to be capable of detecting HA at a concentration range 
between 0 and 20 micromolar with an overall 5.5x fold “turn on” response. The HA titration 
experiment was repeated three times to ensure the repeatability of these fluorescence results. 
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Figure 9 - Time curve of the fluorescence intensity with 63 (0.5 µM), and various concentrations of hydroxylamine (4 - 
Blue, 6 - Green, 8 – Red and 12 µM - Black) in pH = 7.4 PBS buffer solution 1% DMSO, slit width ex = 5 nm, em = 2.5 
nm. λex = 465 nm. λem = 510 nm 
 
 





































Figure 10 – Fluorescence spectra of 63 (0.5 µM) and addition of HA (0 – 20 µM) in pH = 7.4 PBS buffer solution 1% 


















Figure 11 - Fluorescence intensity changes (I/IO) for 63 (0.5 µM) with addition of HA (0 – 20 µM). PBS Buffer, 1% DMSO 
pH = 7.4. slit width ex = 5 nm, em = 2.5. λexc = 465 nm, λem = 510 nm. 5 min wait between additions.  
 
We then explored the scope of 63 with different hydroxylamines (Figure 12). It was 
discovered that 63 was able to detect N-benzyl or N-alkyl hydroxylamines (containing a 
primary hydroxylamine group). The addition of a N-alkylhydroxylamine is believed to result 
in the formation of a stable hemiaminal derivative (Scheme 32). This was further reinforced 
through mass spectral analysis for the addition N-methylHA to 63 (Mass spec ESI [M+H]+ 
– theoretical mass – 484.2218; found - 484.2255.  ESI [M+Na]+ – theoretical mass – 
506.2038; found – 506.2072).  
 















Figure 12 – Selectivity of 63 (0.5 µM) towards various hydroxylamines (1 – Hydroxylamine, 2 – N-
(methyl)hydroxylamine,  3 – N-(Benzyl)hydroxylamine, 4 – N-(Propargyl)Hydroxylamine, 5 – N-(tert-
Butyl)Hydroxylamine, 6 – O-(Benzyl)Hydroxylamine, 7 – N-(Phenyl)Hydroxylamine, 8 - Blank. 15 min incubation with 
each analyte (50 µM) in PBS Buffer, 1% DMSO pH = 7.4. slit width ex = 5 nm, em = 2.5 nm. λexc = 465 nm, λem = 510 nm. 
 
The addition of N-propargyl HA with 63 also resulted in an increase in fluorescence 
intensity. In 2001, Sharpless et al. developed methodology for a cycloaddition reaction 
between an alkyne and an azide that results in the formation of a 1,2,3 triazole.94 This 
methodology has now been used extensively in the literature as a method to “tag” specific 
molecules such as a fluorophore to a target compound. For example, Ju and co-workers 
developed a 6-carboxyfluorescein derivative 76 with an alkyne moiety attached, which 
underwent a ‘click’ reaction with an azido labelled single-stranded DNA 77 (ssDNA). This 
‘click’ product 78 was then used successfully as a primer to produce DNA sequencing 







Scheme 33 – 6-Carboxyfluorescein alkyne for the use in ‘click’ chemistry 
 
Therefore, the alkyne-hemiaminal has the capacity to undergo ‘click’ chemistry with a 
number of azide substrates, thus enabling it to be used as a fluorescent tag. If the azide-HA 






Scheme 34 – Formation of an alkyne hemiaminal derivative that could be a substrate for “click” chemistry 
 
When an O-alkyl-hydroxylamine was used as an analyte, then no change in fluorescence 
was observed, which is consistent with the proposed mechanism (Scheme 26) that requires 
the presence of a nucleophilic nitrogen and an exchangeable OH. It was also found that if 
the R group directly attached onto the nitrogen of the HA was aromatic (N-PhenylHA) or 
sterically demanding (N-tert-butylHA), then no change in fluorescence intensity was 
observed, which may be due to lower nucleophilicity of the aromatic HA and the increased 
steric hindrance of the sterically demanding HA. 
Lastly, we screened the probe against H2S, GSH and various amines. The overall selectivity 
is shown below in Figure 13. As expected, 63 displayed a large “turn on” response towards 
H2S. Therefore, in a complex biological environment it would be hard to distinguish between 
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HA and H2S. Treatment of 63 with glutathione (GSH) and various other amines resulted in 
no change in fluorescence, however a small fluorescence increase was observed when 63 
was incubated with a large concentration of the amino acid, cysteine (5 mM). 










Figure 13 - Overall selectivity of 63 (0.5 µM) with various hydroxylamines, amino acids, amines and sulphur containing 
compounds (1 – H2S (50 µM, 15 min), 2 – Hydroxylamine (50 µM, 15 min), 3 - N-(Methyl)Hydroxylamine (50 µM, 15 
min), 4 – N-(Benzyl)Hydroxylamine (50 µM, 15 min), 5 - N-(Propargyl)Hydroxylamine (50 µM, 15 min), 6 - N-(tert-
Butyl)Hydroxylamine (50 µM, 15 min), 7 - O-(Benzyl) Hydroxylamine (50 µM, 15 min), 8 – GSH (5 mM, 30 min), 9 – 
Cysteine (5 mM, 30 min), 10 - Methionine (5 mM, 30 min), 11 – Lysine (5 mM, 30 min), 12 – Serine (5 mM, 30 min), 13 
– Histidine (5 mM, 30 min), 14 – Tyrosine (5 mM, 30 min), 15 – Arginine (5 mM, 30 min), 16 – Proline (5 mM, 30 min), 
17 – Glycine (5 mM, 30 min), 18 – Glutamic acid (5 mM, 30 min), 19 – Blank in  PBS Buffer, 1% DMSO pH = 7.4. slit 
width ex = 5 nm, em = 2.5 nm. λex = 465 nm, λem = 510 nm. 
 
The ability of the probe to detect HA in cells was evaluated by our collaborator Professor 
Juyoung Yoon at EWHA Womans University in Seoul, South Korea. Unfortunately, due to 
its poor selectivity towards sulphur containing compounds there was no change in 
fluorescence intensity with the addition of exogenous HA (Figure 13). This observation is 
believed to be due to endogenous thiols being present at large concentrations (GSH - 




Figure 14 – HeLa cells were incubated with 0, 10, 50, 150 μM NH2OH for 30 min and washed with DPBS and incubated 
with 1 μM 63 for 30 min and acquired the fluorescence images by confocal microscopy. Ex. 473 nm/ em. 490-590 nm. 
Scale bar: 20 μm.  
 
2.3 Conclusion 
In summary, synthetic methodology that was developed by Bull et al. was used as a sensing 
strategy to develop a fluorescent probe for the detection of HA. The reactive motif was 
known in the literature for the detection of H2S and as expected there was a fluorescence 
change in the presence of H2S. 
1H NMR spectroscopy and fluorescence spectroscopy was 
used to demonstrate that 63 could react with HA. Selectivity studies were then carried out 
using a range of analytes, with no fluorescence changes observed for amines, GSH, N-
phenylHA and N-tert-butylHA. Interestingly, N-BnHA was shown to give a fluorescence 
response with 63 and an N-propargylHA was synthesised and shown to generate a 
fluorescence response on reaction with 63, which should allow it be used as a fluorescent 













3.0 Chapter Two: Boronate based ESIPT probes for the 
detection of Peroxynitrite 
 
In addition to the traditional fluorescence mechanisms that are discussed in 1.3.. A number 
of new sensing mechanisms are now emerging in the literature. These include aggregation-
induced emission (AIE), C=N isomerisation and excited state intramolecular proton transfer 
(ESIPT). The research described in this chapter, will focus solely on the use of ESIPT for 
fluorescent sensing, however, the reader is directed to some excellent reviews on the use of 
AIE and C=N isomerisation for fluorescent sensing.97-99 
The ESIPT process is depicted in Scheme 35, using 2-(2-hydroxyphenyl)-benzoxazole 
(HBO) as an example fluorophore. In the ground state, HBO adopts the enol form, which is 
stabilised by intramolecular hydrogen bonding. Upon excitation, the singlet excited state of 
the enol form is now populated. In the excited state, the enol form (E*) is quickly converted 
into its excited keto tautomer (K*) by ESIPT. As a result the fluorescence emission of the 
keto form occurs at a longer wavelength accompanied by a large Stokes shift. The keto form 
(K) then reverts back to the enol form in the ground state via a reversible proton transfer 
event.97  
 
Scheme 35 - The ESIPT process97 
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ESIPT-based fluorophores have been reported in the literature for use in a range of 
applications, which include molecular probes, molecular logic gates and luminescent 
materials.97, 100-102 These compounds include 2-(2-hydroxyphenyl)-benzoxazole (HBO), 2-
(2-hydroxyphenyl)-benzothiazole (HBT), 1-aminoanthraquinone (1-AAQ) and 3-
hydroxyflavone (3-HF). The popularity of these compounds is down to their good 
photophysical properties, which include intense luminescence, good photostability and a 
large Stokes shift. In the design of an ESIPT fluorescent probe, a “turn-on” probe can be 
achieved through the “blocking” of the hydrogen bond donor. An example of this 
“protection/deprotection” method was shown by G. Yang et al., in which, a HBT derived 
ratiometric ESIPT probe for the detection of fluoride ions in micellar solution was developed 
(Scheme 36). Enol-like emission was only observed when the phenol was protected as tert-
butyldiphenylsilyl ether (TBDPS). Addition of fluoride,  resulted in silyl deprotection and a 
ratiometric change in the absorption and emission spectra, thus providing a method to detect 
fluoride at very low levels.103 
 
 
Scheme 36 – The detection of fluoride using a HBT derived ESIPT fluorophore 
 
X. Li et al. developed a HBT derived fluorescent sensor for tracking in situ generated 
ONOO- in live cells and mice. The design of this HBT derived fluorophore was shown to be 
highly efficient as it provided a “turn-on” sensor 81 (600 fold), which was shown to be highly 
selective towards ONOO-, accompanied by the ability to penetrate the blood brain barrier.104 
X. Li and co-workers blocked the ESIPT process of 81 by incorporating a “protecting group” 
that was selective for cleavage by ONOO-. The p-hydroxyaniline protecting group reacts 
specifically with ONOO- through an oxidative cleavage process to form a benzoquinone 
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fragment105. Upon deprotection of 81, an ESIPT process take places with a large 
fluorescence increase being observed (Scheme 37).104 
 
 
Scheme 37 – Oxidative cleavage of a p-hydroxyaniline protecting group with ONOO-104  
 
Therefore, the use of a HBT derived core as an ESIPT fluorophore provides a new avenue 
for the synthesis of a range of selective sensors. Another protecting group strategy that can 
be employed to block the ESIPT process is the attachment of the widely used benzyl boronic 
ester. This motif has been employed successfully by a number of research groups.22, 68, 106 
An example is shown in Scheme 38, where treatment of the boronate ester fragment with 










In this research, we were interested in designing a number of new “turn on” ESIPT 
fluorescent probes for the detection of ONOO- using the benzyl boronate protecting group 
strategy shown above in Scheme 38. ONOO- has been shown to have a greater reactivity 
with boronates than HOCl/ClO- and H2O2, as discussed in 1.4.2.8. Therefore, we believed 
we could develop ‘off-on’ fluorescent probes with high selectivity and high sensitivity for 
ONOO-. The first target was the development of the HBT derived fluorescent probe 84 





Figure 15 – A novel boronate ESIPT probe 84   
 
3.2 Results and discussion 
The desired fluorescent probe shown in Figure 15, was synthesised over three steps. The 
first step of the synthesis involved reacting 2-aminothiophenol with isatoic anhydride to 
afford 2-(benzo[d]thiazol-2-yl)aniline 85. A one pot reductive amination was then carried 
out using sodium triacetoxyborohydride (NaBH(OAc)3, 2-(benzo[d]thiazol-2-yl)aniline and 
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde to afford boronate ester 86 in 
good 78% yield. Unfortunately, 86 was found to be particularly unreactive towards a number 
of alkylating conditions, including treatment with excess NaH and MeI. Therefore, reductive 
amination protocol was employed to obtain 84 in low yield, with a large excess of reagents 




Scheme 39 – Synthesis of 84 
 
With 84 in hand, UV/Vis and fluorescence experiments were performed in a PBS solution 
at pH = 8.2 containing 52.1 % MeOH. Initially, the UV-Vis of 84 displayed a low absorption 
at 380 – 400 nm, however, the addition of ONOO- resulted in the increase in UV absorption 
(Figure 16). From the results of the UV-Vis spectrum (Figure 16), an excitation wavelength 



























Figure 16 - UV spectra of 84 (10 µM), with and without ONOO- in pH 8.21 buffer solution [52.1 wt% methanol] 
 
As predicted, 84 was shown to detect ONOO- at micromolar concentrations with an increase 
in fluorescence intensity (4.5-fold) at 460 nm (Figure 17 and Figure 18). This is due to the 
oxidative cleavage of the benzyl boronic ester protecting group, which enables the ESIPT 
process to take place (Scheme 40). 
 
 







































Figure 17 – Fluorescence spectra of 84 (0.25 µM) with addition of ONOO- (0 – 10 µM) in pH = 8.21 buffer solution [52.1 
wt% methanol] at 25 oC. Fluorescence intensities were measured with λex = 400 nm with slit widths ex slit 10 nm and em 
slit 10 nm 
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Figure 18 - Fluorescence intensity changes (I/IO) for 84 (0.25 µM) with addition of ONOO- (0 – 10 µM). λex 400 nm/ λem 
461 nm in pH 8.2 buffer solution [52 wt% methanol]. Each measurement was made after 1 min with slit widths ex 10 nm 




Due to the complexity of a biological system containing various competing analytes, the 
selectivity of 84 was evaluated towards other ROS/RNS. HOCl/ClO- (100 µM) led to a 
decrease in fluorescence intensity (0.71), which is believed to be due to its strong oxidative 
ability, degrading 84 in a non-selective manner. As shown in Figure 19 and Figure 20, 15 
required larger concentrations of H2O2 (up to 14 Mm) to generate a fluorescence response. 
 
































Figure 19 - Fluorescence spectra of 84 (0.5 µM) with the addition of hydrogen peroxide (0-14 mM), λex 400 nm in pH 8.2 
buffer solution [52 wt% methanol]. Each measurement was made after 30 minutes.  Fluorescence intensities were 
measured with λex = 400 nm with slit widths ex slit: 10 nm and em slit 10 nm 
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Figure 20 - Fluorescence intensity changes (I/I0) for 84 (0.5 µM) with increasing concentrations of hydrogen peroxide 
(H2O2) λex 400 nm/ λem 461 nm in pH 8.2 buffer solution [52 wt% methanol] each measurement was made after 30 minutes 
with slit widths ex 10 nm and em slit:10 nm 
 



















































Figure 21 - Fluorescence spectra of 84 (0.25 µM) in the presence of various ROS/RNS: ONOO- (10 µM, 1 min), -OCl (100 
µM, 30 min), H2O2 (100 µM, 30 min), ROO. (100 µM, 30 min), NO (100µM, 1 min) -O2 (100 µM, 1 min), .OH (100 µM, 
1 min) λex 400 nm in pH 8.21 buffer solution [52.1 wt% methanol] with slit widths ex slit 10 nm and em 10 nm 
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Figure 22 – Selectivity bar chart of 84 (0.25 µM) with various ROS/RNS – (1 – ONOO_, 2 – H2O2, 3 – ClO-, 4 – KO2, 5 - 
ROO., 6 –  HO., 7 – 1O2, 8 – NO, 9 – Blank).  10 µM ONOO-, All other ROS 100 µM, H2O2, ClO- and ROO; incubated for 
30 mins, λex 400 nm/ λem 461 nm in pH 8.21 buffer solution [52.1 wt% methanol] with slit widths ex 10 nm and em10 nm 
 
Overall, 84 demonstrated excellent selectivity towards ONOO-. This enabled us to evaluate 
its ability to visualise endogenous and exogenous ONOO- using cell imaging experiments. 
84 was sent to our collaborator Professor Juyoung Yoon at EWHA Womans University in 
South Korea. HeLa cells were incubated with 84 (20 µM) for 30 minutes and washed with 
DPBS. Cells were observed using a confocal laser microscope (ex = 405 nm, em = 430 – 
455 nm). As depicted in Figure 23, 84 was cell permeable and provided a clear “turn on” 
response in the presence of exogenous ONOO-. No “turn on” was observed when cells 
containing 84 were pretreated with the ONOO- scavenger ebselen, which indicates the 






b  c  d 
 
Figure 23 - Fluorescence property in the live cell. HeLa cells were incubated with 20 μM 84 for 30 min and washed with 
DPBS and added (a) 0, (b) 30, (c) 100 μM ONOO- and (d) after pretreatment with 100 μM ebselen, add 100 μM ONOO- 
for 30 min. Fluorescence images were acquired by confocal microscopy. Ex. 405 nm/ em. 430 – 455 nm. Scale bar: 10 
μm.  
 
84 was shown to be able to detect endogenous ONOO- using RAW 264.7 cells when the 
cells were stimulated using 1 µg/mL LPS and 50 ng/mL IFN-γ, with no “turn on” being 
observed when 84 was pretreated with the ONOO- scavengers ebselen and uric acid (Figure 
c and d).  
 






Figure 24 - Detection of ONOO generated by immune reaction within the macrophage. RAW 264.7 cells were treated with 
(a) no, (b) 1 μg/ml LPS 16hr, 50 ng/ml interferon-γ 4hr, (c), LPS, IFN-γ + 100 μM ebselen and (d) LPS, IFN-γ + 100 μM 
uric acid. The cells were stained with 20 μM 84 for 30 min and washed with DPBS and imaged by confocal microscopy. 




The ability of 84 to detect exogenous ONOO- was evaluated at longer wavelengths in cells 
(ex = 473 nm and em = 490 – 590 nm) however, changes observed in fluorescence intensity 
were not as obvious (Figure 25).  
 
 






Figure 25 - Fluorescence property in the live cell. HeLa cells were incubated with 20 μM 84 for 30 min and washed with 
DPBS and added (a) 0, (b) 30, (c) 100 μM ONOO- and (d) after pretreatment with 100 μM ebselen, add 100 μM ONOO- 
for 30 min. Fluorescence images were acquired by confocal microscopy. Ex. 473 nm/ em. 490 – 590 nm.  
 
We then turned our attention towards the synthesis of benzyl boronic ester protected 3-HF 
fluorescence probes for the detection of ONOO-. 3-Hydroxyflavones (3HFs) are commonly 
found in natural plant sources.107 The most well-known 3HFs are quercetin 87 and 
kaempferol 88 (Figure 26).108 Quercetin and kaempferol have a number of health benefits, 
due to their ability to scavenge a number of ROS/RNS. As a result their consumption has 
been reported to have a beneficial effect on human health as they protect against ROS related 
diseases.109, 110  
 
 




In addition to their biological properties, 3HFs have been shown to be environmentally 
sensitive (solvatochromic) fluorescent dyes and they have been used extensively as 
fluorescent probes for the detection of a wide range of analytes.111-113 The attractiveness of 
these fluorescent dyes is because of their dual fluorescence emissions, which arise from the 
normal (N) and phototautomer (T*) forms formed in the ESIPT process.114 However, the 
ratio of the intensity of these two emission peaks are dependent on the surrounding 
environment of the molecule especially the polarity of the solvent.115 Therefore, a number 
of fluorescent probes were synthesised to identify the ideal fluorescence emission properties 
of this type of probe. 
 
 
Figure 27 – Normal and phototautomer forms from the ESIPT process 
 
We believed we could design a ‘turn on’ ratiometric probe for the detection of ONOO- by 
blocking the ESIPT process of 3HF fluorophores using a benzyl boronic ester protecting 
group. Three novel boronate 3HF fluorescent probes (89, 90 and 91) were synthesised using 
a simple two step synthesis, based on the oxidative cyclisation methodology developed by 
T. Ozturk et. al.115 To obtain the 3HF core unit, 2-hydroxyacetophenone was simply mixed 
with the chosen aldehyde and refluxed for three hours in a basic methanol solution. The 
reaction mixture was subsequently cooled to rt and treated with H2O2. After 1 hour, the 
reaction mixture was poured into ice-cold water and the 3HF precipitated out as a bright 
yellow solid and it was subsequently isolated via vacuum filtration. Once the three HFs were 
isolated, their alcohol functionalities were then alkylated with 2-(4-(bromomethyl)phenyl)-




Scheme 41 - Synthesis of 3HF ESIPT ONOO- probes 
 
We initially tested the ability of 89 to detect ONOO-, unfortunately, in aqueous buffer 
solution, the addition of ONOO- only led to a decrease in the emission intensity of N (425 
nm) with no T* emission peak being observed (Figure 29). It has been reported that, the N 
emission in aqueous media is favoured through intermolecular hydrogen bonding, thus 
explaining the absence of the T* emission peak.116 
 
Figure 28 – 89 ONOO- Probe 
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Figure 29 – Fluorescence spectra of 89 (1 µM) with addition of ONOO- (10 µM) in PBS buffer, 20 % DMSO and CTAB 
(2 mM) at pH = 8.00. λex = 370 nm. Slit widths ex = 10 nm and em = 8 nm.  
 
K. Bhattacharyya et al. reported that the presence of micelles can create a hydrophobic 
microenvironment within the micelle, that can enhance T* tautomer emission.117 Therefore, 
we decided to create a micellar environment for the 3HF fluorescent probe through addition 
of the surfactant cetyl trimethylammonium bromide (CTAB). The micellar enhancement 
process that was envisaged is shown below, with the micelles forming a hydrophobic pocket 






Scheme 42 – Simple diagram of micelle formation with a 3HF fluorescent probe 
 
Gratifyingly, the addition of ONOO- (10 µM) in the presence of CTAB (2 mM) led to a 




T* emission peak at 530 nm and a decrease in fluorescence emission at 425 nm. This enabled 
89 to be used to detect micromolar concentrations of ONOO, although only a relatively small 
increase in fluorescence intensity was observed (~ 4 fold).  




































Figure 30 - Fluorescence spectra of 89 (1 µM) with addition of ONOO- (10 µM) in PBS buffer, 20 % DMSO with CTAB 
(2 mM) at pH = 8.00. λex = 370 nm. Slit widths ex = 10 nm and em = 8 nm.  
 



































Figure 31 – Fluorescence spectra of 89 (1 µM) with addition of ONOO- (0 - 8 µM) in PBS buffer, 20 % DMSO with CTAB 



















Figure 32 – Fluorescence intensity changes (I/IO) of 89 (1 µM) with addition of ONOO- (0 - 8 µM) in PBS buffer, 20 % 
DMSO with CTAB (2 mM). pH = 8.00. λex = 370 nm/ λem = 530 nm. Slit widths ex = 10 nm and em = 8 nm 
 


















Figure 33 -Fluorescence intensity changes (I530/I425) of 89 (1 µM) with addition of ONOO- (0 - 8 µM) in PBS buffer, 20 % 
DMSO with CTAB (2 mM). pH = 8.00. λex = 370 nm/ λem = 530 nm. Slit widths exc = 10 nm and em = 8 nm 
 
In order to test the ability of 89 for the detection of ONOO-  in cells, selectivity experiments 
against various ROS were carried out. As shown in Figure 34, 89 demonstrated an excellent 
selectivity with a clear T* emission peak (530 nm) for ONOO-. However, the N emission 
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peak was found to be unstable, so each ROS measurement was determined immediately to 
avoid any anomalies. A similar  instability was also observed by Bai et al.112 


































Figure 34 -Fluorescence spectra of 89 (1 µM) in the presence of various ROS/RNS: ONOO- (10 µM, 1 min), -OCl (100 
µM, 1 min), H2O2 (100 µM, 1 min), ROO. (100 µM, 1 min), -O2 (100 µM, 1 min), .OH (100 µM, 1 min) in PBS buffer, 20 
% DMSO with CTAB (2 mM), pH = 8.00. λex = 370 nm/ λem = 530 nm. Slit widths exc = 10 nm and em = 8 nm 















Figure 35 - Selectivity bar chart of 89 (1 µM) with various ROS/RNS – (1 – ONOO_, 2 – H2O2, 3 – ClO-, 4 – KO2, 5 - 
ROO., 6 –  1O2, 7 – HO., 8 – Blank).  10 µM ONOO-, All other ROS 100 µM. in PBS buffer, 20 % DMSO with CTAB (2 




Due to the small change in fluorescence intensity for the T* emission peak of 89. We turned 
our attention onto the evaluation of the fluorescence properties of 90, with and without 
CTAB. Similar to what was observed for 89, addition of ONOO- without CTAB led to a 
decrease of the N emission peak (425 nm). However, an increase in the T* emission peak 
(530 nm) was observed, showing that this fluorescent probe is less sensitive to polar 
environments, in comparison to 89 (Figure 37). 
 
 
Figure 36 – 90 ONOO- probe 
 




































Figure 37 - Fluorescence spectra of 90 (5 µM) with addition of ONOO- (12 µM) in PBS buffer, 20 % DMSO in pH = 8.00. 




The addition of CTAB (2 mM) led to a significant change in fluorescence intensity for the 
T* emission peak, in comparison to the absence of CTAB (Figure 38), with the presence of 
micromolar concentrations of ONOO- resulting in a ratiometric fluorescence change 
(I530/I425). 
 





































Figure 38 - Fluorescence spectra of 90 (5 µM) with addition of ONOO- (10 µM) in PBS buffer, 20 % DMSO with CTAB 
(2 mM) in pH = 8.00. λex = 350 nm. Slit widths ex = 10 nm and em = 8 nm 





































Figure 39 - Fluorescence spectra of 90 (5 µM) with addition of ONOO- (0 - 15 µM) in PBS buffer, 20 % DMSO with 
CTAB (2 mM) in pH = 8.00. λex = 350 nm. Slit widths ex = 10 nm and em = 8 nm 
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Figure 40 - Fluorescence intensity changes (I/IO) of 90 (5 µM) with addition of ONOO- (0 – 15 µM) in PBS buffer, 20 % 
DMSO with CTAB (2 mM) in pH = 8.00. λex = 350 nm/ λem = 530 nm.  Slit widths ex = 10 nm and em = 8 nm 
 




















Figure 41 - Fluorescence intensity changes (I530/I420) of 90 (5 µM) with addition of ONOO- (0 – 15 µM) in PBS buffer, 20 
% DMSO with CTAB (2 mM) in pH = 8.00. λex = 350 nm/ λem = 530 nm.  Slit widths ex = 10 nm and em = 8 nm 
 
The selectivity of 90 for ONOO- was evaluated against other ROS with excellent selectivity 
being observed. These studies demonstrated that 90 is a suitable fluorescent probe for the 
detection of endogenous ONOO- in cell imaging experiments (Figure 42 and Figure 43). 
However, similar to 89, the N emission peak was found to be unstable. 
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Figure 42 - Fluorescence spectra of 90 (5 µM) in the presence of various ROS/RNS: ONOO- (10 µM, 1 min), -OCl (100 
µM, 1 min), H2O2 (100 µM, 1 min), ROO. (100 µM, 1 min), -O2 (100 µM, 1 min),.OH (100 µM, 1 min) in PBS buffer, 20 
% DMSO with CTAB (2 mM), pH = 8.00. λex = 350 nm/ λem = 530 nm. Slit widths ex = 10 nm and em = 8 nm 
 

















Figure 43 - Selectivity bar chart of 90 (5 µM) with various ROS/RNS – (1 – ONOO_, 2 – H2O2, 3 – ClO-, 4 – KO2, 5 - 
ROO., 6 –  1O2, 7 – HO., 8 – Blank).  10 µM ONOO-, All other ROS 100 µM. in PBS buffer, 20 % DMSO with CTAB (2 






Lastly, we tested the ability of 91 to detect ONOO- in the presence and absence of CTAB. 
The addition of ONOO- to 91 without CTAB led to a large increase of the T* emission peak 
(530 nm), with this observation indicating that that 91 is the least effected by polar solvents. 
 
Figure 44 – 91 ONOO- probe 



































Figure 45 – Fluorescence spectra of 91 (10 µM) with addition of ONOO- (10 µM) in PBS buffer 20 % DMSO pH = 8.00. 
λex = 350 nm. Slit widths ex = 10 nm and em = 10 nm 
 
Despite having a large T* fluorescence emission peak in the absence of CTAB, addition of 
ONOO- to 91 in the presence of CTAB further improved its fluorescence intensity, thus 
providing the best performance of all the probes evaluated. 
77 
 






































Figure 46 – Fluorescence spectra of 91 (10 µM) with addition of ONOO- (0 - 12 µM) in PBS buffer, 20 % DMSO with 
CTAB (2 mM). pH = 8.00. λex = 350 nm. Slit widths ex = 10 nm and em = 10 nm 
 
















Figure 47 - Fluorescence intensity changes (I/IO) of 91 (10 µM) with addition of ONOO- (0 - 12 µM) in PBS buffer, 20 % 
DMSO with CTAB (2 mM) in pH = 8.00. λex = 350 nm/ λem = 530 nm.  Slit widths exc = 10 nm and em = 10 nm 
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Figure 48 - Fluorescence intensity changes (I530/I425) of 91 (10 µM) with addition of ONOO- (0 - 12 µM) in PBS buffer, 
20 % DMSO with CTAB (2 mM). pH = 8.00. λex = 370 nm/ λem = 530 nm. Slit widths ex = 10 nm and em = 8 nm 
 
91 also demonstrated an excellent selectivity profile for peroxynitrite over other ROS, which 
permitted its use as a probe for cell imaging studies (Figure 49 and Figure 50).  
 


































Figure 49 - Fluorescence spectra of 91 (10 µM) in the presence of various ROS/RNS: ONOO- (10 µM, 1 min), -OCl (100 
µM, 1 min), H2O2 (100 µM, 1 min), ROO. (100 µM, 1 min), -O2 (100 µM, 1 min),.OH (100 µM, 1 min) in PBS buffer, 20 
% DMSO with CTAB (2 mM), pH = 8.00. λex = 350 nm/ λem = 530 nm. Slit widths ex = 10 nm and em = 10 nm 
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Figure 50 - Selectivity bar chart of 91 (10 µM) with various ROS/RNS – (1 – ONOO_, 2 – H2O2, 3 – ClO-, 4 – KO2, 5 - 
ROO., 6 –  1O2, 7 – HO., 8 – Blank).  10 µM ONOO-, All other ROS 100 µM. in PBS buffer, 20 % DMSO with CTAB (2 
mM), pH = 8.00. λex = 350 nm/ λem = 530 nm. Slit widths ex = 10 nm and em = 10 nm 
 
From the data described above, 89, 90 and 91 were considered to be potentially suitable for 
the detection of ONOO- in cells. However, each of these 3-HF fluorescent probe required 
the presence of CTAB to provide the best results, which makes them unsuitable for live cell 
imaging. However, it has been reported that environmentally sensitive fluorescent dyes can 
be used for imaging amyloid-β plaques (Aβ).118 Aβ plaques are considered as a key 
biomarker for Alzheimer’s disease (AD), which is one of the most common 
neurodegenerative diseases.119 These fluorescent dyes take advantage of the presence of 
multiple β-sheets that entropically form hydrophobic pockets.120 It is also believed that in 
AD, there is widespread ONOO- mediated damage.121 Therefore, the use of these 3-HF 
ONOO- fluorescent probes for AD would provide information on their surrounding 
environment (hydrophilic or hydrophobic) and could be a useful tool for the early diagnostic 
of AD and to understand the role of ONOO- in AD. The biological testing of these 
fluorescent probes is currently being carried out by Professor Xiao-Peng He at East China 






Overall, we have a developed a number of reaction based fluorescent ESIPT probes that can 
be used to detect ONOO- at very low concentrations. Before exposure to ONOO-, the 
fluorescent probes have a low fluorescence intensity due to the ESIPT process being blocked 
through the presence of a boronic ester “protecting group”. This boronic ester group is 
cleaved on exposure to ONOO-, which results in an increase in the probes fluorescence 
response. It is believed that these sensors may have applications in the biological field 
exploring the pathological effect of ONOO- that is produced in relatively hydrophobic 
regions of the cell. Furthermore, these probes could also be used as theranostic sensors 
towards tumour cells as shown by J. S. Kim et al., who developed a probe containing a 
boronic “protecting group” attached to an anti-cancer prodrug 5’-deoxy-5-fluorouridine for 
cancer cells.122 The proposed theranostic probe is shown below in Figure 51 
 
 





4.0 Chapter Three: Long-wavelength boronate 
fluorescent probes for the detection of peroxynitrite  
 
2-Dicyanomethylene-3-cyano-4, 5, 5-trimethyl-2, 5-dihydrofuran (TCF) possesses a strong 
electron withdrawing group, which provides the ideal properties for the development of a 
‘push-pull’ ICT fluorophore. The attachment of an electron donating moiety with TCF has 
been shown to provide long-wavelength, colorimetric ICT fluorescent probes.123-127 For 
example, B. Du et al. developed a TCF-based fluoride sensor using a fluoride-mediated 
deprotection reaction of the TBS protecting group of an alcohol group. As shown in Scheme 
43, when the phenol group is protected the ICT is poor and the probe is weakly fluorescent. 
However, addition of fluoride results in removal of the TBS protecting group, resulting in 
the ICT becoming stronger and the fluorescence intensity of the probe increasing.128 92 was 




Scheme 43 – A TCF-based fluorescent probe 92 for the detection of fluoride 
 
More recently, Li et. al. developed a novel TCF-based fluorescent probe 93 for the detection 
of Pd species.124 93 was shown to have low fluorescence when it had the Pd reactive allyl 
functionality attached. However, in the presence of Pd0 the probe was shown to be able to 
detect low concentrations of Pd0 with a colour change from yellow to purple, in conjunction 








The development of long wavelength/ near infrared (NIR) probes is of particular interest to 
our research because the use of longer excitation/ emission wavelengths enables deeper 
visualisation of tissues and less background auto-fluorescence from proteins. In addition, the 
use of longer wavelengths leads to less photodamage to biological samples. Therefore, in 
this research, we aimed to develop a long wavelength TCF-based boronate fluorescent probe 
for the detection of ONOO-.  It was believed that attachment of the previously used benzyl 
boronic ester unit shown in 3.0 to this TCF fluorophore shown in Scheme 43 and Scheme 
44 would provide an ‘off-on’ fluorescent probe for the detection of ONOO-. A similar TCF-
based aromatic boronate fluorescent probe had been reported for the detection of 
hypochlorite (ClO-).126 Therefore, the aim was to synthesise both boronate fluorescent 
probes (94 and 95) to evaluate the ability of these TCF fluorescent probes for the detection 
of ONOO- (Figure 52).  
 
Figure 52 – Target fluorescent probes for the detection of ONOO- 
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4.2 Results and discussion 
 
The first step of the synthesis required preparation of the TCF fluorophore. TCF (96) was 
synthesised by refluxing NaOEt, malonitrile and 3-hydroxy-3-methyl-2-butanone in EtOH 
for 2 hours, with the TCF fluorophore being isolated via filtration from the crude reaction 
mixture at room temperature. Upon isolating 96, we were able to synthesise 95 and 97 via 
aldol condensation chemistry developed by Bretonnière and co-workers.127 97 was then O-
alkylated with a bromobenzyl boronic ester unit using K2CO3 and NaI as a catalyst to afford 
94 in good yield (47 %) (Scheme 45).  
 
Scheme 45 – Synthesis of 94 and 95 
 
With 94 in hand, the UV-Vis and fluorescence titrations of 94 with ONOO- were performed. 
For these experiments, 94  required 20 % DMSO buffer solution due to it having relatively 
poor aqueous solubility. As shown in the UV-Vis spectra (Figure 53), the addition of 
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ONOO- led to a clear bathochromic shift of the UV absorption of 94 (460 – 590 nm). This 
change in the UV spectrum was accompanied by a colour change from yellow to purple. 
 

























Figure 53 - UV-Vis spectra of 94 (10 µM) with and without ONOO- in PBS buffer solution 20 % DMSO pH = 8.00 
 
94 was initially excited at 460 nm, which led to the observation of an emission peak at 550 
nm. However, the addition of ONOO- led to a decrease in fluorescence intensity at that 
emission wavelength. As seen in the UV-Vis spectra, an absorption peak appears at ~590 
nm after the addition of ONOO- therefore we decided to excite 94 at 560 nm. Subsequently, 
the addition of ONOO- led to a large fluorescence increase (> 6 fold) at 606 nm (Figure 55 
and Figure 56). In comparison to the previously developed ONOO- ESIPT fluorescent 
probes, 94 was considerably less sensitive towards ONOO- requiring larger concentrations 
of analyte to elicit a response. However, an excellent selectivity was observed for ONOO- 
over other ROS (Figure 57 and Figure 58). 
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Figure 54 - Fluorescence spectra of 94 (10 µM) with addition of ONOO- (100 µM) in PBS buffer 20 % DMSO pH = 8.00. 
λex = 460 nm. Slit widths ex = 10 nm and em = 15 nm 
 




































Figure 55 - Fluorescence spectra of 94 (10 µM) with addition of ONOO- (0 – 100 µM) in PBS buffer 20 % DMSO pH = 
8.00. λex = 560 nm. Slit widths exc = 10 nm and em = 15 nm 
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Figure 56 - Fluorescence intensity changes (I/IO) for 94 (10 µM) with addition of ONOO- (0 – 100 µM) in PBS buffer 20 
% DMSO, pH = 8.00. λex = 560 nm/ λem = 606 nm. Slit widths ex = 10 nm and em = 15 nm 
 





































Figure 57 - Fluorescence spectra of 94 (10 µM) in the presence of various ROS/RNS: ONOO- (100 µM, 1 min), -OCl (100 
µM, 30 min), H2O2 (100 µM, 30 min), ROO. (100 µM, 30 min), -O2 (100 µM, 1 min),.OH (100 µM, 1 min) λex = 560/ λem 
= 606 nm in PBS buffer 20 % DMSO, pH = 8.00, Slit widths ex = 10 nm and em = 15 nm 
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Figure 58 - Selectivity bar chart of 94 (10 µM), 100 µM for ROS/RNS – (1 – ONOO_, 2 – H2O2, 3 – ClO-, 4 – KO2, 5 -
1O2, 6 –  ROO., 7 – HO.) All ROS measured immediately except for H2O2, ClO- and ROO. incubated for 30 mins, λex 560 
nm/ λem 606 nm in PBS buffer 20 % DMSO, pH = 8.00 with slit widths ex = 10 nm and em = 15 nm 
 
Since 94 demonstrated excellent selectivity towards ONOO-, The ability of 94 to detect 
ONOO- in live cells was evaluated by Professor Xiao-Peng He at ECUST University in 
Shanghai, China. Unfortunately, 94 was insoluble and large amounts of precipitate was 
observed in the cell imaging experiments. Consequently, the use of 94 in cell imaging 
experiments was no longer pursued and we turned our attention to 95. 
 
 
Figure 59 – HEPG2 cells were incubated with probe 94 (10 μM, 30 min), then imaged (precipitates formed). The 
fluorescence images were recorded using an Operetta high-content imaging system (Perkinelmer, US) with an excitation 
wavelength of 520-590 nm and emission wavelength of 580-650 nm, and was quantified and plotted by columbus analysis 
system (Perkinelmer, US). 
 
95 had previously been reported for the detection of HOCl/ClO-, however, the selectivity of 
95 towards ONOO- was never reported. 95 is bright yellow in solution but with the addition 
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of ONOO- results in a bright purple solution, similar to 94. In the UV-Vis spectra shown in 
Figure 60, there was no UV absorption observed beyond 550 nm. However, the addition of 
ONOO- led to the appearance of a large UV absorption peak at ~590 nm. 
 




























Figure 60 - UV-Vis spectra of 95 (10 µM) with and without ONOO- in PBS buffer 20 % DMSO pH = 8.00 
 
Initially, the probe was excited at 460 nm, which resulted in a large fluorescence emission 
peak at 530 nm. Addition of ONOO- resulted in a decrease in fluorescence intensity and a 
small shift in emission wavelength (530 to 550 nm), with a small emission peak at 606 nm 
also being observed (Figure 61). 
89 
 


































Figure 61 - Fluorescence spectra of 95 (10 µM) with addition of ONOO- (10 µM) in PBS buffer 20 % DMSO. pH = 8.00. 
λex = 460 nm. Slit widths ex = 10 nm and em = 15 nm 
 
Due to the absence of an UV absorption peak at 560 nm, no fluorescence emission peak was 
observed at that excitation wavelength. However, the addition of ONOO- led to a large 
increase in fluorescence. 95 was shown to be as sensitive as the previous ESIPT probes and 
was able to detect much lower concentrations of ONOO- than 94. 




































Figure 62 - Fluorescence spectra of 95 (10 µM) with addition of ONOO- (0 – 10 µM) in PBS buffer 20 % DMSO pH = 




















Figure 63 - Fluorescence intensity changes (I/IFinal) for 95 (10 µM) with addition of ONOO- (0 – 10 µM) in PBS buffer 20 
% DMSO, pH = 8.00. λex = 560 nm/ λem = 606. Slit widths ex = 10 nm and em = 15 nm  
 
The ability of 95 to selectively detect exogenous and endogenous ONOO- in living cells, was 
then determined (Figure 64 and Figure 65). Surprisingly, only a small turn on response was 
observed for the detection of ClO-, with H2O2 (50 µM) shown to produce a reasonable 
fluorescence response after 30 minutes. However, the concentration difference between 
H2O2 and ONOO
- to elicit a fluorescent response was over 5-fold and required a significantly 
longer reaction time. Therefore, it was predicted that this selectivity profile might permit 95 
to be used for the detection of ONOO- in cell imaging studies. 
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Figure 64 - Fluorescence spectra of 95 (10 µM) in the presence of various ROS/RNS: ONOO- (10 µM, 1 min), -OCl (100 
µM, 30 min), H2O2 (50 µM, 30 min), ROO. (100 µM, 30 min), -O2 (100 µM, 1 min),.OH (100 µM, 1 min) λex 560 nm in 
PBS buffer 20 % DMSO, pH = 8.00, Slit widths ex = 10 nm and em = 15 nm 













Figure 65 - Selectivity bar chart of 95 (10 µM) – (1 – ONOO_, 2 – H2O2, 3 – ClO-, 4 – KO2, 5 -1O2, 6 –  ROO., 7 – HO.) 
All ROS measured immediately except for H2O2, ClO- and ROO.. ONOO- (10 µM), H2O2 (50 µM, wait for 30 min), All 
other ROS 100 µM. ClO- and ROO; incubated for 30 mins. λex =560 nm/ λem 606 nm in PBS buffer 20 % DMSO pH = 
8.00. Slit widths ex = 10 nm and em = 15 nm 
 
It was believed that the presence of DMSO in the buffer solution might be interfering with 
the hypochlorite (ClO-) measurement, since it was known that ClO- can oxidise sulfur 
containing compounds, therefore it was believed that the DMSO might have been further 




Scheme 46 – Oxidation of DMSO to dimethyl sulfone by ClO- 
 
Reassuringly, the addition of ClO- (100 µM) to 95 in 100 % PBS buffer pH 7.40 was shown 
to differ to the previous measurements in buffer containing DMSO. An instant increase in 
fluorescence intensity accompanied by a slight colour change was observed. However, a full 
turn-on response and a complete colour change was not observed, clearly demonstrating the 
selectivity of 95 towards ONOO- (Figure 66).  
 
































Figure 66 - Fluorescence spectra of 95 (10 µM) with addition of ClO- (100 µM) and ONOO (10 µM) in PBS buffer pH = 
7.4. λex = 560 nm. Slit widths ex = 10 nm and em = 15 nm 
 
95 was then sent to Professor Xiao-Peng He at ECUST to be evaluated in cell imaging 
experiments. Hep-G2 cells were incubated with 95 (10 µM) for 30 minutes and washed with 
PBS buffer solution three times. As shown in Figure 67, 95 was shown to be cell permeable 
in Hep-G2 cells and provided a clear ‘turn on’ response in the presence of 3-
morpholinosydnonimine (SIN-1 – ONOO- donor). No ‘turn on’ response was observed when 
95 was incubated with SIN-1 and uric acid (ONOO- scavenger). This indicates the 
requirement of ONOO- to generate a fluorescence response in cells. 
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Figure 67 - (a) Hep-G2 cells were incubated with 95 (10 μM, 30 min), then imaged. (b) Hep-G2 cells were pretreated with 
probe 95 (10 μM, 30 min), subsequently incubated 3-morpholinosydnonimine (SIN-1, a ONOO- donor. 0.5 mM, 30min), 
then imaged (c) Hep-G2 cells were pretreated with  95 (10 μM, 30 min), subsequently incubated 3-morpholinosydnonimine 
(SIN-1, a ONOO- donor. 0.5 mM, 30min), finally incubated with uric acid (ONOO- scavengers. 100 μM, 30 min), then 
imaged. (d) Quantification of Hep-G2 cells with 95 (10 μM) in the absence or presence of SIN-1 and uric acid. The 
fluorescence images were recorded using an Operetta high-content imaging system (Perkinelmer, US) with an excitation 
wavelength of 520-590 nm and emission wavelength of 580-650 nm, and was quantified and plotted by columbus analysis 
system (Perkinelmer, US). 
 
It is known that H2O2 is a metabolic by-product in a number of enzymatic reactions. Due to 
the excellent reactivity of 95 towards H2O2, it was decided to employ it as a probe to develop 
a glucose oxidase (GOx) assay. Currently, there are only a limited number of small-molecule 
fluorescent probes that can be used to detect glucose using GOx.129-131 GOx catalytically 
converts glucose to gluconolactone with the production of H2O2. The development of a 95 
GOx assay would allow the indirect measurement of the glucose concentration in a specific 
sample.  
 
Scheme 47 – GOx catalytic pathway  
 
As shown below in Figure 68, 95 was successful in detecting H2O2 that was produced by 
the GOx enzyme using different concentrations of glucose. Interestingly, the reactivity of 









addition of GOx to glucose led to an immediate fluorescence increase with minimal lag time, 
which indicates the conversion of glucose being instantaneous. As shown in Figure 68, 
Figure 69 and Figure 70, the increasing additions of glucose led to an increase in 
fluorescence intensity. From these results, it was shown that 95 was able to detect glucose 
in the range of 0 – 2 mM. 
 






































Figure 68 - Time drive of 95 (10 µM) with addition of glucose (0 – 10 mM) and Glucose oxidase (10 U/mL) in PBS buffer 







































Figure 69 - Fluorescence spectra of 95 (10 µM) with addition of glucose (0 – 2 mM) and GOx (10 U/mL) in PBS buffer 
solution pH = 7.4. λex = 560 nm.  The measurements were made 30 min after glucose addition. Slit widths ex = 10 nm and 
em = 15 nm 














Figure 70 – Fluorescence intensity changes (I/IFinal) for 95 (10 µM) with addition of glucose (0 – 2 mM) and GOx (10 
U/mL) in PBS buffer solution pH = 7.4. The measurements were made 30 min after glucose addition. λex = 560 nm/ λem = 









Overall, we have developed two TCF-based fluorescent boronate probes for the detection of 
ONOO-. 94 was shown to have excellent selectivity towards ONOO-. Unfortunately, 94 
lacked sensitivity towards ONOO- and was shown to have poor aqueous solubility, which 
resulted in the formation of insoluble precipitates in cell imaging experiments. On the other 
hand, 95 was shown to be very sensitive towards ONOO- with the ability to detect very low 
concentrations of ONOO-. 95 was also shown to be sensitive towards H2O2. More 
importantly, 95 was permeable to Hep-G2 cells conferring it with the ability to detect SIN-
1 generated ONOO-. 95 was further applied as a probe for the indirect determination of 
glucose utilising the GOx enzyme that produces H2O2 when it oxidises glucose to 
glucolactone. 95 was shown to be able to used as a probe to detect glucose in a concentration 






5.0 Chapter Four: Dual-analyte fluorescent probe for the 
detection of ONOO- and GSH 
 
As discussed previously, ONOO- is a powerful oxidant with a wide range of biological 
targets, including glutathione (GSH).66 GSH is a natural tripeptide (γ-L-glutamyl- L-
cysteinyl-glycine), which exists in the thiol reduced form (GSH) and disulphide-oxidised 
(GSSG) form. GSH is the predominant form, existing in millimolar concentrations in most 
cells where it functions as an antioxidant.96 GSH is directly oxidised by ONOO-, therefore 
GSH acts as a cellular defence against ONOO- by serving as an effective ONOO- scavenger. 
Elevated levels of GSH are common in the presence of oxidative stress and the susceptibility 
of a cell towards ONOO- largely depends on the concentration of intracellular GSH 
present.66, 132, 133 In this work, we were interested in the development of a dual-activated 
fluorescent probe to further understand the relationship between GSH and ONOO-. Most 
fluorescent probes require a single analyte to produce a fluorescence response (GSH or 
ONOO-), with an example of a single analyte probe for the detection of GSH shown below 
in Figure 71.68, 134-138  
 
 
Figure 71 – NIR fluorescent probe 98 for the detection of GSH developed by James et. al.134 
 
In recent years, a number of fluorescent probe for dual or multi-analyte detection have been 
developed.6, 41, 139-142 These fluorescent probes have been used for applications as molecular 
logic gates, or as probes for medical diagnostics. The dual-activation (multi) of a fluorescent 
probe requires both analytes being present and working in tandem in order to create a 
fluorescence response. This method has number of advantages, including being faster for the 
serial measurements for different analytes within the same biological sample, or as a method 
98 
 
for the monitoring bimolecular events that may contribute to specific diseases.6 Current dual 
GSH/ONOO- fluorescent probes include a near-infrared (NIR) reversible selenium based 
fluorescent probe for the monitoring of ONOO- oxidation and reduction events developed 
by Han et. al.143 with the fluorescence of the CyPSe (100) probe being quenched by a 
photoinduced electron transfer (PET) process. The presence of ONOO-, oxidises selenium 
to CyPSe=O (101) causing the fluorescence emission to be ‘turned on’. When 101 is exposed 
to thiols such as cysteine and GSH, the probe is reduced back to its non-fluorescent selenide 
form (Scheme 48). These oxidation and reduction processes could be observed in live cells. 
Following on from this work, Han and co-workers developed a similar reversible NIR 
Tellurium-based fluorescent probe for monitoring the redox cycles between ONOO- and 
GSH. This probe was successfully applied for the visualisation of the redox cycles of ONOO- 
and GSH in living cells and animals.144 
 
 
Scheme 48 – A selenium based reversible NIR fluorescent probe 100 for the monitoring of ONOO- and GSH 
 
More recently, Zhao et al. developed a dual responsive fluorescent probe (102) for the 
detection of thiols and H2O2.
145 102 consists of a non-fluorescent diboronate xanthene 
isobenzofuran attached to a coumarin unit via a disulphide link. The presence of thiols results 
in cleavage of the disulphide link, which terminate the PET process leading to a ‘turn on’ 
fluorescence response from the coumarin unit. Alternatively, the addition of H2O2 results in 
the formation of fluorescein, converting the PET process to an intramolecular FRET process. 
Cellular imaging experiments demonstrated the probes ability to detect both endogenous 









In this research project, we aimed to develop a ‘dual-activated GSH-ONOO- fluorescent 
probe, which we believed could be achieved using Chang et al. boronate fluorescein based 
probe 106 shown in Figure 72.40 The reactivities of boronates with ONOO- are significantly 
greater than hypochlorite (ClO-) and H2O2,
67 therefore it was decided to attach the GSH 




Figure 72 – 106 and 107 fluorescent probes for the detection of H2O2. 
 
5.2 Results and discussion 
 
106 and 108 were synthesised in three steps according to literature precedent. Fluorescein 
was triflated using N-phenyl-bis(trifluoromethanesulfonamide) and DIPEA to afford 
fluorescein mono-triflate 109 in good yield. Pd(0) mediaited Suzuki-Miyaura coupling with 
B2Pin was then carried out to afford the known fluorescein mono-boronate 106. 2, 4-
dinitrobenzenesulfonyl was subsequently attached to 106 via its reaction with 2, 4-
dinitrobenzenesulfonyl chloride, DCM and NEt3 at 0 
oC. These conditions furnished 108 in 





Scheme 50 – Synthesis of 108 
 
Once 108 was isolated, the fluorescence experiments for the detection of GSH and ONOO- 
were carried out. As shown in Figure 73, 108 is initially non-fluorescent, with the addition 
of ONOO- (10 µM) resulting in a small fluorescence increase. However, subsequent 
incremental addition of GSH resulted in a much larger increase in fluorescence intensity (> 
30 fold) (Figure 73 and Figure 74). Thus demonstrating the requirement for both GSH and 
ONOO- being present in order to achieve a full ‘turn-on’ response. An illustration of the 




Scheme 51 – Reaction of 108 with both GSH and ONOO- to form the highly fluorescent fluorescein 
 






































Figure 73 - Fluorescence spectra of 108 (0.5 µM) with addition of ONOO- (10 µM) followed by the addition of GSH (0 - 
80 µM), 5 min wait between addition in buffer solution [52 wt% methanol]. pH = 8.21 at 25 oC. Fluorescence intensities 
were measured with λex = 488 nm with slit widths ex 5 nm and em 2.5 nm 
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Figure 74 - Fluorescence intensity changes (I/IONOO-) for 108 (0.5 µM) with addition of ONOO- (10 µM) followed by the 
addition of GSH (0 - 80 µM), 5 min wait between addition in buffer solution [52 wt% methanol]. pH = 8.21 at 25 oC. 
Fluorescence intensities were measured with λex = 488 nm/ λem = 512 nm with slit widths ex 5 nm and em 2.5 nm 
 
The selectivity of 108 was evaluated against a series of amino acids. Unsurprisingly, the 
probe also responded to the other sulfydryl containing amino acid cysteine. 108 displayed 
an excellent selectivity over other amino acids including serine, methionine and lysine. 







































Figure 75 – Fluorescent spectra of 108 (0.5 µM) with addition of ONOO- (10 µM) then addition of GSH, Cysteine and 
various other amino acids (100 µM). 5 min wait before measurement in buffer solution [52 wt% methanol].  pH = 8.21 at 
25 oC. Fluorescence intensities were measured with λex = 488 nm/ λem = 512 nm. Slit widths with ex slit: 5 nm and em slit: 
















Figure 76 - Selectivity bar chart of 108 (0.5 µM) with addition of ONOO- (10 µM) then addition of various amino acids - 
100 µM (1- GSH, 2 – Cys, 3 – Met, 4 – Tryp, 5 – Ser, 6 – Lys, 7 – Leu, 8 – Glu, 9 – Val, 10 – Arg, 11 – His, 12 – Asp, 13 
– Blank). 5 min wait before measurement in buffer solution [52 wt% methanol]. pH = 8.21 at 25 oC. Fluorescence intensities 
were measured with λex = 488 nm/ λem = 512 nm with Slit Widths ex 5 nm and em 2.5 nm.  
 
In order to demonstrate that 108 required both GSH and ONOO- for a complete ‘turn-on’ 
response, the fluorescence experiments were performed in reverse. Therefore, an excess of 
GSH (200 µM) was added to 108 and the probe was incubated for 10 min. Remarkably, this 
only led to a small increase in fluorescence intensity, with subsequent additions of ONOO- 
resulting in a large fluorescence increase (Figure 77 and Figure 78). This result confirms 
that the probe requires both GSH and ONOO- for a full fluorescent ‘turn-on’ response. 
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Figure 77 - Fluorescence spectra of 108 (0.5 µM) with addition of GSH (200 µM) wait 10 min then addition of ONOO- 
(0 - 10 µM) in buffer solution [52 wt% methanol], pH = 8.21 at 25 oC. Fluorescence intensities were measured with λex = 
488 nm with slit widths ex slit: 5 nm and Em slit: 2.5 nm  















Figure 78 - Fluorescence intensity changes (I/IGSH) for 108 (0.5 µM) with addition of GSH (200 µM) wait 10 min then 
addition of ONOO- (0 - 10 µM) in buffer solution [52 wt% methanol], pH = 8.21 at 25 oC. Fluorescence intensities were 







108 demonstrated excellent selectivity for ONOO- over other ROS including H2O2 (Figure 
79 and Figure 80), which enabled it to be explored in cell imaging experiments. 





































Figure 79 – Fluorescent spectra of 108 (0.5 µM) with addition of GSH (200 µM) wait 10 min then addition of ONOO- (10 
µM) and various ROS (100 µM) in buffer solution [52 wt% methanol] pH = 8.21 at 25 oC. Fluorescence intensities were 
measured with λex = 488 nm with slit widths Ex slit: 5 nm and Em slit: 2.5 nm 











Figure 80 - Selectivity bar chart of 108 (0.5 µM) with addition of GSH (200 µM) wait 10 min then addition of various 
ROS 100 µM (1 – ONOO- (10 µM), 2 – H2O2, 3 – ClO-, 4 – KO2, 5 – 1O2, 6 – HO., 7 – ROO.) in buffer solution [52 wt% 
methanol], pH = 8.21 at 25 oC. Fluorescence intensities were measured with λex = 488 nm\ λem = 512 nm with Slit Widths 




108 was sent to Professor Xiao-Peng He at ECUST to carry out cell imaging experiments. 
Initially, 108 was incubated in Hep-G2 cells, where it was seen to exhibit good aqueous 
solubility and cell permeability properties. No fluorescence response was observed on 
treatment with GSH (Figure 82, b), whilst incubation with SIN-1 (ONOO- donor) also only 
led to a small fluorescence increase. However, simultaneous treatment with both GSH and 
SIN-1 with 108 led to a clear fluorescence response in Hep-G2 cells, agreeing with the 
analytical data obtained previously using our fluorimeteric assay. 
 
Figure 81 - (a) Cells were incubated with 108 (10 μM, 30 min), then imaged. (b) Cells were pretreated with 108 (10 μM, 
30 min), subsequently incubated GSH (0.3 mM, 30min), then imaged (c) Cells were pretreated with probe 108 (10 μM, 30 
min), subsequently incubated 3-morpholinosydnonimine (SIN-1, a ONOO- donor. 0.5 mM, 30min), then imaged. (d) Cells 
were pretreated with 108 (10 μM, 30 min), subsequently incubated the mixture of GSH (0.3 mM), and 3-
morpholinosydnonimine (SIN-1, a ONOO- donor. 0.5 mM, 30min), then imaged. (e) Quantification of Hep-G2 cells with 
108 (10 μM) in the absence or presence of GSH and SIN-1. Fluorescence images were recorded using an Operetta high-
content imaging system (Perkinelmer, US) with an excitation wavelength of 460-490 nm and emission wavelength of 580-
650 nm, and was quantified and plotted by columbus analysis system (Perkinelmer, US). 
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5.3 Conclusion and Future work 
 
Overall, we have developed novel fluorescent probe 108 for the simultaneous detection of 
ONOO- and GSH that incorporates commercially available fluorescein, and the GSH 
reactive 2,4-dinitrobenzenesulfonyl motif and the previously reported H2O2 fluorescent 
probe, 106.  108 produced no fluorescent response when GSH or ONOO- were added 
individually, however, when the probe was exposed to both analytes there was a > 40-fold 
increase in fluorescence. 108 demonstrated excellent selectivity for the combination of GSH 
and ONOO-, which enabled us to evaluate the probe for cell imaging experiments. The probe 
was cell permeable for Hep-G2 cells and only gave a small ‘turn-on’ response for the 
individual addition of either GSH or ONOO-.  However, a clear fluorescence response was 
observed in cells when both analytes were present. In summary, 108 is an easy to prepare 
fluorescent probe that provides a platform for the development of other dual-activated 
fluorescent probes. Additionally, the use of 6-carboxyfluorescein provides an opportunity to 
further attach other fluorophores for dual-activated ratiometric fluorescence sensing 










6.0 Chapter Five: Development of resorufin based 
fluorescent probes for the detection of ONOO- 
 
As discussed previously in 1.4.2.2, Chang et al. developed a range of fluorescent sensors for 
the selective detection of H2O2 (24, 25 and 26).
38 These boronate sensors are all non-
fluorescent compounds, whose aromatic boronate units are oxidised on exposure to H2O2 to 
produce aromatic phenol groups that result in strong fluorescence. These fluorescent probes 
were shown to be cell permeable and exhibited the ability to detect low concentrations of 
H2O2 in live cells. 
 
 
Figure 83 – Boronate fluorescent probes for the detection of H2O2 
 
More recently, Yin et al. developed a 3,7-dihydroxyphenoxazine fluorescent probe, which 
uses a benzyl boronic ester protecting group to detect H2O2 in live cells.
146 The addition of 
H2O2 results in the elimination of the benzyl boronic ester protecting group to form the highly 




Scheme 52 - 3,7-Dihydroxyphenoxazine fluorescent probe (110) for the detection of H2O2 
 
6.1 Aim  
 
In this chapter, our attention was focussed on functionalisation of the N-H position of the 




Figure 84 – Proposed synthetic target 25 for further functionalisation  
 
6.2 Results and discussion  
The literature route to obtain 25 involved a very low yielding first step, which used harsh 
conditions (hydrobromic acid (HBr)) (Scheme 53). Therefore, we decided to pursue an 




Scheme 53 – Literature synthesis of 25 
The first step of the synthesis was the alkylation of the phenoxazine core with benzyl 
bromide, which required the use of the strong base - sodium hydride (NaH) to afford 112. 
112 was subsequently dissolved in CHCl3 and NBS was added portionwise to afford the 
dibrominated intermediate 113. Lastly, Suzuki-Miyaura conditions were then applied using 
bis(pinacolato)diboron (B2pin2) as a boron transfer agent to furnish benzyl protected 114. 
 
Scheme 54 – Synthesis of 114 
112 
 
As expected the addition of ONOO- to 114, resulted in no fluorescence increase at the 
emission wavelength of resorufin (590 nm). This result confirmed the importance of the free 
N-H of 32 for an appropriate fluorescent response. 
 



































Figure 85 - Fluorescence spectra of 114 (50 nM) with ONOO- (10 µM) in pH 8.21 buffer solution [52.1 wt% methanol. 
Fluorescence intensity were measured with λex = 550nm with slit widths ex slit: 10 nm and em slit:10 nm 
 
114 enabled us to access 25 through an alternative synthetic route avoiding the undesirable 
low yielding literature conditions. Treating 114 with 10 mol % Pd/C and H2 in a 1:1 
THF/MeOH solution resulted in successful cleavage of the benzyl fragment furnishing the 
desired 25 in essentially quantitative yield. 
 
 
Scheme 55 – Pd/C Benzyl deprotection to afford 25 
113 
 
With 25 in hand, we attempted to further functionalise the N-H moiety. Unfortunately, 25 
was found to be unreactive towards a number of alkylation conditions including the use of 
NaH and common electrophiles.  Nevertheless, the fluorescence studies of 25 were carried 
to evaluate its ability to detect H2O2 and ONOO
-. As shown in Figure 86 and Figure 87, an 
increase in fluorescence intensity was observed with H2O2. However, 25 was shown to lack 
sensitivity towards H2O2 requiring millimolar concentrations to achieve fluorescence 
saturation. 
 
































Figure 86 - Fluorescence spectra of 25 (50 nM) with the addition of hydrogen peroxide (0–1.6 mM). λex 550 nm in pH 


















Figure 87 - Fluorescence intensity changes (I/IFinal) for 25 (50 nM) with increasing concentrations of hydrogen peroxide 
(H2O2). λex 550 nm/ λem 590 nm in pH 8.2 buffer solution [52 wt% methanol]. Each measurement was made after 30 min. 
Slit widths: ex 10 nm and em 10 nm 
 
The selectivity of 25 towards ONOO- has never been reported. As shown in Figure 88, 25 
displays a high sensitivity for ONOO- having the ability to detect micromolar concentrations. 
This result demonstrated that 25 exhibits excellent selectivity towards ONOO- over H2O2, 
with Figure 90 and Figure 91, 25 also revealing that ONOO- displayed excellent selectivity 





































Figure 88 - Fluorescence spectra of 25 (50 nM) with addition of ONOO- (0 – 10 µM) in pH = 8.21 at 25 oC. Fluorescence 
intensities were measured with λex = 550nm in pH 8.2 buffer solution [52 wt% methanol]. Slit widths Ex slit: 10 nm and 
Em slit:10 nm 














Figure 89 - Fluorescence intensity changes (I/IFinal) with 25 (50 nM) and additions of ONOO- (0 – 10 µM) in PBS Buffer 
pH = 8.21 at 25 oC. Fluorescence intensities were measured with λex = 550nm/ λem 590 nm in pH 8.2 buffer solution [52 
wt% methanol]. Slit widths with ex slit: 10 nm and Em slit: 10 nm 
116 
 








































Figure 90 - Fluorescence spectra of 25 (50 nM) in the presence of various ROS/RNS: ONOO- (10 µM, 1 min), -OCl (100 
µM, 30 min), H2O2 (500 µM, 30 min), ROO. (100 µM, 30 min), NO (100 µM, 1 min) -O2 (100 µM, 1 min),.OH (100 µM, 
1 min) λex 550 nm/ λem 590 nm in pH 8.2 buffer solution [52 wt% methanol]. Slit widths with ex 10 nm and em 10 nm 














Figure 91 - Selectivity bar chart of 25 (50 nM) in the presence of various ROS/RNS: 1- ONOO- (10 µM, 1 min), 2 - H2O2 
(500 µM, 30 min), 3 - -OCl (100 µM, 30 min), 4 - -O2 (100 µM, 1 min), ), 5 -.OH (100 µM, 1 min), 6 - 1O2 (100 µM, 1 
min),     7 - ROO. (100 µM, 30 min), 8 - NO (100 µM, 1 min). λex 550 nm/ λem 590 nm in pH 8.2 buffer solution [52 wt% 
methanol]. 
 
Therefore, it was decided to develop methodology to enable 25 analogues to be prepared 
that contained oxidative cleavable N-benzyl substituents based on the benzyl boronate 
protecting group described previously in Chapter 2 and 3. Similar to the synthesis of 25, 
117 
 
the first step of the synthesis was to alkylate phenoxazine with 4-bromobenzyl bromide using 
NaH in DMF (Scheme 56).   
 
 
Scheme 56 – Alkylation of phenoxazine with 4-bromobenzyl bromide to afford 115 
 
115 was then dissolved in CHCl3, followed by portionwise addition of NBS with 
dibromination proceeding smoothly and 116 was isolated through aqueous work up requiring 
no purification. 116 was then subjected to a Suzuki-Miyaura reaction with 3 equivalents of 
(BPin)2 to furnish benzyl tris-boronic ester 117 in a modest yield (36 %) (Scheme 57).   
 
  




Exposure of an aqueous buffer solution of 117 to H2O2, resulted in a visual colour change 
from a clear solution to a pink solution, clearly demonstrating the oxidation of all three of 
the boronates contained in 117 to form the biological dye resorufin  (Scheme 58). This 
observation was further confirmed through the evaluation of its fluorescence response, with 
the presence of H2O2 resulting in an increase in fluorescence at 590 nm. However, millimolar 
concentrations (1.6 mM) of H2O2 were required to reach fluorescence saturation levels, 








Scheme 58 – Colorimetric change of 117 using H2O2 to form highly fluorescent resorufin  
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Figure 92 - Fluorescence spectra of 117 (50 nM) with the addition of hydrogen peroxide (0–1.6 mM). λex 550 nm in pH 
8.2 buffer solution [52 wt% Methanol]. Each measurement was made after 30 min with slit widths ex 10 nm and em 10 nm 
 


















Figure 93 - Fluorescence intensity changes (I/IFinal) for 117 (50 nM) with increasing concentrations of hydrogen peroxide 
(H2O2). λex 550 nm/ λem 590 nm in pH 8.2 buffer solution [52 wt% methanol]. Each measurement was made after 30 min 
with slit widths ex 10 nm and em 10 nm 
 
117 was then evaluated with ONOO- and displayed a clear fluorescence “turn on” response 
for the addition of micromolar concentrations of ONOO-. 117 was shown to have an 
120 
 
improved selectivity in comparison to 25. As shown in Figure 96, 117 displayed an excellent 
selectivity for ONOO- over H2O2. 

































Figure 94 - Fluorescence spectra of 117 (50 nM) with addition of ONOO- (0 – 10 µM) in pH 8.2 buffer solution [52 wt% 
methanol]. Fluorescence intensities were measured with λex = 550nm with slit widths ex 10 nm and em 10 nm 
 















Figure 95 - Fluorescence intensity changes (I/IFinal) with 117 (50 nM) and additions of ONOO- (0 – 10 µM) in pH 8.2 buffer 







































Figure 96 - Fluorescence spectra of 117 (50 nM) in the presence of various ROS/RNS: ONOO- (10 µM, 1 min), -OCl (100 
µM, 30 min), H2O2 (500 µM, 30 min), ROO. (100 µM, 30 min), 1O2 (100 µM, 1 min), NO (100 µM, 1 min), -O2 (100 µM, 
1 min), .OH (100 µM, 1 min) λex 550 nm/ λem 590 nm in pH 8.2 buffer solution [52 wt% methanol] with slit widths ex 10 
nm and em 10 nm 
 
 














Figure 97 - Selectivity bar chart of 117 (50 nM) in the presence of various ROS/RNS: 1 - ONOO- (10 µM, 1 min), 2 - -OCl 
(100 µM, 30 min), 3 - H2O2 (500 µM, 30 min), 4 - -O2 (100 µM, 1 min), 5 - ROO. (100 µM, 30 min), 6 -.OH (100 µM, 1 
min), 7 - 1O2 (100 µM, 1 min),   8 - NO (100 µM, 1 min). λex 550 nm in pH 8.2 buffer solution [52 wt% methanol] with slit 
widths ex 10 nm and em 10 nm 
Overall, 117 and literature reported 25 can both be used to detect ONOO- at low 
concentrations. However, 117 demonstrates a greater sensitivity towards ONOO- (Figure 
122 
 
98) and an improved overall selectivity towards other ROS therefore making it the better 
probe to use for the detection of ONOO-. 


















Figure 98 - Fluorescence intensity changes (I/IFinal) with 25 (50 nM) versus 117 (50 nM) and additions of ONOO- (0 – 10 
µM) in pH 8.2 buffer solution [52 wt% methanol]. Fluorescence intensities were measured with λex = 550nm/ λem 590 nm 
with slit widths ex = 10 nm em = 10 nm 
 
6.2.1 Phenothiazine analogues of 35 and 32 
 
Recently, Cao et al. developed an aggregated-induced emission phenothiazine probe for the 
selective ratiometric detection of hypochlorite (ClO-).147 This fluorescent probe was 
analogous to 25 and 117, but with a phenothiazine core and the N-H functionalised with a 
quarternary phosphonium salt, which was used to prevent aggregation. Exposure to ClO- 
resulted in the sulfur atom of 118 being oxidised to a sulfone unit 119 accompanied with a 




Scheme 59 – A boronate phenothiazine probe for the ratiometric detection of hypochlorite 
 
Based on this literature precedent, we thought that the synthesis of a phenothiazine version 
of 25, would result in a new fluorescent probe for the detection of ONOO- 120 (Figure 99).  
 
 
Figure 99 – A boronate phenothiazine fluorescent probe 120 
 
120 was synthesised over two steps, starting from the inexpensive starting material 
phenothiazine (£74.30 for 1 Kg, Aldrich),148 which was dissolved in acetic acid (AcOH) and 
bromine (Br2) in AcOH added dropwise over an hour. The reaction was left overnight and 
the dibrominated intermediate 121 was isolated in excellent yield (70 %). This synthetic step 
is considerably higher yielding than the comparative literature dibromination of 25 as this 
was only isolated in 10 % yield. 121 was then subjected to the previously established Suzuki-





Scheme 60 – Synthesis of 120 
 
Interestingly, with the addition of ONOO-, 120 changed from a clear solution to a violet 
solution shown in Scheme 61. A colour change was also observed in the UV-Vis spectra 
with a new absorption peak appearing at 590 nm (Figure 100). This observation tentatively 
indicates the formation of thionol due to Mascharak et al. reporting thionol with a similar 
UV absorption and violet colour.149, 150 The fluorescence of 120 was then evaluated against 
ONOO-, which resulted in a large fluorescence response at a longer emission wavelength 
(610 nm). 120 was shown to be able to detect ONOO- at low concentrations similar to results 







Scheme 61 – Colorimetric change of 120 (clear to violet) with the addition of ONOO- to form highly fluorescent thionol  
 




























Figure 100 – UV-Vis spectra of 120 (10 µM) with and without the addition of peroxynitrite in PBS Buffer solution 51% 
MeOH, pH = 8.21.  
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Figure 101 - Fluorescence spectra of 120 (1 µM) with addition of ONOO- (0 – 10 µM) in PBS Buffer pH = 8.21 at 25 oC. 
Fluorescence intensities were measured with λex = 575nm with slit widths ex 10 nm and em 8 nm 
 

















Figure 102 - Fluorescence intensity changes (I/IFinal) for 120 (1 µM) with addition of ONOO- (0 – 10 µM)). λex 575 nm/ 





As shown in Figure 103, 120 displays excellent selectivity towards ONOO- making it a 
suitable fluorescent probe for cell imaging. 









































Figure 103- Fluorescence spectra of 120 (1 µM) in the presence of various ROS/RNS: ONOO- (10 µM, 1 min), -OCl (100 
µM, 30 min), H2O2 (100 µM, 30 min), ROO. (100 µM, 30 min), 1O2 (100 µM, 1 min), -O2 (100 µM, 1 min), .OH (100 µM, 
1 min) λex 575 nm in pH 8.2 buffer solution [52 wt% methanol]. ]. Slit widths ex = 10 nm em = 8 nm 
















Figure 104 - Selectivity bar chart of 120 (1 µM) in the presence of various ROS/RNS: 1 - ONOO- (10 µM, 1 min), 2 - -
OCl (100 µM, 30 min), 3 - H2O2 (500 µM, 30 min), 4 - -O2 (100 µM, 1 min), 5 - ROO. (100 µM, 30 min), 6 -.OH (100 µM, 
1 min), 7 - 1O2 (100 µM, 1 min). λex 550 nm/ λem 610 nm in pH 8.2 buffer solution [52 wt% methanol]. Slit widths ex = 10 




We then turned our attention to the synthesis of benzyl tris-boronic ester 124. The first step 
of the synthesis involved the alkylation of phenothiazine with 4-bromobenzyl bromide using 
NaH to afford 122 in high yield (83 %). The subsequent dibromination step required different 
conditions in comparison to the phenoxazine analogue including different solvent and 
reaction time. The identified reaction conditions were dissolving 122 in DCM followed by 
slow addition of NBS over two hours to afford tribrominated 123 in reasonable yield (61 %). 
123 was subsequently dissolved in DMF and then subjected to a Suzuki-Miyaura reaction 
with an excess of (BPin)2 to furnish benzyl tris-boronic ester 124 in 30% yield.  
 
 
Scheme 62 – Synthesis of 124 
 
With 124 in hand, the UV-Vis and fluorescence experiments were performed. As expected, 
ONOO- completely oxidised 124 to the violet thionol dye. This is shown in the UV-Vis and 
fluorescence spectra. Similarly, 124 displayed excellent sensitivity and selectivity towards 
ONOO-, making it suitable as a fluorescent probe for the detection of ONOO-. The little 
reactivity of the probe towards towards H2O2 and ClO
- may be due to the reactivity of these 
oxidants towards the sulfur atom of the phenothiazine core, which could result in sulfoxide 
or sulfone products. Due to time constraints another member of the James group will attempt 
to identify the final oxidised product to further validate the production of thionol. 
129 
 






















Figure 105 - UV-Vis spectra of 40 (10 µM) with and without the addition of ONOO- in PBS Buffer, 51% MeOH, pH = 
8.21.  
 


































Figure 106 - Fluorescence spectra of 124 (1 µM) with addition of ONOO- (0 – 6 µM) in pH 8.2 buffer solution [52 wt% 
methanol] at 25 oC. Fluorescence intensities were measured with λex = 575nm with slit widths ex 10 nm and em 8 nm 
130 
 
















Figure 107 - Fluorescence intensity changes (I/IFinal) for 124 (1 µM) with addition of ONOO- (0 – 6 µM). λex 575 nm/ λem 
610 nm in pH 8.2 buffer solution [52 wt% methanol] with slit widths ex 10 nm and em 8 nm 



































Figure 108 - Fluorescence spectra of 124 (1 µM) in the presence of various ROS/RNS: ONOO- (10 µM, 1 min), -OCl (100 
µM, 30 min), H2O2 (100 µM, 30 min), ROO. (100 µM, 30 min), 1O2 (100 µM, 1 min), -O2 (100 µM, 1 min), .OH (100 µM, 
1 min) λex 575 nm in pH 8.2 buffer solution [52 wt% methanol]. ] with slit widths ex = 10 nm em = 8 nm 
131 
 















Figure 109 - Selectivity bar chart of 124 (1 µM) in the presence of various ROS/RNS: 1 - ONOO- (10 µM, 1 min), 2 - -
OCl (100 µM, 30 min), 3 - H2O2 (500 µM, 30 min), 4 - -O2 (100 µM, 1 min), 5 - ROO. (100 µM, 30 min), 6 -.OH (100 µM, 
1 min), 7 - 1O2 (100 µM, 1 min). λex 550 nm/ λem 610 nm in pH 8.2 buffer solution [52 wt% methanol]. Slit widths ex = 10 
nm em = 8 nm 
 
6.2.2 Other analogues of 25 
 
Having developed dual-activated 108 as discussed in Chapter 4, we turned our attention 
towards the synthesis of a dual-activated 25. For proof of concept, we decided to develop a 
dual fluoride-ONOO- probe using the design shown below in Figure 110.  
 
 




The first step of the synthesis was to alkylate phenoxazine with TBS-protected 4-
hydroxybenzyl bromide, this intermediate had to be first synthesised. 4-
Hydroxybenzaldehyde was protected using TBDMS-Cl and imidazole to afford O-silyl-
intermediate 126 that was subsequently reduced using NaBH4. Upon isolating 127, its 
alcohol moiety was converted to the desired benzyl bromide intermediate 128 using 
phosphorous tribromide (PBr3). 128 was then used to N-alkylate phenoxazine using our 
standard conditions. (Scheme 63). 
 
 
Scheme 63 – Synthesis of intermediate 128 
 
Phenoxazine was dissolved in DMF and cooled to 0 oC followed by the slow addition of 
NaH. 128 was added and the reaction was stirred for 4 hours. Interestingly, the isolated 
product was not the expected TBS-phenoxazine product shown in Figure 111, but the 
deprotected 4-hydroxybenzylphenoxazine 129.  
 
Figure 111 – Expected vs isolated alkylation product 
 
To obtain the desired product shown in Figure 110, 129 was re-protected using TBDMS-
Cl. The re-protected TBS-phenoxazine 130 was then subjected to the standard dibromination 
133 
 
conditions affording 131 in excellent yield (72 %). Unfortunately, the Suzuki-miyaura 
reaction led to complete degradation of the starting material and no product was observed in 
the 1H NMR.  
 
 
Scheme 64 – Unsuccessful synthesis of a fluoride-ONOO- fluorescent probe 
 
As a result of isolating unexpected 129, it was proposed that we could synthesise the target 
bis-boronate 132 shown in Figure 112. The synthesis of this compound would offer a probe 
template that could subsequently be functionalised to develop dual activated systems for the 
detection of other analytes.  
 




In order to synthesise 132, a stable protecting group was chosen to protect the 4-
hydroxybenzyl bromide intermediate. We chose to use the pivaloyl (Piv) protecting group 
as the removal of this protecting group could be achieved using mild acid hydrolysis, or the 
use of a mild reducing agent. Therefore, the first part of the synthesis was to prepare the O-
pivaloyl protected 4-hydroxybenzyl bromide 134.  
Taking advantage in the difference of nucleophilicity between the phenol and benzyl alcohol 
when deprotonated, the 4-hydroxy position of p-hydroxybenzyl alcohol was selectively 
acylated using pivaloyl chloride (PivCl). However, attempts to employ PBr3 to brominate 
133 were unsuccessful, therefore, its corresponding mesylate was generated in situ, which 
reacted with lithium bromide (LiBr) to form the desired bromide.151  
 
 
Scheme 65 – Synthesis of piv-protected 4-hydroxybenzyl bromide 134 
 
With piv-protected 4-hydroxybenzyl bromide in hand, it was used to N-alkylate phenoxazine 
to form 135, that was then dibrominated using NBS to form N-benzyl-bis-bromo-
phenoxazine 136. Unfortunately, the attempts to to carry out Suzuki-Miyaura conditions 




Scheme 66 - Unsuccessful synthetic route to isolate 132 
Eventually, 132 was synthesised through deprotection of the O-piv protecting group of 136 
via reductive cleavage using DIBAL-H as the reducing agent. 137 was then subjected to the 
previously used Suzuki-Miyaura conditions, which furnished the desired compound in 
excellent yield (83 %) (Scheme 67). To prove that 132 was stable, an x-ray crystal structure 
was obtained in collaboration with the X-ray technician Gabriele Kociok-Köhn (Figure 
113). 
 




Figure 113 – X-ray crystal structure of 132 
 
The fluorescence of 132 was then evaluated towards ONOO-.  Interestingly, 132 was shown 
to be more sensitive towards ONOO- than the other previously synthesised 25 derived 
fluorescence probes. Furthermore, excellent selectivity was observed with 132 since only a 
small fluorescence response was observed for the addition of large concentrations of H2O2 
(1 mM). As illustrated in Scheme 68, it is believed that once the boronates are oxidised to 
the corresponding phenols, the 4-hydroxy benzyl unit becomes unstable and eliminates to 




Scheme 68 – Proposed ONOO- mediated ‘turn on’ mechanism of 132 
 



































Figure 114 - Fluorescence spectra of 132 (0.5 µM) with addition of ONOO- (0 – 7 µM) in pH 8.2 buffer solution [52 wt% 

















Figure 115 - Fluorescence intensity changes (I/IFinal) with 132 (0.5 µM) and additions of ONOO- (0 – 7 µM) in pH = 8.21 
buffer solution [52 wt% methanol] at 25 oC. Fluorescence intensities were measured with λex = 550nm/ λem 590 nm with 
Ex slit: 10 nm and Em slit: 2.5 nm 















Figure 116 - Selectivity bar chart of 132 (0.5 µM) in the presence of various ROS/RNS: 1 - ONOO- (7 µM, 1 min), 2 - -
OCl (100 µM, 30 min), 3 - H2O2 (1 mM, 30 min), 4 - -O2 (100 µM) 5 - ROO. (100 µM, 30 min), 1 min), 6 - .OH (100 µM, 
1 min), 7 - NO (100 µM, 1 min) ), 8 – 1O2 (100 µM, 1 min) in pH = 8.21 buffer solution [52 wt% methanol]. λex = 550 nm/ 
λem = 590 nm with Slit width ex = 10 nm em = 2.5 nm.  
 
With 132 in hand, the dual fluoride-ONOO- fluorescent probe was synthesised. 132 was 
treated with TBDMS-Cl and imidazole in DMF to form the desired fluoride-ONOO- probe. 
However, the reaction was found to be very low yielding with a long reaction time. This is 





Scheme 69 – Synthesis of dual Fluoride-ONOO- probe 125 
 
We then turned our attention towards the synthesis of two other dual-activated fluorescent 
probes: GSH-ONOO- and esterase/N2H4-ONOO
- fluorescent probes. In contrast to the 
synthesis of the 125, 132 reacted smoothly with 2,4-dinitrobenzenesulfonyl chloride and 
acetyl chloride separately to afford both GSH-ONOO- and esterase-ONOO- fluorescent 




Scheme 70 – Synthesis of a GSH-ONOO- 138 and esterase-ONOO- probe 139 
 
Preliminary fluorescence studies of the 139 were carried out. To our surprise, just the 
addition of ONOO- led to a large fluorescence response and a good selectivity profile was 
observed for the detection of ONOO-. This fluorescence ‘turn-on’ response was believed to 
be due to the oxidation of the boronates and the nucleophilicity of ONOO- hydrolysing the 
acetate group resulting in the formation of the unstable phenolate 139, which then eliminates 




Scheme 71 – ONOO- ester hydrolysis 


































Figure 117 - Fluorescence spectra of 139 (0.5 µM) with addition of ONOO- (0 – 100 µM) in pH = 8.21 buffer solution [52 
wt% methanol] at 25 oC. Fluorescence intensities were measured with λex = 550nm with Slit Widths Ex slit: 10 nm and Em 




















Figure 118 - Fluorescence intensity changes (I/IFinal) with 139 (0.5 µM) and additions of ONOO- (0 – 100 µM in pH = 8.21 
buffer solution [52 wt% methanol] at 25 oC. Fluorescence intensities were measured with λex = 550nm/ λem 590 nm with 
slit widths ex: 10 nm and em 5 nm 















Figure 119 Selectivity bar chart of 139 (0.5 µM) in the presence of various ROS/RNS: 1 - ONOO- (100 µM, 1 min), 2 - -
OCl (100 µM, 30 min), 3 - H2O2 (1 mM, 30 min),4 - ROO. (100 µM, 30 min), 5 - NO (100 µM, 1 min), 6 - -O2 (100 µM, 1 
min),7 - .OH (100 µM, 1 min), 8 – 1O2 (100 µM, 1 min) in pH = 8.21 buffer solution [52 wt% methanol]. Slit width ex = 
10 nm em = 2.5 nm. λex = 550 nm/ λem = 590 nm  
 
From these interesting results, it was believed we could attach a number of target units at the 
4-hydroxy position via an ester linkage. A number of target compounds were proposed, these 
included an azide probe 140 (for click chemistry applications), triphenylphosphine 
fluorescent probe 141 (as a mitochondrial targeting group42), a fluorouracil fluorescent probe 
143 
 
142 (theranostic probe for treatment and diagnostic of cancer cells) and a biotinylated probe 




Figure 120 – Target fluorescent probes  
 
Due to time constraints, we aimed to synthesise the azide probe 140 shown in Figure 120 as 
this probe could be used for future functionalisation reactions. The corresponding azide 
carboxylic acid 142 was synthesised through refluxing methyl 5-bromovalerate and sodium 
azide (NaN3) in acetone/ H2O affording methyl ester azide 141, which then underwent base 




Scheme 72 – Synthesis of azide carboxylic acid 142 
 
Upon isolating 142, a Steglich esterification between 142 and phenol 132 was carried out 
using the coupling reagent dicyclohexylcarbodiimide (DCC) in DCM at 0 oC in the presence 
of a catalytic amount of dimethylaminopyridine (DMAP), which gave 140 in reasonable 
yield (39 %) after 48 h (Scheme 73). 140 has now been sent to our Chinese collaborators 
(Xiao Peng-He) to investigate its application as a click reagent for the functionalisation of 
nanoparticles for bioimaging applications. 
 
 
Scheme 73 – Synthesis of 140 
 
We then turned our attention towards the synthesis of developing a dual activated ONOO--
nitroreductase (NTR) fluorescent probe (Figure 121). Nitroreductases (NTR) are members 
of flavin-containing oxidoreductases, which is one of a series of biomarkers that have been 
145 
 
shown to be significantly upregulated in cells under hypoxic stress.153 Since cells under 
hypoxic conditions are known to result in elevated, ROS/RNS levels154 this probe would 
provide a useful tool for discriminating between healthy cells and hypoxic cells under 
oxidative stress. 
 
Figure 121 - A potential ONOO—NTR fluorescent probe 143  
 
Interestingly, 143 was shown to behave similarly to 139, with addition of ONOO- leading to 
an increase in fluorescence intensity, which indicated the elimination of the 4-nitrobenzyl 
group (Figure 122 and Figure 123). Therefore, from the results of 143 and 139, we believe 
that this fluorescent probe undergoes a different oxidative cleavage mechanism to that seen 
for the benzyl boronic ester probes 117 and 124. As shown in Scheme 74, it is believed that 
if the functionality in the para position is electron withdrawing, it has the ability to accept 





Scheme 74 – Oxidation mechanisms of 117 and 143 
 





































Figure 122 - Fluorescence spectra of 143 (0.5 µM) with addition of ONOO- (0 – 100 µM) in PBS Buffer pH = 8.21 at 25 

























Figure 123 - Fluorescence intensity changes (I/IFinal) with 143 (0.5 µM) and additions of ONOO- (0 – 100 µM) in PBS 
Buffer pH = 8.21 at 25 oC. Fluorescence intensities were measured with λex = 550nm/ λem 590 nm with slit widths ex 10 
nm and em 5 nm 
 
An excellent selectivity profile for ONOO- was observed for 143 towards other ROS, with 
no response to H2O2, and a partial response to ClO
- (Figure 124).  
 














Figure 124 - Fluorescence spectra of 143 (0.5 µM) in the presence of various ROS/RNS: ONOO- (100 µM, 1 min), -OCl 
(100 µM, 30 min), H2O2 (1 mM, 30 min), ROO. (100 µM, 30 min), NO (100 µM, 1 min) -O2 (100 µM, 1 min),.OH (100 
µM, 1 min), 1O2 (100 µM, 1 min) in PBS Buffer, 51% MeOH pH = 8.21. slit width ex = 10 nm em = 5 nm. λex = 550 nm. 




6.2.3 Cell imaging and future work 
 
Unfortunately, all of the fluorescent probes that were sent to our collaborators for cell 
imaging were insoluble and not cell permeable. Therefore, whilst these probes have an 
excellent application for the detection of ONOO- in solution based studies, further work is 
required if they are to be used as probes for biological applications. 
 
 
Figure 125 - HEPG2 cells were incubated with probes (a) 117 (b) 124 (c) 143 (10 μM, 30 min), then imaged (precipitates 
formed). The fluorescence images were recorded using an Operetta high-content imaging system (Perkinelmer, US) with 
an excitation wavelength of 520-590 nm and emission wavelength of 580-650 nm, and was quantified and plotted by 
columbus analysis system (Perkin elmer, US). 
 
Promisingly, the pre-incubation of 139 with fructose led to an increase in cell internalisation 
as shown in Figure 126. This is due to the ability of the boronates to bind to saccharides.155, 
156 From these results, further cell imaging experiments are now being carried out to optimise 
the cell internalisation of the probes, which include the use of lactulose to help solubilise the 





Figure 126 - HEPG2 cells were incubated without and with fructose and 139 (a) no fructose (b) with fructose (10 μM, 
30 min), then imaged. The fluorescence images were recorded using an Operetta high-content imaging system 
(Perkinelmer, US) with an excitation wavelength of 520-590 nm and emission wavelength of 580-650 nm, and was 
quantified and plotted by columbus analysis system (Perkin Elmer, US). 
 
Another strategy that could be used to overcome the issues of solubility, would be to 
synthesise the benzyl protected diaminophenoxazine probe 144 shown below in Figure 127. 
It was proposed that the increased polarity of the amino groups might improve the aqueous 
solubility of the probe and thus improve its cell permeability.  
 
 
Figure 127 – Diaminophenoxazine fluorescent probe 144 
 
Remarkably, it was discovered that treatment of 115 with fuming nitric acid in acetic acid at 
0 oC resulted in the nitration of 115 to form the bright red dinitrophenoxazine intermediate 
145 in high yield (63 %). The previously used Suzuki-Miyaura conditions were then applied 
to 145 to form the boronate intermediate 146.  
The last step of the synthesis was to reduce the nitro functionalilty of 146 to form desired 
147. Unfortunately, all the attempted conditions were unsuccessful. This is potentially due 
to the diamino compound being unstable and decomposing via the alternative mechanism 




Scheme 75 – Initial synthetic route to the desired amine fluorescent probe  
 
To overcome this synthetic and stability issue, we have proposed that a carbamate protection 
strategy may enable the synthesis of the bis-amino variant of the stable dihydroxy analogue 
(Scheme 52). However, due to the time constraints the synthesis of this fluorescent probe 
will now be pursued by another PhD student in the James group. 
 
 






Overall, a new synthetic route has been established that provides access to a number of novel 
fluorescent boronate probes for the detection of ONOO-. The synthetic route offers an 
alternative approach for the synthesis of the literature reported 25 avoiding the very low 
yielding first step. The fluorescent probes in this chapter demonstrate an excellent selectivity 
towards ONOO-, which permitted them to be evaluated in cell imaging experiments. Sadly, 
the fluorescent probes were shown to be cell impermeable, however, recent studies have 
shown that their pre-incubation with fructose increases both their solubility and 
permeability. This strategy is now being pursued to allow the probes to be used to detect 








7.1 General Experimental Information 
Solvents and Reagents 
Solvents and reagents were reagent grade unless stated otherwise and were purchased from 
Fisher Scientific UK, Fluorochem Ltd, TCI UK, Alfa Aesar and Sigma-Aldrich Company 
Ltd and were used without further purification. 
Thin Layer Chromatography (TLC) 
Thin layer chromatography was performed using commercially available Macherey-Nagel 
aluminium backed plates coated with a 0.20 mm layer of silica gel 60 Å with fluorescent 
indicator UV254. These plates were visualised using either ultraviolet light of 254 nm or 
365 nm wavelength, or by staining the plates with vanillin or ninhydrin solution. Silica gel 
column chromatography was carried out using Fisher or Sigma- Aldrich 60 Å silica gel (35-
70 μm). 
Nuclear Magnetic Resonance (NMR) Spectra 
Nuclear magnetic resonance (NMR) spectra were run in chloroform-D, methanol-D4, and 
dimethyl sulfoxide-d6. Where a Bruker AVANCE 300 was used, 1H spectra were recorded 
at 300 MHz, 11B spectra at 96 MHz and 13C at 75 MHz where a Bruker AVANCE 250 was 
used. Chemical shifts (δ) are expressed in parts per million and are reported relative to the 
residual solvent peak as an internal standard in 1H and 13C spectra. The multiplicities and 
general assignments of the spectroscopic data are denoted as: singlet (s), doublet (d), 
triplet (t), double of doublets (dd), unresolved multiplet (m), broad (br) and aryl (Ar). 
Mass Spectra 
High resolution mass spectrometry (HRMS) results were typically acquired on an externally 
calibrated Bruker Daltonics micrOTOF time-of-flight mass spectrometer coupled to an 
electrospray source (ESI-TOF). Calibration was achieved using a sodium formate solution. 
Samples were introduced either by syringe pump or flow injection using an autosampler in 
an Agilent 1100 LC system. Molecular ions were detected in positive mode as either the 
153 
 
protonated or sodiated form and Bruker Daltonics software, DataAnalysis, was used to 
process the data. Alternatively, data was acquired externally at the EPSRC National Mass 
Spectrometry Facility, Swansea University. 
Melting Points (MP) 
Capillary melting points were determined using Stuart MDP10. Compounds were purified 
and dried before melting points were determined. 
Fluorescence Measurements 
Fluorescence measurements were performed on a Perkin-Elmer Luminescence 
Spectrophotometer LS 50B/ LS 55 B utilising Starna Silica (quartz) cuvette with 10 mm path 
length, four faces polished. Data were collected via the Perkin-Elmer FL Winlab software 
package. All solvents used in fluorescence measurements were HPLC or fluorescence grade 
and the water was de-ionised. Further reprocessing of the data was carried in OriginPro 8.0 
graph software. 
pH Measurement 
All pH measurements taken during fluorescence/absorption experiments were recorded on a 
Hanna Instruments HI 9321 Microprocessor pH meter which was routinely calibrated using 
Fisher Chemicals standard buffer solutions (pH 4.0 - phthalate, 7.0 - phosphate, and 10.0 - 
borate). 
UV-Vis Measurement 
UV-Vis measurements were performed on a Perkin-Elmer Lambda 20 Spectrophotometer, 
utilising Starna Silica (quartz) cuvette with 10 mm path lengths, two faces polished. Data 
was collected via the Perkin-Elmer UVWinlab software package. Further reprocessing of 




7.2 Synthesis of ROS/RNS 
Preparation of NO 
 
Nitrogen was flowed through the system before the production of Nitric oxide (NO). NO 
was prepared by treating a sodium nitrite solution (7.3 M) with H2SO4 (3.6 M). The NO 
stock solution (2.0 mM) was prepared by bubbling the produced gas into deoxygenated de-
ionized water for 30 min. H2SO4 drop speed was carefully controlled through a dropping 
funnel. The produced NO and NO2 passed through the tubing and the NO2 was absorbed 
through the reaction with aqueous sodium hydroxide solution, whilst NO passed into the 3rd 
flask. In the final flask, the saturated NO solution can be formed through prolonged bubbling 
Preparation of 1O2 
1O2 was generated by the reaction of H2O2 (1 mM) with NaClO (1 mM). Drop the solution 
of H2O2 into the aqueous NaClO and stir for 2 min and then use immediately 
Preparation of ROO• 
ROO• was generated from 2, 2'-azobis (2-amidinopropane) dihydrochloride. AAPH (2,2’-
azobis (2-amidinopropane) dihydrochloride, 10 M) was added in de-ionized water, and then 
stirred at 37 ºC for 30 min 
Preparation of -O2 





Preparation of HO. 
Hydroxyl radical was generated by Fenton reaction. To prepare •OH solution, ferrous 
chloride (1 M) was added in the presence of 10 equiv of H2O2 (37.0 wt%) 
Preparation of ONOO− 
Peroxynitrite stock solution was prepared by the reaction of hydrogen peroxide with sodium 
nitrite and stabilized in basic solution. Simultaneously, at 0 ºC the following solutions were 
added 0.6 M KNO2, 0.6 M HC1 and 0.7 M in H2O2, into a 3 M NaOH solution. The yellow 
product solution was analysed spectrophotometrically. The stock solution of peroxynitrite 
was fresh-made and re-analysed each time in the detection experiments. The concentration 
of peroxynitrite was estimated by using an extinction coefficient of 1670 ± 50 cm−1 M−1 at 
302 nm in 0.5 M sodium hydroxide (aq) 
Preparation of –OCl and H2O2 
The concentration of –OCl was determined from the absorption at 292 nm (Ɛ = 350 M-1cm-
1).  





7.3 Synthesis of compounds 
 
Ethyl 3-bromo-4-methylbenzoate (65)  
 
 
3-Bromo-4-methylbenzoic acid (25 g, 116.3 mmol) in EtOH (400 mL) and H2SO4 (10 mL) 
was refluxed for 18 h. The reaction mixture was cooled to rt and the solvent was removed 
under reduced pressure. The mixture was slowly quenched with saturated NaHCO3 solution 
and the aqueous layer was extracted three times with EtOAc. The combined organics were 
dried (MgSO4) and concentrated in vacuo to afford an orange oil, no further purification was 
required (quantitative yield). 1H NMR (500 MHz, CDCl3) δ 8.19 (s, ArH, 1 H), 7.86 (d, ArH, 
J = 7.8 Hz, 1 H), 7.28 (d, ArH, J = 7.8 Hz, 1 H), 4.36 (q, COCH2CH3, J = 7.3 Hz, 2 H), 2.44 
(s, ArCH3, 3H), 1.39 (t, COCH2CH3,  J = 7.1 Hz, 3 H); 
13C NMR (125.75 MHz CDCl3) δ 
165.3, 143.1, 133.4, 130.6, 129.8, 128.6, 124.7, 61.2, 23.2, 14.3; I.R (thinfilm) ν max (cm-
1): 1716.86 (C=O); HRMS (ESI): m/z calculated for C10H11BrO2: requires: 264.9840 for 














A mixture of Ethyl 3-bromo-4-methylbenzoate (26.00 g, 106.95 mmol), NBS (22.78 g, 
128.34 mmol) and a catalytic amount of benzoyl peroxide (2.6 g, 10.695 mmol) in CCl4 (300 
mL) was refluxed for 5 h. The reaction mixture was cooled to rt. The solid by-products were 
filtered and the filtrate was concentrated in vacuo. The residue was dissolved in EtOAc (200 
mL) and the organic was washed with H2O (3 x 100 mL), brine (100 mL), dried (MgSO4) 
and concentrated in vacuo to afford the crude mixture which was mostly the desired 
bromomethyl product and a small amount of undesired dibromoproduct. This was used 
directly in the next reaction without any further purification. 
CaCO3 (32 g, 328 mmol) was added to a solution of bromomethyl product 66 in (150 mL) 
H2O and (150 mL) 1,4-dioxane, which was then stirred at 100
 oC for 24 h. The reaction 
mixture was then cooled to rt and the solid was filtered. The solvent was concentrated in 
vacuo to remove the 1,4-dioxane. The mixture was diluted with (400 mL) EtOAc and the 
organic layer was washed with H2O (2 x 100 mL), Brine (100 mL), dried (MgSO4) and 
concentrated in vacuo to afford the crude material. The crude material was purified via 
column chromatography 5 to 20% (EtOAc/Pentane) to afford the title compound as a white 
solid (7.5 g, 28.94 mmol, 27 %). M.p. 71-73 oC. 1H NMR (500 MHz ,CDCl3) δ 8.20 (s, ArH, 
1 H), 8.00 (d, ArH, J = 7.8 Hz, 1 H), 7.60 (d, ArH, J = 7.8 Hz, 1 H), 4.80 (s, CH2OH, 2 H), 
4.39 (q, CH2CH3 J = 6.8 Hz, 2 H), 2.14 (br. s., CH2OH, 1 H), 1.41 (t, CH2CH3, J = 7.1 Hz, 
3 H); 13C NMR (125.75 MHz CDCl3) δ 165.2, 144.6, 133.5, 131.1, 128.7, 128, 121.8, 64.6, 
61.4, 14.3; I.R (thinfilm) ν max (cm-1): 3487.19 (O-H), 1694.97 (C=O); HRMS (ESI): m/z 
calculated for C10H11BrO3: requires: 256.9813 for [M-H]









A mixture of ethyl 3-bromo-4-(hydroxymethyl)benzoate (7.50 g, 28.94 mmol), tert-
butyldimethylsilyl chloride (4.6 g, 30.39 mmol), imidazole (3 g, 43.41 mmol) in DCM (200 
mL) was stirred at rt for 16 h. The reaction mixture was partitioned with H2O (200 mL) and 
the organic layer was washed with H2O (2 x 100 mL), brine (100 mL) and dried (MgSO4). 
The solvent was removed in vacuo to afford the title compound as a clear oil (9.47 g, 25.36 
mmol, 88 %).  No further purification was required. 1H NMR (500 MHz ,CDCl3) δ 8.17 (s, 
ArH, 1 H), 8.02 (d, ArH, J = 7.8 Hz, 1 H), 7.65 (d, ArH, J = 8.3 Hz, 1 H), 4.77 (s, CH2OSi, 
2 H), 4.38 (q, COCH2CH3, J = 7.3 Hz, 2 H), 1.40 (t, COCH2CH3,  J = 7.1 Hz, 3 H), 0.98 (s, 
OSi(CH3)2C(CH3)3 9 H), 0.15 (s, OSi(CH3)2C(CH3)3, 6 H); 
13C NMR (75.5 MHz, CDCl3) δ 
165.4, 145.4, 133.1, 130.5, 128.5, 127.2, 120.6, 64.6, 61.2, 25.9, 18.4, 14.3, -5.4; I.R 
(thinfilm) ν max (cm-1): 1722.22 (C=O); HRMS (FTMS): m/z calculated for C16H25BrO3Si: 













A solution of ethyl 3-bromo-4-(hydroxymethyl)benzoate (9.40 g, 25.18 mmol) in dry THF 
(250 mL) was cooled to -78 oC under N2 followed by the dropwise addition of LiAlH4 - 1 M 
in THF (25 mL, 60.44 mmol). The reaction was allowed to warm to rt and stir for 5 h before 
being quenched at -78 oC with phosphate buffer. The quenched reaction mixture was 
immediately filtered through celite and the filtrate was concentrated in vacuo to afford a 
clear oil. No further purification was required. (5.15 g, 25.18 mmol, 62 %). 1H NMR (500 
MHz, CDCl3) δ 7.55 - 7.52 (m, ArH, 2 H), 7.33 - 7.30 (m, ArH, 1 H), 4.73 (s, CH2O, 2 H), 
4.66 (s, CH2O, 2 H), 0.96 (s, OSi(CH3)2C(CH3)3, 9 H), 0.13 (s, OSi(CH3)2C(CH3)3, 6 H); 
13C 
NMR (125.75 MHz CDCl3) δC: 141.1, 139.9, 130.5, 127.7, 125.8, 121.1, 64.50, 64.40, 25.9, 
18.4, -5.3; I.R (thinfilm) ν max (cm-1): 3340.73 (br O-H); HRMS (ESI): m/z calculated for 















A solution of (3-bromo-4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)methanol (5.00 g, 
15.09 mmol) in DCM (50 mL) was poured slowly into a mixture of PCC (4. 87 g, 22.64 
mmol), celite (3.63 g) and DCM (50 mL). The reaction mixture was stirred at rt for 1 h before 
being filtered through celite and a silica pad (DCM) and then concentrated in vacuo to obtain 
the product as a clear oil. No further purification was necessary. (3.60 g, 10.93 mmol, 72 %). 
1H 1H NMR (300 MHz, CDCl3) δ 9.95 (s, CHO, 1 H), 8.01 (s, ArH, 1 H), 7.85 (dd, J = 1.5, 
7.9 Hz, ArH, 1 H), 7.76 (d, J = 7.9 Hz, ArH, 1 H), 4.77 (s, ArCH2, 2 H,), 0.98 (s, 
OSi(CH3)2C(CH3)3, 9 H), , 0.16 (s, OSi(CH3)2C(CH3)3, 6 H,); 
13C NMR (75.5 MHz,  CDCl3) 
δ 190.7, 147.4, 136.4, 132.8, 128.9, 127.9, 121.5, 64.7, 25.9, 18.4, -5.4; I.R (thinfilm) ν max 















2,4-Dimethylpyrrole (0.693 g, 7.29 mmol) was added to a solution of 3-bromo-4-(((tert-
butyldimethylsilyl)oxy)methyl)benzaldehyde (1.20 g, 3.65 mmol) in dry DCM (150 mL). 
The reaction mixture was stirred at rt for 16 h under N2. DDQ (1.24 g, 5.48 mmol) was added 
to the reaction mixture and stirred for 2 h. The reaction mixture was then cooled to 0 oC 
before the addition of DIPEA (6.3 mL) and BF3.Et2O (11.33 mL), which was then stirred for 
a further 16 hrs. The solid impurities were filtered through celite and the filtrate was washed 
with H2O (100 mL), Brine (100 mL), dried (MgSO4) and concentrated in vacuo to afford the 
crude material. The crude material was purified via column chromatography 10 % 
(EtOAc/Pentane) to afford the title compound as a red gum (0.81 g, 41 %). 1H NMR (500 
MHz , CDCl3) δ 7.69 (d, ArH, J = 7.8 Hz, 1 H), 7.47 (d, ArH, J = 2.0 Hz, 1 H), 7.28 (d, ArH, 
J = 2.0 Hz, 1 H), 6.00 (s, (PyrH)2, 2 H), 4.82 (s, CH2OSi, 2 H), 2.56 (s, ArCH3 6 H), 1.44 (s, 
ArCH3, 6 H), 0.99 (s, 9 H), 0.17 (s, 6 H); 
13C NMR (125.75 MHz CDCl3) δ 155.8, 143, 141.5, 
139.7, 134.9, 131.4, 128.1, 127.14, 121.4, 121.2, 64.4, 25.9, 14.7, -5.3; I.R (thinfilm) ν max 
(cm-1): No presence of carbonyl stretch; HRMS (ESI): m/z calculated for 
C26H34BBrF2N2OSi: requires: 547.1763 for [M+H]
+, found: 547.1768. requires: 569.1582 










A solution of 10-(3-bromo-4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)-5,5-difluoro-
1,3,7,9-tetramethyl-5H-4l4,5l4-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinine (1.14 g, 2.08 
mmol) and TBAF – 1M in THF (2.1 mL, 2.08 mmol) in THF (20 mL) was stirred at rt for 
30 min. The reaction mixture was quenched with saturated NaHCO3 solution and extracted 
EtOAc (3 x 100 mL). The combined organics were dried (MgSO4) and concentrated in vacuo 
to afford the crude material, which was purified via column chromatography 40 to 60% 
(EtOAc/Pentane) to collect the title compound as an orange solid (0.36 g, 40%). M.p. 236-
237 oC. 1H NMR (500 MHz ,CDCl3) δ 7.66 (d, ArH, J = 7.8 Hz, 1 H), 7.53 (d, ArH, J = 2.0 
Hz, 1 H), 7.30 (dd, ArH, J = 2.0, 7.8 Hz, 1 H), 6.00 (s, (PyrH)2, 2 H), 4.86 (d, CH2OH, J = 
5.9 Hz, 2 H), 2.56 (s, ArCH3, 6 H), 1.44 (s, ArCH3, 6 H);
 13C NMR (125.75 MHz CDCl3) δ 
156, 142.9, 140.8, 139.2, 135.8, 132.0, 131.2, 129.0, 127.0, 123.0, 121.5, 65.0, 14.8; I.R 
(thinfilm) ν max (cm-1): 3529.29 (O-H); HRMS (ESI): m/z calculated for C20H21BBrF2N2O: 














f][1,3,2]diazaborinin-10-yl)phenyl)methanol (0.57 g, 1.32 mmol) in DCM (100 mL) was 
poured carefully into a solution of PCC (0.431 g, 2.00 mmol) and MgSO4 (0.550 g) in DCM 
(100 mL). The reaction mixture was stirred for 1.5 h before being filtered through celite and 
a silica pad and then concentrated in vacuo to afford the title compound as a red solid in 43 
% yield (0.245 g, 0.57 mmol). No purification was required. M.p. 217 – 219 oC. 1H NMR 
(500 MHz, CDCl3) δ 10.44 (s, CHO,  1 H), 8.06 (d, ArH, J = 7.8 Hz, 1 H), 7.68 (s, ArH, 1 
H), 7.43 (d, ArH, J = 7.8 Hz, 1 H), 6.03 (s, (PyrH)2, 2 H), 2.57 (s, ArCH3, 6 H), 1.45 (s, 
ArCH3, 6 H); 
13C NMR (125.5 MHz, CDCl3) δ  185.7, 151.5, 137.4, 137.2, 132.5, 128.5, 
125.3, 123.0, 122.1, 116.7, 9.5; I.R (thinfilm) ν max (cm-1): 1695.49 (C=O); HRMS (ESI): 
m/z calculated for C20H18
10BBrF2N2O: requires 429.0694 for [M]














74 (0.24 g, 0.57 mmol) in dry MeCN (5 mL) was bubbled with argon for 30 min in a sealed 
tube before the addition of methyl acrylate (0.956 mL, 2.85 mmol), P(O-Tol)3 (0.052 g, 
0.171 mmol), NEt3 (0.07 mL, 0.86 mmol) and Pd(OAc)2 (0.019 g, 0.086 mmol).  The 
reaction mixture was heated at 95 oC for 16 h in a sealed vessel. The reaction was cooled to 
rt and diluted with diethyl ether (50 mL), filtered through celite and washed with H2O (2 x 
50 mL) and brine (50 mL). The organic layer was dried (MgSO4) and concentrated in vacuo 
to afford the crude material that was purified via column chromatography 20 to 40 % 
(EtOAc/Pentane) to afford the title compound as a red gum (0.15 g, 0.34 mmol, 60 %). 1H 
NMR (500 MHz ,CDCl3) δ 10.39 (s, CHO, 1 H), 8.56 (d, CHCHCOOMe, J = 16.1 Hz, 1 H), 
8.04 (d, ArH, J = 7.8 Hz, 1 H), 7.67 - 7.61 (d, ArH, J = 1.5 Hz, 1 H), 7.55 (dd, ArH, J = 1.5, 
7.8 Hz, 1 H), 6.39 (d, CHCHCOOMe, J = 15.7 Hz, 1 H), 6.02 (s, (PyrCH)2 2 H), 3.83 (s, 
COOMe, 3 H), 2.57 (s, ArCH3, 6 H), 1.39 (s, ArCH3, 6 H);  
13C NMR (125.75 MHz CDCl3) 
δ 191, 166.2, 156.7, 142.5, 140, 137.5, 133.9, 132.9, 129.8, 127.9, 123.8, 121.8, 52, 14.8;  
I.R (thinfilm) ν max (cm-1): 1687.6 (C=O); HRMS (ESI): m/z calculated for C24H23BF2N2O3: 












A solution of 63 (0.07 g, 0.16 mmol) in THF (2 mL) was cooled to -20 oC before the addition 
of NH2OH- 50 % in H2O (0.012 ml, 0.24 mmol). The reaction was stirred at -20 
oC for 30 
min then it was allowed to warm to rt for 30 min. The reaction mixture was partitioned with 
DCM (50 mL) and H2O (50 mL). The aqueous layer was extracted twice with DCM (2 x 50 
ml) and the combined organics were dried (MgSO4) and concentrated in vacuo to afford the 
title compound as a shiny red/green solid (quantitative yield). M.p 143-144 oC 1H NMR (500 
MHz, CDCl3) δ 7.48 (d, ArH, J = 6.8 Hz, 1 H), 7.31 (dd, ArH, J = 1.5, 6.8 Hz, 1 H), 7.26 (s, 
ArH, 1 H), 6.00 (s, (PyrH)2, 2 H), 5.11 (s, CH2COOMe, 2 H), 3.91 (s, CH2NO, 2 H), 3.70 
(s, COOMe, 3 H), 2.55 (s, ArCH3, 6 H), 1.41 (s, ArCH3, 6 H);
 13C NMR (125.75 MHz 
CDCl3) δ 167.5, 156.0, 142.8, 140.9, 140.0, 137.0, 135.7, 133.5, 131.3, 127.6, 122.3, 121.5, 
119.2, 66.1, 52.6, 29.3, 14.7, 14.6;  I.R (thinfilm) ν max (cm-1): 1738.03 (C=O); HRMS 
(ESI): m/z calculated for C24H24BF2N3O3: requires 452.20 for [M+H]












Propargyl bromide (80 % solution in PhMe, 0.23 mL, 2.07 mmol) was added to a mixture 
of N,O-dibochydroxlamine (0.435 g, 1.86 mmol)  and K2CO3 (0.343 g, 2.48 mmol) in DMF 
(15 mL). The reaction mixture was stirred for 16 h before the addition of H2O (100 mL). The 
aqueous layer was extracted with EtOAc (2 x 50 mL). The combined organics were washed 
with H2O (2 x 100 mL), brine (100 mL) and dried (MgSO4). The solvent was removed in-
vacuo to afford the title compound as a colourless oil (0.304 g, 1.12 mmol, 60 %). 1H NMR 
(300 MHz, CDCl3) δ 4.33 (br. s., NCH2CCH, 2 H), 2.28 (t, J = 2.4 Hz, NCH2CCH, 1 H), 




















tert-Butyl ((tert-butoxycarbonyl)oxy)(prop-2-yn-1-yl)carbamate (0.304 g, 1.12 mmol) was 
dissolved in EtOAc (10 mL) and H2O (5 mL). Conc. HCl (5 mL) was added dropwise and 
the reaction mixture was stirred for 2 h. The solvent was then removed in-vacuo to afford 
the title compound as a brown solid (quant. Yield). 1H NMR (300 MHz, DMSO-d6) δ 11.90 
(br. s., H2N(OH)CH2, 2 H), 11.11 (br. s., H2N(OH)CH2, 1 H), 4.04 (d, J = 2.6 Hz, 
NCH2CCH, 2 H), 3.67 (t, J = 2.5 Hz, NCH2CCH, 1 H); 
13C NMR (75.5 MHz, DMSO-d6) δ 
79.7, 74.2; I.R (thinfilm) ν max (cm-1): 3094.6 (Br, O-H); HRMS (FTMS): m/z calculated 
for C3H6ON: requires 72.0444 for [M-Cl]



















Isatoic anhydride (2.93 g, 15.27 mmol), 2-Aminothiophenol (2.55 mL, 20.37 mmol), 
Sodium acetate (1.2 g, 12.43 mmol) in AcOH (120 mL) was refluxed for 1.5 h under Argon. 
The reaction was cooled to rt and EtOAc (100 mL) was added and the solution was quenched 
with solid NaHCO3. The organic layer was washed with H2O (2 x 50 mL), brine (50 mL), 
dried (MgSO4) and concentrated in vacuo to afford the crude material. The crude product 
was purified via column chromatography 5:95 (EtOAc:Pet ether) to afford a cream solid 
(3.33 g, 14.7 mmol, 72 %). M.p. 123-127 oC. 1H NMR (500 MHz, CDCl3) δ 7.97 (d, J = 8.8 
Hz, 1 H, ArH), 7.88 (d, J = 9.3 Hz, 1 H, ArH), 7.71 (dd, J = 1.5, 7.8 Hz, 1 H, ArH), 7.50 - 
7.42 (m, 1 H, ArH), 7.40 - 7.33 (m, 1 H, ArH), 7.23 (ddd, J = 1.5, 7.2, 8.4 Hz, 1 H, ArH), 
6.79 (dd, J = 1.0, 8.3 Hz, 1 H, ArH), 6.76 - 6.73 (m, 1 H, ArH), 6.40 (br. s., 2 H, Ar-NH2); 
13C NMR (125.75 MHz, CDCl3) δ 169.2, 153.7, 146.7, 133.3, 131.5, 130.3, 126.0, 124.8, 
122.4, 121.2, 116.9, 116.8, 115.3; I.R (thinfilm) ν max (cm-1): 3461.97 (N-H); HRMS (ESI): 
m/z calculated for C13H10N2S: requires 227.0643 for [M+H]
+, found 227.0637; requires 

















4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde (1.18 g, 5.08 mmol) was 
added to a solution of 85 (0.72 g, 3.18 mmol) in DCE (10 mL) and AcOH (1.11 mL). The 
reaction mixture was stirred for 1 h before the addition of NaBH(OAc)3 (1.75 g, 8.26 mmol). 
The reaction mixture was stirred for 24 h before being quenched with saturated NaHCO3 
solution. The organic layer was washed with H2O (3 x 50 mL), brine (50 mL), dried (MgSO4) 
and concentrated in vacuo to afford the crude product. The product was purified via column 
chromatography 10:90 (EtOAc:Pet ether) to afford a yellow oil (1.10 g, 2.49 mmol, 78 %). 
1H NMR (500 MHz, CDCl3) δ 9.52 (t, J = 5.4 Hz, 1 H, N-H), 7.93 (d, J = 7.8 Hz, 1 H, ArH), 
7.89 (d, J = 7.3 Hz, 1 H, ArH), 7.83 (d, J = 7.8 Hz, 2 H, ArH), 7.78 (dd, J = 1.5, 8.3 Hz, 1 
H, ArH), 7.27 - 7.20 (m, 1 H, ArH), 6.74 - 6.68 (m, 2 H, ArH), 4.65 (d, J = 5.4 Hz, 2 H, 
NHCH2Ar), 1.36 (s, 12 H, BPin); 
13C NMR (125.75 MHz, CDCl3) δ 169.5, 153.5, 147.3, 
142.5, 135.1, 133.1, 132.0, 130.6, 126.2, 126.0, 124.8, 122.3, 121.1, 115.6, 115.0, 111.9, 
83.7, 47.3, 24.9; I.R (thinfilm) ν max (cm-1): 3282.94 (N-H); HRMS (ESI): m/z calculated 
for C26H27BN2O2S: requires 443.1965 for [M+H]













A solution of 86 (0.82 g, 1.85 mmol), formaldehyde – 37 % in H2O (1.3 mL, 18.54 mmol), 
AcOH (1.6 mL, 27.75 mmol) in MeCN (20 mL) was cooled to 0 oC before the portion wise 
addition of NaBH3CN (0.3 g, 4.81 mmol). The reaction was stirred for 24 h before being 
quenched with saturated NaHCO3 solution. Ether (100 mL) was then added and the organic 
layer was washed with H2O (3 x 50 mL), brine (50 mL), dried (MgSO4) and concentrated in 
vacuo to afford the crude material. The product was purified via column chromatography 
5:95 (EtOAc:Pet ether) to afford a pale green foam (0.12 g, 0.263 mmol, 14 %). 1H NMR 
(500 MHz , CDCl3) δ 8.39 (dd, J = 2.0, 7.8 Hz, 1 H, ArH), 8.10 (d, J = 8.3 Hz, 1 H, ArH), 
7.93 (d, J = 7.3 Hz, 1 H, ArH), 7.79 (d, J = 7.8 Hz, 2 H, ArH), 7.53 - 7.46 (m, 1 H, ArH), 
7.42 - 7.33 (m, 4 H, ArH), 7.26 - 7.20 (m, 1 H, ArH), 7.16 (d, J = 7.8 Hz, 1 H, ArH), 4.20 
(s, 2 H, CH3NCH2Ar), 2.66 (s, 3 H, CH3NCH2Ar ), 1.36 (s, 12 H, BPin); 
13C NMR (125.75 
MHz, CDCl3) δ 165.0, 152.2, 151.4, 140.0, 136.7, 134.6, 130.9, 130.4, 129.0, 125.8, 124.9, 
124.3, 122.9, 122.1, 121.4, 83.8, 61.1, 43.0, 24.9; HRMS (ESI): m/z calculated for 
C27H29BN2O2S: requires 479.1940 for [M+Na]











4-Methoxybenzaldehyde (0. 6 mL, 4.98 mmol), 2-hydroxyacetophenone (0.60 mL, 4.98 
mmol) and NaOH (0.60 g) in MeOH (20 mL) was refluxed for 3 h. The reaction mixture 
was then cooled to rt and 0.5 M NaOH (10 mL) and H2O2 – 35 % in H2O (2.00 mL) was 
added. The reaction mixture was stirred for a further 2 h before being quenched in ice-water. 
The precipitate was filtered and the title compound was isolated as a yellow solid (0.445 g, 
1.66 mmol, 33 %). M.p. 230 – 232 oC; 1H NMR (300 MHz, DMSO-d6) δ 8.47 (d, J = 8.1 Hz, 
2 H, ArH), 8.06 (d, J = 7.7 Hz, 1 H, ArH), 7.67 (br. s., 2 H, ArH), 7.41 - 7.28 (m, 1 H, ArH), 
7.02 (d, J = 8.1 Hz, 2 H, ArH), 3.81 (s, 3 H, OMe); 13C NMR (125.5 MHz, DMSO-d6) δ 
182.6, 163.8, 158.9, 149.5, 136.7, 132.9, 131.9, 129.9, 128.2, 126.4, 123.2, 118.7, 60.3; I.R 
(thinfilm) ν max (cm-1): 3200.59 (O-H, Br); HRMS (FTMS): m/z calculated for C16H12O4: 

















3-hydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one (0.15 g. 0.55 mmol), 2-(4-
(bromomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.16 g, 0.55 mmol), 
K2CO3 (0.15 g, 1.12 mmol) in DMF (5 mL) was stirred for 16 h. The reaction mixture was 
then quenched with H2O (20 mL) and EtOAc (20 mL). The aqueous layer was extracted with 
EtOAc (2 x 20 mL). The combined organics were then washed with H2O (3 x 30 mL), Brine 
(50 mL) and dried (MgSO4). The solvent was then removed in-vacuo to afford the crude 
material, which was then purified via trituration (Et2O). The title compound was isolated as 
a cream solid (0.142 g, 0.29 mmol, 53 %). M.p. 161-164 oC;  1H NMR (300 MHz, CDCl3) δ 
8.28 (d, J = 8.1 Hz, 1 H, ArH), 8.11 - 7.99 (d, J = 9.0 Hz, 2 H, ArH), 7.75 - 7.63 (m, 3 H, 
ArH), 7.52 (d, J = 7.9 Hz, 1 H, ArH), 7.37 (m, 3 H, ArH), 7.00 - 6.93 (d, J = 9.0 Hz, 2 H, 
ArH), 5.17 (s, 2 H, CH2Ar), 3.90 (s, 3 H), 1.35 (s, 12 H); 
13C NMR (75 MHz, CDCl3) δ 
175.0, 161.5, 156.4, 155.2, 139.8, 139.2, 134.7, 133.3, 130.6, 127.9, 125.8, 124.6, 124.2, 
123.3, 117.9, 113.8, 83.8, 73.8, 55.4, 24.9; I.R (thinfilm) ν max (cm-1): 1630.57 (C=O); 














p-Tolualdehyde (0. 60 mL, 4.98 mmol), 2-hydroxyacetophenone (0.60 mL, 4.98 mmol) and 
NaOH (0.60 g) in MeOH (20 mL) was refluxed for 3 h. The reaction mixture was then cooled 
to rt and 0.5 M NaOH (10 mL) and H2O2 – 35 % in H2O (2.00 mL) was added. The reaction 
mixture was stirred for a further 2 h before being quenched in ice-water. The precipitate was 
filtered and the title compound was isolated as a yellow solid (0.355 g, 1.41 mmol, 28 %). 
M.p >250 oC (Decomp); 1H NMR (300 MHz, DMSO-d6) δ 8.48 - 8.34 (d, J = 8.3 Hz, 2 H, 
ArH), 8.05 (d, J = 7.7 Hz, 1 H, ArH), 7.71 - 7.58 (m, 2 H, ArH), 7.36 - 7.28 (m, 1 H, ArH), 
7.28 - 7.18 (d, J = 8.3 Hz, 2 H, ArH), 2.34 (s, 3 H, ArCH3); 
13C NMR (75 MHz, DMSO-d6) 
δ 177.8, 154.2, 144.4, 137.0, 132.1, 131.6, 129.0, 126.2, 125.1, 123.3, 121.5, 118.5, 21.4; 
I.R (thinfilm) ν max (cm-1): 3281.52 (O-H); HRMS (FTMS): m/z calculated for C16H12O3: 

















3-Hydroxy-2-(p-tolyl)-4H-chromen-4-one (0.15 g. 0.60 mmol), 2-(4-
(bromomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.18 g, 0.60 mmol), 
K2CO3 (0.165 g, 1.20 mmol) in DMF (5 mL) was stirred for 16 h. The reaction mixture was 
then quenched with H2O (20 mL) and EtOAc (20 mL). The aqueous layer was extracted with 
EtOAc (2 x 20 mL). The combined organics were then washed with H2O (3 x 30 mL), Brine 
(50 mL) and dried (MgSO4). The solvent was then removed in-vacuo to afford the crude 
material, which was then purified via column chromatography 10:90 (EtOAc/ Pet Ether). 
The title compound was isolated as a cream solid (0.15 g, 0.32 mmol, 53 %); M.p 132 - 135 
oC .1H NMR (500 MHz, CDCl3) δ 8.28 (d, J = 7.8 Hz, 1 H, ArH), 7.94 (d, J = 8.3 Hz, 2 H, 
ArH), 7.74 - 7.64 (m, 3 H, ArH), 7.52 (d, J = 8.3 Hz, 1 H, ArH), 7.41 (t, J = 7.6 Hz, 1 H, 
ArH), 7.35 (d, J = 7.8 Hz, 2 H, ArH), 7.26 (d, J = 7.3 Hz, 2 H, ArH), 5.16 (s, 2 H, CH2Ar), 
2.43 (s, 3 H, ArCH3), 1.34 (s, 12 H, BPin); 
13C NMR (125.5 MHz, CDCl3) δ 175.1, 156.6, 
155.2, 141.1, 139.8, 139.6, 134.7, 133.3, 129.1, 128.8, 128.1, 127.8, 125.8, 124.6, 124.2, 
118.0, 83.8, 73.8, 24.9, 21.6; I.R (thinfilm) ν max (cm-1): 2979.06 (C-H sp3);  HRMS 
(FTMS): m/z calculated for C29H29BO6: requires 466.2061 for [M-H]











Benzaldehyde (0. 6 mL, 4.98 mmol), 2-hydroxyacetophenone (0.60 mL, 4.98 mmol) and 
NaOH (0.60 g) in MeOH (20 mL) was refluxed for 3 h. The reaction mixture was then cooled 
to rt and 0.5 M NaOH (10 mL) and H2O2 – 35 % in H2O (2.00 mL) was added. The reaction 
mixture was stirred for a further 2 h before being quenched in ice-water. The precipitate was 
filtered and the title compound was isolated as a yellow solid (0.324 g, 1.36 mmol, 27 %). 
M.p. >245 oC (decomp); 1H NMR (300 MHz, DMSO-d6) δ 8.58 (d, J = 7.5 Hz, 2 H, ArH), 
8.05 (d, J = 8.9 Hz, 1 H, ArH), 7.71 - 7.57 (m, 2 H, ArH), 7.49 - 7.20 (m, 5 H, ArH); 13C 
NMR (75 MHz, DMSO-d6) δ 177.8, 154.3, 148.0, 144.2, 134.3, 132.3, 128.4, 127.6, 126.2, 
125.1, 123.4, 121.6, 118.5; I.R (thinfilm) ν max (cm-1): 3063.66 (C-H sp2); HRMS (FTMS): 
m/z calculated for C15H10O3: requires 239.0703 for [M+H]



















3-Hydroxy-2-phenyl-4H-chromen-4-one (0.15 g. 0.63 mmol), 2-(4-(bromomethyl)phenyl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.19 g, 0.63 mmol), K2CO3 (0.173 g, 1.26 mmol) 
in DMF (5 mL) was stirred for 16 h. The reaction mixture was then quenched with H2O (20 
mL) and EtOAc (20 mL). The aqueous layer was extracted with EtOAc (2 x 20 mL). The 
combined organics were then washed with H2O (3 x 30 mL), Brine (50 mL) and dried 
(MgSO4). The solvent was then removed in-vacuo to afford the crude material, which was 
then purified via column chromatography 10:90 (EtOAc/Pet ether). The title compound was 
isolated as a pale green solid (0.095 g, 0.21 mmol, 33 %); M.p. 107 - 109 oC; 1H NMR (300 
MHz, CDCl3) δ 8.30 (dd, J = 1.3, 8.1 Hz, 1 H, ArH), 8.07 - 7.96 (m, 2 H, ArH), 7.74 - 7.63 
(m, 3 H, ArH), 7.56 - 7.38 (m, 5 H, ArH), 7.31 (d, J = 8.1 Hz, 2 H, ArH), 5.18 (s, 2 H, 
CH2Ar), 1.35 (s, 12 H, BPin) 
13C NMR (75.5 MHz, CDCl3) δ 175.2, 156.5, 155.3, 139.8, 
139.7, 134.7, 133.5, 130.9, 130.7, 128.9, 128.3, 127.9, 125.8, 124.8, 124.2, 118.1, 83.8, 73.9, 
24.9; I.R (thinfilm) ν max (cm-1):  2976.68 (C-H sp3); HRMS (FTMS): m/z calculated for 
C28H27BO5: requires 452.1904 for [M-H]













NaOEt (0.391 g, 5.75 mmol) was added to a solution of 3-hydroxy-3-methyl-2-butanone (4 
mL, 38 mmol) and malonitrile (4.9 g, 74 mmol) in EtOH (10 mL) and stirred for 1.5 h. The 
reaction mixture was then refluxed for 1 h, which was then cooled to rt. The mixture was 
cooled and the solid precipitate was filtered to afford the title compound as a pale grey solid 
(4.92 g, 24.70 mmol, 65 %); M.p. 204 – 208 oC (decomp). 1H NMR (500 MHz, CDCl3) δ 
2.37 (s, 3 H), 1.64 (s, 6 H); 13C NMR (75.5 MHz, CDCl3) δ 182.6, 175.2, 111.1, 110.4, 109.0, 
104.8, 99.8, 58.5, 24.4, 14.2; I.R (thinfilm) ν max (cm-1): 2232.78, 2222.00 (CN); HRMS 
(FTMS-NSI): m/z calculated for C11H9N3O: requires 200.0108 for [M+H]






















Two drops of Piperidine were added to a mixture of 4-hydroxybenzaldehyde (0.122 g, 1 
mmol) and TCF (0.228 g, 1.15 mmol) in EtOH (10 mL). The reaction mixture was heated in 
the microwave for 15 min at 100 oC, which was then cooled to rt. The solid precipitate was 
filtered off to afford the title compound as an orange solid (0.218 g, 0.72 mmol, 72 %) M.p. 
202 – 206 oC (decomp). 1H NMR (300 MHz, DMSO-d6) δ = 7.95 - 7.73 (m, 3 H), 7.01 (d, J 
= 16.2 Hz, 1 H), 6.89 (d, J = 8.7 Hz, 2 H), 1.77 (s, 6 H); 13C NMR (75.5 MHz, DMSO-d6) δ 
177.6, 176.2, 162.7, 148.7, 132.7, 126.0, 116.8, 113.3, 112.5, 112.0, 111.6, 99.4, 96.9, 53.5, 
25.7; I.R (thinfilm) ν max (cm-1): 3361.61 (O-H), 2224.73 (CN); HRMS (FTMS-NSI): m/z 
calculated for C18H13N3O2: requires 304.1081 for [M+H]



















g, 0.297 mmol), 2-(4-(bromomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(0.088 g, 0.297 mmol), K2CO3 (0.123 g, 0.89 mmol) and NaI (0.044 g, 0.297 mmol) in 
MeCN (5 mL) was stirred overnight at rt. The reaction mixture was partitioned with EtOAc 
(50 mL) and H2O (50 mL). The organic layer was washed with H2O (2 x 50 mL), Brine (50 
mL) and dried (MgSO4). The solvent was removed in-vacuo and the crude material was 
triturated (MeOH) to afford the title compound as a red solid (0.073 g, 0.14 mmol, 47 %) 
M.p. 267 – 269 oC. 1H NMR (500 MHz, CDCl3) δ 7.88 - 7.82 (d, J = 8.3 Hz, 2 H), 7.67 - 
7.57 (m, 3 H), 7.48 - 7.40 (d, J = 8.3 Hz, 2 H), 7.05 (d, J = 8.8 Hz, 2 H), 6.90 (d, J = 16.1 
Hz, 1 H), 5.19 (s, 2 H), 1.79 (s, 6 H), 1.36 (s, 12 H); 13C NMR (125.5 MHz, CDCl3) δ 175.5, 
174.0, 162.8, 147.2, 138.8, 135.2, 131.3, 126.9, 126.5, 116.0, 112.5, 111.8, 111.0, 110.4, 
97.4, 83.9, 70.3, 26.5, 24.8; I.R (thinfilm) ν max (cm-1): 2227.39 (CN); HRMS (FTMS-NSI): 
m/z calculated for C31H30BN3O4: requires 536.2704 for [M+NH4]













Two drops of Piperidine was added to a mixture of 4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)benzaldehyde (0.232 g, 1 mmol) and TCF (0.288 g, 1.15 mmol) in EtOH 
(10 mL). The reaction mixture was heated in the microwave at 100 oC for 15 min. The 
reaction mixture was cooled and the solid was filtered off to afford the title compound as an 
orange solid (0.310 g, 0.75 mmol, 75 %)  M.p. 275 – 278 oC; 1H NMR (300 MHz, CDCl3) δ 
7.90 (d, J = 8.1 Hz, 2 H), 7.71 - 7.59 (m, 3 H), 7.11 (d, J = 16.4 Hz, 1 H), 1.82 (s, 6 H), 1.37 
(s, 12 H); 13C NMR (75.5 MHz, CDCl3) δ 175.2, 173.7, 147.3, 135.9, 135.7, 128.1, 115.6, 
111.6, 110.8, 110.1, 100.6, 97.9, 84.4, 58.2, 26.5, 24.9; I.R (thinfilm) ν max (cm-1): 2231.63 
(CN); HRMS (FTMS-NSI): m/z calculated for C24H24BN3O3: requires 430.2285 for 
[M+NH4]


















Following the literature procedure40, Fluorescein (2.00 g, 5.8 mmol) and N-Phenyl 
bis(trifluoromethanesulfonamide) (2.1g, 5.8 mmol) were dissolved in dry DMF (15 mL) and 
flushed with nitrogen. Diisopropylethylamine (3.8 mL) was then added and the reaction 
mixture was stirred for 48 h. The reaction mixture was quenched with 1 M HCl (100 mL) 
and extracted with EtOAc (3 x 100 mL). The combined organics were dried (MgSO4) and 
concentrated in-vacuo to afford the crude material. The crude was purified via column 
chromatography EtOAc/Pet Ether (10:90 to 50:50) and the title compound was isolated as a 
white solid (1.24 g, 2.67 mmol, 46 %). M.P. 139 – 142 oC; 1H NMR (300 MHz, DMSO-d6) 
δ 10.30 (br. s., 1 H, O-H), 8.05 (d, J = 7.0 Hz, 1 H, ArH), 7.87 - 7.67 (m, 4 H, ArH), 7.38 (d, 
J = 7.5 Hz, 1 H, ArH), 7.24 (dd, J = 2.6, 8.9 Hz, 1 H, ArH), 7.02 (d, J = 8.9 Hz, 1 H, ArH), 
6.78 - 6.72 (m, 1 H, ArH), 6.63 (s, 2 H, ArH); 13C NMR (75.5 MHz, DMSO-d6) δ 168.8, 
160.2, 152.4, 151.7, 151.6, 150.0, 136.3, 130.9, 129.6, 125.9, 125.3, 124.5, 120.7, q, 1J = 
321.30 Hz, 116.4, q, 1J = 321.30 Hz,113.8, 111.1, 109.1, 102.6, 81.6; I.R (thinfilm) ν max 
(cm-1): 3389.62 (O-H), 1736.19 (C=O); HRMS (TOF MS ASAP+): m/z calculated for 
C21H11F3O7S: requires 465.0256 for [M+H]












To a solution of 3'-hydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthen]-6'-yl 
trifluoromethanesulfonate (0.630 g, 1.36 mmol) in DMF (10 mL). Bis(pinacolato) diboron 
(0.62 g, 2.44 mmol), KOAc (0.80 g, 8.15 mmol) and Pd(dppf)Cl2.DCM (0.10 g, 0.14 mmol) 
was added and the reaction mixture was heated at 95 oC under N2 for 16 h. The reaction 
mixture was then cooled to rt and EtOAc (100 mL) and H2O (100 mL) were added. The 
aqueous layer was extracted with EtOAc (2 x 100 mL). The combined organics were then 
washed with H2O (2 x 100 mL), brine (100 mL) and dried (MgSO4) and concentrated in-
vacuo to afford the crude material. The crude material was purified via column 
chromatography EtOAc:Pet Ether (10:90 to 40:60) to afford the title compound as a pale 
clear oil (0.15 g, 0.34 mmol, 25 %). 1H NMR (500 MHz, CDCl3) δ 8.04 (d, J = 7.3 Hz, 1 H), 
7.73 (s, 1 H), 7.68 - 7.59 (m, 2 H), 7.43 (d, J = 7.8 Hz, 1 H), 7.14 (d, J = 7.3 Hz, 1 H), 6.81 
- 6.76 (m, 2 H), 6.65 (d, J = 8.8 Hz, 1 H), 6.56 (dd, J = 2.2, 8.6 Hz, 1 H), 1.36 (s, 12 H); 13C 
NMR (125.75 MHz, CDCl3) δ 170.0, 158.2, 153.4, 152.4, 150.7, 135.2, 129.8, 129.3, 129.2, 
127.2, 126.3, 125.1, 123.9, 123.5, 121.4, 112.4, 110.6, 103.3, 84.3, 24.8, 24.8; I.R (thinfilm) 
ν max (cm-1): 1746.51 (C=O); HRMS (TOF MS ASAP+): m/z calculated for C26H23BO6: 












2,4-Dinitrobenzenesulfonyl chloride (0.089 g, 0.033 mmol) in DCM (3 mL) was added 
dropwise to a solution of 3'-hydroxy-6'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-
spiro[isobenzofuran-1,9'-xanthen]-3-one (0.15 g, 0.34 mmol) and NEt3 (95 µL, 0.69 mmol) 
in DCM (5 mL) at 0 oC. The reaction mixture was stirred at 0 oC for 2 h before the addition 
of H2O (15 mL) and DCM (15 mL). The organic layer was washed with H2O (2 x 10 mL), 
brine (10 mL) and dried (MgSO4) and concentrated in-vacuo to afford the crude material. 
The crude material was purified via column chromatography EtOAc:Pet Ether (10:90 to 
40:60) to afford the title compound as a pale yellow solid (0.115 g, 0.17 mmol, 52 %); M.p. 
119-122 oC; 1H NMR (500MHz, CDCl3) δ 8.67 (d, J = 2.0 Hz, 1 H, ArH), 8.53 (dd, J = 2.0, 
8.8 Hz, 1 H, ArH), 8.25 (d, J = 8.8 Hz, 1 H, ArH), 8.03 (d, J = 7.3 Hz, 1 H, ArH), 7.73 (s, 1 
H, ArH), 7.69 - 7.62 (m, 2 H, ArH), 7.47 (d, J = 7.8 Hz, 1 H, ArH), 7.19 (d, J = 2.0 Hz, 1 H, 
ArH), 7.11 (d, J = 7.8 Hz, 1 H, ArH), 6.91 (dd, J = 2.2, 8.6 Hz, 1 H, ArH), 6.86 (d, J = 8.3 
Hz, 1 H, ArH), 6.82 (d, J = 7.8 Hz, 1 H, ArH), 1.35 (s, 12 H, BPin); 13C NMR (125.75 MHz, 
CDCl3) δ 169.0, 153.0, 151.9, 151.1, 150.0, 149.5, 149.0, 135.4, 134.0, 133.3, 130.2, 130.2, 
129.8, 127.0, 126.7, 125.6, 125.4, 123.7, 123.4, 121.0, 120.5, 119.2, 117.2, 111.0, 84.3, 24.9, 
24.8, 24.8; I.R (thinfilm) ν max (cm-1): 1766.44 (C=O); HRMS (FTMS-NSI): m/z calculated 
for C32H25BN2O12S: requires 672.1330 for [M+H]









Phenoxazine (1.00 g, 5.46 mmol) was dissolved in DMF (25 mL) before being cooled to 0 
oC. NaH – 60% in mineral oil (0.327 g, 8.18 mmol) was then added portion wise to the 
solution over the period of 5 min, which was then left to stir at 0 oC for a further 10 min. 
Benzyl bromide (1.3 mL, 10.92 mmol) was then added portion-wise to the reaction mixture 
and then was left to stir for 4 hrs at rt. The reaction mixture was then cooled to 0 oC before 
being quenched with dropwise addition of H2O. The reaction mixture was partitioned with 
EtOAc (100 mL) and H2O (100 mL). The organic layer was washed with H2O (3 x 50 mL), 
brine (50 mL) and dried (MgSO4) and concentrated in-vacuo to afford the crude product. 29 
was purified via trituration (Pet ether) to afford a white solid (1.11 g, 4.06 mmol, 75 %). Mp 
122- 125 oC; 1H NMR (300 MHz, CDCl3) δ 7.47 - 7.21 (m, 5 H, CH2ArH), 6.78 - 6.59 (m, 
6 H, ArH), 6.35 (d, J = 7.0 Hz, 2 H, ArH), 4.80 (br. s., 2 H, CH2Ar); 
13C NMR (75.5 MHz, 
CDCl3) δ 145.2, 136.3, 133.9, 129.0, 127.2, 126.0, 123.7, 121.3, 115.3, 112.2, 49.3; HRMS 
(ESI): m/z calculated for C19H15NO: requires 274.1231 for [M+H]
+, found 274.1212; 













To a solution of 112 (1.10 g, 4.26 mmol) in CHCl3 (100 mL), NBS (1.62 g, 9.08 mmol) was 
added portion-wise and the reaction was left to stir for 1 hr. The reaction was then quenched 
with H2O (100 mL) and the organic layer was washed with H2O (3 x 100 mL), brine (100 
mL) and dried (MgSO4) and concentrated in-vacuo to afford a blue/green solid. No further 
purification was required (1.11 g, 2.16 mmol, 48 %). M.p. 161-164 oC; 1H NMR (300 MHz, 
CDCl3) δ 7.42 - 7.22 (m, 5 H, CH2ArH), 6.86 - 6.78 (m, 4 H, ArH), 6.19 (d, J = 9.0 Hz, 2 H, 
ArH), 4.72 (s, 2 H, CH2Ar); 
13C NMR (75.5 MHz, CDCl3) δ 145.4, 135.1, 132.7, 129.1, 


















113 (1.14 g, 2.64 mmol), bis(pinacolato) diboron (2.01 g, 7.93 mmol), potassium acetate 
(1.55 g, 15.84 mmol) and Pd(dppf)Cl2 (0.193 g, 0.264 mmol) was dissolved in anhydrous 
DMF (15 mL) and refluxed under argon for 2 hrs. The reaction was cooled to rt and 
partitioned with EtOAc (50 mL) and H2O (50 mL). The organic layer was washed with H2O 
(3 x 50 mL), brine (50 mL), dried (MgSO4) and concentrated in-vacuo to afford the crude 
product. 114 was purified via column chromatography 5:95 (EtOAc/Pet Ether) and 
trituration (Pet ether) to afford a white solid (0.81 g, 1.54 mmol, 58 %). M.p. 218-221 oC. 
1H NMR (300 MHz, CDCl3) δ 7.37 - 7.23 (m, 5 H, CH2ArH), 7.20 - 7.11 (d, J = 7.9 Hz, 2 
H, ArH), 7.08 (s, 2 H, ArH), 6.37 - 6.30 (d, J = 7.9 Hz, 2 H, ArH), 4.81 (s, 2 H, CH2Ar), 
1.31 (s, 24 H, BPin); 13C NMR (75.5 MHz, CDCl3) δ 144.8, 136.0, 135.6, 131.0, 129.0, 
127.3, 126.0, 121.0, 111.7, 83.6, 48.7, 24.8; HRMS (TOF MS ASAP+): m/z calculated for 
C31H38B2NO5: requires 524.3009 for [M+H]














To a solution of 114 (0.81 g, 1.54 mmol) in MeOH (5 mL) and THF (5 mL) were added 10 
% Pd/C (0.082 g, 0.077 mmol). The resulting suspension was placed under a hydrogen 
atmosphere (1 atm) and stirred for 5 h. The reaction mixture was filtered through a pad of 
celite and the filtrate was dried (MgSO4) and concentrated in vacuo to afford the title 
compound as a dark red-orange solid (quant yield). M.p. 214-217 oC. 1H NMR (500 MHz, 
Acetone-d6) δ 7.73 (s, 1 H, N-H), 7.16 - 7.09 (d, J = 7.3 Hz, 2 H, ArH), 6.92 (s, 2 H, ArH), 
6.51 - 6.45 (d, J = 7.3 Hz, 2 H, ArH), 1.29 (s, 24 H); 13C NMR (125.75 MHz, Acetone-d6) 

















Phenoxazine (1.00 g, 5.46 mmol) was dissolved in DMF (25 mL) before being cooled to 0 
oC. NaH – 60% in mineral oil (0.26 g, 6.60 mmol) was then added portion wise to the solution 
over the period of 5 min, which was then left to stir at 0 oC for a further 10 min. 4-
Bromobenzyl bromide (1.65 g, 6.60 mmol) was then added portion-wise to the reaction 
mixture and then was left to stir for 4 hrs at rt. The reaction mixture was then cooled to 0 oC 
before being quenched with dropwise addition of H2O. The reaction mixture was partitioned 
with EtOAc (100 mL) and H2O (100 mL). The organic layer was washed with H2O (3 x 50 
mL), brine (50 mL) and dried (MgSO4) and concentrated in-vacuo to afford the crude 
product. 115 was purified via column chromatography 5:95 (EtOAc/Pet ether) to afford a 
white solid (1.50 g, 4.26 mmol, 78 %). M.p. 109-111 oC; 1H NMR (500 MHz, CDCl3) δ  7.47 
(d, J = 8.8 Hz, 2 H, CH2ArH), 7.19 (d, J = 8.8 Hz, 2 H, CH2ArH), 6.72 - 6.66 (m, 6 H, ArH), 
6.28 (d, J = 7.3 Hz, 2 H, ArH), 4.72 (s, 2 H, CH2Ar); 
13C NMR (125.5 MHz, CDCl3) δ 145.1, 
132.0, 131.6, 129.3, 127.8, 123.7, 121.5, 121.0, 115.4, 112.0, 48.9; I.R (thinfilm) ν max (cm-
1): 3037.8 (C-H sp2), 2933.66 (C-H Sp3), 1485.95 (C=C); HRMS (ESI): m/z calculated for 
C19H14BrNO: requires 352.0337 for [M+H]













To a solution of 115 (1.50 g, 4.26 mmol) in CHCl3 (120 mL), NBS (1.62 g, 9.08 mmol) was 
added portion-wise and the reaction was left to stir for 1 hr. The reaction was then quenched 
with H2O (100 mL) and the organic layer was washed with H2O (3 x 100 mL), brine (100 
mL) and dried (MgSO4) and concentrated in-vacuo to afford the crude product. 116 was 
purified via trituration (EtOAc) to afford a cream solid (1.11 g, 2.16 mmol, 48 %). M.p. 204-
206 oC; 1H NMR (300 MHz, CDCl3) δ 7.54 - 7.43 (d, J = 8.3 Hz, 2 H, CH2ArH), 7.17 - 7.10 
(d, J = 8.3 Hz, 2 H, CH2ArH), 6.86 - 6.78 (m, 4 H, ArH), 6.14 (d, J = 9.0 Hz, 2 H, ArH), 
4.67 (s, 2 H, CH2Ar); 
13C NMR (75.5 MHz, CDCl3) δ 145.3, 134.2, 132.4, 132.3, 127.7, 


















116 (0.20 g, 0.39 mmol), bis(pinacolato) diboron (0.40 g, 1.56 mmol), potassium acetate 
(0.229 g, 2.34 mmol) and Pd(dppf)Cl2.DCM (0.028 g, 0.039 mmol) was dissolved in 
anhydrous DMF (7 mL) and refluxed under argon for 2 h. The reaction was cooled to rt and 
partitioned with EtOAc (50 mL) and H2O (50 mL). The organic layer was washed with H2O 
(3 x 50 mL), brine (50 mL), dried (MgSO4) and concentrated in-vacuo to afford the crude 
product. 117 was purified via column chromatography 5:95 (EtOAc/Pet Ether) and 
trituration (Pet ether) to afford a white solid (0.088 g, 0.14 mmol, 36 %). M.p. 265-268 oC 
(decomposed); 1H NMR (500 MHz, Acetone-d6) δ 7.76 - 7.71 (d, J = 7.8 Hz, 2 H, CH2ArH), 
7.39 - 7.33 (d, J = 7.8 Hz, 2 H, CH2ArH), 7.16 - 7.11 (d, J = 7.8 Hz, 2 H, ArH), 6.99 (s, 2 H, 
ArH), 6.53 - 6.45 (d, J = 7.8 Hz, 2 H, ArH), 4.98 (s, 2 H, CH2Ar), 1.32 (s, 12 H, BPin), 1.29 
(s, 24 H, BPin); 13C NMR (75.5MHz, CDCl3) δ 144.8, 139.1, 136.0, 135.5, 131.0, 125.4, 
121.0, 111.7, 83.8, 83.6, 83.5, 49.2, 25.1, 24.9, 24.8; HRMS (TOF MS ASAP+): m/z 
calculated for C37H49B3NO7: requires 650.3861 for [M+H]












Phenoxazine (5.00 g, 25 mmol) was dissolved in AcOH (200 mL) and Br2 (3.3 mL) in AcOH 
(200 mL) was added dropwise to the reaction mixture over the course of 1 h. The reaction 
mixture was left to stir overnight and the reaction was then cooled to 0 oC. Na2SO3 (6.5 g) 
was added and the reaction was stirred for another 1 h before the addition of KOH (4.5 g) in 
H2O (1 L). a blue precipitate formed, which was filtered and recrystallized with Acetone to 
afford the title compound as a pale green solid (6.24 g, 17.5 mmol, 70 %). M.p. 191 – 193 
oC; 1H NMR (300 MHz, DMSO-d6) δ 8.85 (s, 1 H), 7.20 - 7.09 (m, 4 H), 6.58 (d, J = 8.3 Hz, 
2 H); 13C NMR (75.5 MHz, DMSO-d6) δ 141.3, 130.7, 128.5, 118.6, 116.4, 113.1; I.R 
(thinfilm) ν max (cm-1): 3310.68 (N-H); HRMS (TOF MS ASAP+): m/z calculated for 
C12H7Br2NS requires 354.8666 for [M+]

















3,7-Dibromo-10H-phenothiazine (0.50 g, 1.4 mmol), bis(pinacolato) diboron (1.06 g, 4.20 
mmol), potassium acetate (0.824 g, 8.40 mmol) and Pd(dppf)Cl2 (0.102 g, 0.14 mmol) was 
dissolved in anhydrous DMF (10 mL) and refluxed under argon for 17 hrs. The reaction was 
cooled to rt and partitioned with EtOAc (50 mL) and H2O (50 mL). The organic layer was 
washed with H2O (3 x 50 mL), brine (50 mL), dried (MgSO4) and concentrated in-vacuo to 
afford title crude product. This was purified via column chromatography 20:80 (EtOAc/Pet 
Ether) to afford a pale yellow solid (0.188 g, 0.42 mmol, 30 %). M.P. >300 oC; 1H NMR 
(300 MHz, Acetone-d6) δ 7.37 - 7.30 (m, 2 H), 7.24 (s, 2 H), 6.67 (dd, J = 1.1, 7.9 Hz, 2 H), 
1.30 (s, 24 H); 13C NMR (75.5 MHz, Acetone-d6) δ 145.3, 135.6, 133.8, 118.0, 115.3, 84.7, 
25.6; HRMS (FTMS-NSI): m/z calculated for C24H31B2NO4S requires 450.2305 for 
















Phenothiazine (2.00 g, 10.00 mmol) was dissolved in DMF (50 mL) and cooled to 0 oC 
before the portionwise addition of NaH – 60 % in mineral oil (0.6 g, 15 mmol). The reaction 
mixture was stirred for 10 min before the addition of 4-bromobenzylbromide (2.50 g, 10 
mmol), which was then stirred for 4 h. The reaction mixture was quenched with H2O (50 
mL) and EtOAc (150 mL) was added. The organic layer was washed with H2O (3 x 50 mL), 
Brine (50 mL) and dried (MgSO4). The solvent was removed in-vacuo to afford the title 
compound as a purple solid (3.08 g, 8.36 mmol, 84 %). M.p. 131 – 134 oC. 1H NMR (300 
MHz, CDCl3) δ 7.54 - 7.38 (d, J = 8.3 Hz, 2 H), 7.25 - 7.17 (d, J = 8.3 Hz, 2 H), 7.11 (dd, J 
= 1.5, 7.5 Hz, 2 H), 7.06 - 6.95 (m, 2 H), 6.89 (m, 2 H), 6.61 (d, J = 7.9 Hz, 2 H), 5.04 (s, 2 
H); 13C NMR (75.5 MHz, CDCl3) δ 144.3, 135.8, 131.9, 128.5, 127.3, 127.0, 123.4, 122.7, 
120.8, 115.4, 52.1; I.R (thinfilm) ν max (cm-1): 3047.43 (C-H sp2); HRMS (TOF MS 
ASAP+): m/z calculated for C19H14BrNS requires 368.0103 for [M+H]













10-(4-bromobenzyl)-10H-phenothiazine (2.00 g, 5.43 mmol) was dissolved in DCM (120 
mL) before NBS (1.92 g, 10.86 mmol) was added portion wise. The reaction mixture was 
left to stir for 2 h before being quenched with H2O (100 mL). The reaction mixture was 
partitioned and the aqueous layer was extracted with DCM (50 mL). The combined organics 
was washed with H2O (3 x 50 mL), brine (50 mL) and dried (MgSO4). The solvent was 
removed in-vacuo to afford the crude material, which was purified via trituration (EtOAc) 
to afford the title compound as a pale blue solid (1.73 g, 3.29 mmol, 61 %). M.p. 214 – 216 
oC; 1H NMR (300 MHz, CDCl3)  7.51 - 7.43 (d, J = 8.5 Hz, 2 H), 7.20 (d, J = 2.4 Hz, 2 
H), 7.17 - 7.12 (d, J = 8.5 Hz, 2 H), 7.09 (dd, J = 2.3, 8.7 Hz, 2 H), 6.44 (d, J = 8.7 Hz, 2 H), 
4.95 (s, 2 H); 13C NMR (75.5 MHz, CDCl3)  143.1, 134.7, 132.1, 130.2, 129.3, 128.3, 
















3,7-dibromo-10-(4-bromobenzyl)-10H-phenothiazine (0.25 g, 0.48 mmol), bis(pinacolato) 
diboron (0.487 g, 1.92 mmol), KOAc (0.283 g, 2.88 mmol) and Pd(dppf)Cl2.DCM (0.035 g, 
0.048 mmol) was dissolved in anhydrous DMF (10 mL) and refluxed under argon for 17 hrs. 
The reaction was cooled to rt and partitioned with EtOAc (50 mL) and H2O (50 mL). The 
organic layer was washed with H2O (3 x 50 mL), brine (50 mL), dried (MgSO4) and 
concentrated in-vacuo to afford title crude product. This was purified via trituration (Pet 
ether) to afford a white solid (0.10 g, 0.15 mmol, 31 %). M.p. 275 – 277 oC; 1H NMR (300 
MHz, Acetone-d6) δ 7.71 (d, J = 8.1 Hz, 2 H), 7.43 - 7.32 (m, 7 H), 6.76 (d, J = 8.1 Hz, 2 
H), 5.24 (s, 2 H), 1.31 (s, 12 H), 1.28 (s, 24 H); 13C NMR (75.5 MHz, Acetone-d6) δ 147.9, 
141.3, 136.3, 135.4, 134.1, 127.4, 123.4, 116.6, 84.9, 53.2, 25.5; I.R (thinfilm) ν max (cm-
1): 2978.79 (C-H sp3); HRMS (TOF ASAP+): m/z calculated for C37H48B3NO6S requires 










   
 
4-Hydroxybenzaldehyde (4.00 g, 32.75 mmol) was dissolved in DMF (50 mL) followed by 
the addition of imidazole (4.90 g, 72.05 mmol) and tert-butyldimethylsilyl chloride (5.20 g, 
34.40 mmol). The reaction mixture was stirred for 16 h before the addition of H2O (100 mL) 
and EtOAc (100 mL). The aqueous layer was extracted with EtOAc (100 mL). The combined 
organic layers were then washed with H2O (3 x 100 mL), brine (100 mL) and dried (MgSO4). 
The solvent was removed in-vacuo affording the title compound as a clear oil, no purification 
was required. (6.12 g, 25.90 mmol, 79 %). 1H NMR (300 MHz, CDCl3) δ 9.88 (s, 1 H, CHO), 
7.85 - 7.75 (d, J = 8.7 Hz, 2 H, ArH), 7.00 - 6.88 (d, J = 8.5 Hz, 2 H, ArH), 0.99 (s, 9 H, 
OSi(CH3)2)C(CH3)3), 0.25 (s, 6 H, OSi(CH3)2)C(CH3)3); 
13C NMR (75.5 MHz, CDCl3) δ 
191.1, 161.6, 132.0, 130.3, 120.5, 25.6, 18.3, -4.3; I.R (thinfilm) ν max (cm-1): 1697.55 
















4-((tert-butyldimethylsilyl)oxy)benzaldehyde (6.12 g, 25.89 mmol) was dissolved in MeOH 
(200 mL) and NaBH4 (1.47 g, 38.84 mmol) was added portionwise. The reaction mixture 
was stirred at rt for 2 h before being quenched with saturated aqueous ammonium chloride 
(50 mL). The solution was then extracted with DCM (3 x 50 mL) and the combined organics 
were washed with H2O (50 mL), brine (50 mL) and dried (MgSO4). The solvent was then 
removed in-vacuo to afford the title compound as a clear oil. No purification was required 
(4.27 g, 17.91 mmol, 70%). 1H NMR (300 MHz, CDCl3) δ 7.25 - 7.15 (d, J = 8.5 Hz, 2 H, 
ArH), 6.86 - 6.78 (d, J = 8.5 Hz, 2 H, ArH), 4.56 (s, 2 H, ArCH2O), 1.00 (s, 9 H, 
OSi(CH3)2)C(CH3)3),  0.20 (s, 6 H, OSi(CH3)2)C(CH3)3); 
13C NMR (75.5 MHz, CDCl3) δ 
155.2, 133.8, 128.6, 120.1, 64.9, 25.7, 18.2, -4.4; I.R (thinfilm) ν max (cm-1): 3320.84  (br 














A solution of (4-((tert-butyldimethylsilyl)oxy)phenyl)methanol (3.00 g,12.58 mmol) in Et2O 
(120 mL) was cooled to 0 oC before the dropwise addition of PBr3 (1.35 mL, 13.84 mol). 
The reaction mixture was stirred at 0 oC for 1 h before being quenched with saturated 
aqueous ammonium chloride. The organic layer was washed with H2O (50 mL), brine (50 
mL), dried (MgSO4) and the solvent was removed in-vacuo to afford the title compound as 
a clear oil (2.70 g, 8.96 mmol, 71 %). 1H NMR (300 MHz, CDCl3) δ 7.10 - 7.02 (d, J = 8.7 
Hz, 2 H, ArH), 6.65 - 6.56 (d, J = 8.5 Hz, 2 H, ArH), 4.28 (s, 2 H, ArCH2), 0.78 (s, 9 H, 
OSi(CH3)2)C(CH3)3), 0.00 (s, 6 H, OSi(CH3)2)C(CH3)3); 
13C NMR (75.5 MHz, CDCl3) δ 















Phenoxazine (1.50 g, 8.20 mmol) was dissolved in DMF (60 mL) and cooled to 0 oC before 
the potionwise addition of NaH – 60 % in mineral oil (0.650 g, 16.40 mmol). The reaction 
mixture was stirred for 10 min before the dropwise addition of (4-
(bromomethyl)phenoxy)(tert-butyl)dimethylsilane (2.50 g, 8.20 mmol) in DMF (10 mL). 
The reaction was stirred at rt for 4 h before being quenched with H2O (10 mL). The reaction 
mixture was partitioned with EtOAc (100 mL) and H2O (100 mL). The aqueous layer was 
extracted with EtOAc (100 mL). The combined organics were then washed with H2O (100 
mL), brine (100 mL) and dried (MgSO4). The solvent was removed in-vacuo to afford the 
crude material, which was purified via column chromatography 5:95 to 40:60 (EtOAc/Pet 
ether) to afford the title compound as a pink solid (1.30 g, 4.49 mmol, 55 %). M.p. 196 – 
199 oC. 1H NMR (300 MHz, Acetone-d6) δ 8.33 (s, 1 H, O-H), 7.18 - 7.11 (d, J = 8.7 Hz, 2 
H, ArH), 6.85 - 6.79 (d, J = 8.7 Hz, 2 H, ArH), 6.79 - 6.62 (m, 6 H, ArH), 6.48 (d, J = 7.7 
Hz, 2 H, ArH), 4.78 (s, 2 H, ArCH2); 
13C NMR (75.5 MHz, Acetone-d6) δ 157.8, 146.2, 
135.1, 128.6, 128.2, 125.1, 122.3, 116.9, 116.3, 113.8, 48.7; I.R (thinfilm) ν max (cm-1): 
3456.21 (O-H); HRMS (FTMS-NSI): m/z calculated for C19H15NO2: requires: 290.1176 for 












To a solution of 4-((10H-phenoxazin-10-yl)methyl)phenol (1.00 g, 3.46 mmol) in DMF (50 
mL), imidazole (0.518 g, 7.61 mmol) and tert-butyldimethylsilyl chloride (0.572 g, 3.80 
mmol) was added. The reaction mixture was stirred at rt for 16 h before the addition of 
EtOAc (50 mL) and H2O (50 mL). The aqueous layer was extracted with EtOAc (2 x 50 
mL). The combined organics were washed with H2O (3 x 50 mL), brine (50 mL) and dried 
(MgSO4). The solvent was removed in-vacuo to afford the crude material, which was 
purified via column chromatography 2:98 (EtOAc: Pet ether). Purification afforded the title 
compound as a brown oil (0.87 g, 2.16 mmol, 62 %). 1H NMR (300 MHz, CDCl3) δ 7.21 - 
7.11 (d, J = 8.7 Hz, 2 H, ArH), 6.89 - 6.78 (m, J = 8.7 Hz, 2 H, ArH), 6.77 - 6.61 (m, 6 H, 
ArH)), 6.36 (d, J = 7.2 Hz, 2 H, ArH), 4.72 (s, 2 H, ArCH2), 0.99 (s, 9 H, 
OSi(CH3)2)C(CH3)3), 0.20 (s, 6 H, OSi(CH3)2)C(CH3)3); 
13C NMR (75.5 MHz, CDCl3) δ 
154.8, 145.2, 133.9, 128.6, 127.1, 123.7, 121.1, 120.4, 115.2, 112.3, 48.9, 25.7, 18.2, -4.4; 
I.R (thinfilm) ν max (cm-1): 3065.41 (C-H sp2); HRMS (ESI): m/z calculated for 
C25H29NO2Si: requires: 426.1865 for [M+H]














NBS (0.767 g, 4.31 mmol) was added portionwise to a solution of 10-(4-((tert-
butyldimethylsilyl)oxy)benzyl)-10H-phenoxazine in CHCl3 (50 mL). The reaction mixture 
was left to stir for 1 h before being quenched with H2O (50 mL). The organic layer was 
washed with H2O (3 x 50 mL), brine (50 mL)  and dried (MgSO4). The solvent was removed 
in-vacuo to afford the title compound as a blue/green oil (0.87 g, 1.55 mmol, 72 %).  1H 
NMR (300 MHz, CDCl3) δ 7.21 (d, J = 8.7 Hz, 2 H, ArH), 6.98 - 6.80 (m, 7 H, ArH), 6.45 
(d, J = 8.7 Hz, 2 H, ArH), 4.82 (s, 2 H, ArCH2), 0.98 (s, 9 H, OSi(CH3)2)C(CH3)3), 0.20 (s, 
6 H, OSi(CH3)2)C(CH3)3); 
13C NMR (75.5 MHz, Acetone-d6) δ 156.1, 146.5, 134.1, 129.4, 
128.7, 128.1, 121.6, 119.4, 115.3, 113.4, 48.8, 26.4, 19.1, -3.9; I.R (thinfilm) ν max (cm-1): 
2929.55 (C-H sp3); HRMS (FTMS-NSI): m/z calculated for C25H27Br2NO2Si: requires: 















NEt3 (4.5 mL, 32.22 mmol) was added to a solution of 4-hydroxybenzyl alcohol (2.0 g, 16.11 
mmol) in DCM (50 mL). The solution was then cooled to 0 oC and trimethylacetyl chloride 
(2.2 mL, 17.72 mmol) was added dropwise. The reaction mixture was stirred overnight and 
was allowed to warm to rt. The reaction was partitioned with DCM (100 mL) and H2O (100 
mL). The organic layer was washed with H2O (3 x 50 mL), brine (50 mL), dried (MgSO4) 
and concentrated in-vacuo to afford the crude material. The title compound was purified via 
column chromatography 5:95 to 20:80 (EtOAc/Pet ether) to afford a clear oil (2.63 g, 12.63 
mmol, 78 %) 1H NMR (300 MHz, CDCl3) δ 7.37 - 7.30 (d, J = 8.7 Hz, 2 H, ArH), 7.05 - 
6.97 (d, J = 8.5 Hz, 2 H, ArH)), 4.62 (s, 2 H, ArCH2OH), 1.36 (s, 9H, ArOC(O)C(CH3)3); 
13C NMR (75MHz, CDCl3) δ 177.3, 150.4, 138.4, 128.0, 121.5, 64.6, 39.1, 27.2; I.R 
(thinfilm) ν max (cm-1): 3257.85 (br, O-H), 1740.41 (C=O);  HRMS (ESI+) m/z calculated 
for C12H16O3: requires 226.1438 [M+NH4]














Methanesulfonyl chloride (1.79 mL, 23.1 mmol) was added dropwise to a mixture of 4-
(hydroxymethyl)phenyl pivalate (2.3 g, 11 mmol), LiBr ( 9.55 g, 110 mmol) and NEt3 (1.8 
mL, 23.1 mmol) in DCM (50 mL) at 0 oC. The reaction mixture was stirred for 2 h before 
the addition of H2O (50 mL). The organic layer was washed with H2O (3 x 50 mL), brine 
(50 mL) and dried (MgSO4) and concentrated in-vacuo to afford title compound as a pale 
brown solid (2.1 g, 77.1 mmol, 70 %). No further purification was required. 1H NMR (300 
MHz, CDCl3) δ 7.45 - 7.37 (d, J = 8.5 Hz, 2 H, ArH), 7.08 - 7.00 (d, J = 8.5 Hz, 2 H, ArH), 
4.50 (s, 2 H, ArCH2Br), 1.36 (s, 9 H, ArOC(O)C(CH3)3); 
13C NMR (75 MHz, CDCl3) δ 
177.0, 151.0, 135.1, 130.2, 121.9, 39.1, 32.8, 27.1; I.R (thinfilm) ν max (cm-1): 1743.54 
















Phenoxazine (1.40 g, 7.56 mmol) was dissolved in DMF (40 mL) before being cooled to 0 
oC. NaH – 60% in mineral oil (0.36 g, 9.07 mmol) was then added portion wise to the solution 
over the period of 5 min, which was then left to stir at 0 oC for a further 10 min. 4-
(bromomethyl)phenyl pivalate (2.05 g, 7.56 mmol) in DMF (10 mL) was then added 
dropwise to the reaction mixture and then was left to stir for 4 hrs at rt. The reaction mixture 
was then cooled to 0 oC before being quenched with dropwise addition of H2O. The reaction 
mixture was partitioned with EtOAc (100 mL) and H2O (100 mL). The organic layer was 
washed with H2O (3 x 50 mL), brine (50 mL) and dried (MgSO4) and concentrated in-vacuo 
to afford the crude product. The title compound was purified via column chromatography 
5:95 to 10:90 (EtOAc/Pet ether) to afford a white solid (1.43 g, 3.83 mmol, 51 %). M.p. 101-
103 oC. 1H NMR (300 MHz, CDCl3) δ 7.38 - 7.27 (d, J = 8.5 Hz, 2 H, ArH), 7.10 - 6.99 (d, 
J = 8.5 Hz, 2 H, ArH), 6.75 - 6.64 (m, 6 H, ArH), 6.33 (d, J = 8.1 Hz, 2 H, ArH), 4.78 (s, 2 
H, NCH2Ar), 1.36 (s, 9 H, ArOC(O)C(CH3)3); 
13C NMR (75 MHz, CDCl3) δ 177.2, 150.2, 
145.2, 133.7, 129.0, 127.0, 123.8, 115.3, 112.3, 49.0, 39.1, 27.2; I.R (thinfilm) ν max (cm-
1): 1744.94 (C=O); ); HRMS (ESI): m/z calculated for C24H23NO3 requires 374.1756 for 











To a solution of 4-((10H-phenoxazin-10-yl)methyl)phenyl pivalate (1.22 g, 3.27 mmol) in 
CHCl3 (100 mL), NBS (1.16 g, 6.54 mmol) was added portion-wise and the reaction was left 
to stir for 1 hr. The reaction was then quenched with H2O (100 mL) and the organic layer 
was washed with H2O (3 x 100 mL), brine (100 mL) and dried (MgSO4) and concentrated 
in-vacuo to afford the title compound as a blue solid (Quantiative yield). Mp. 162-165 oC; 
1H NMR (300 MHz, Acetone – d6) δ 7.41 - 7.34 (d, J = 8.3 Hz, 2 H, ArH), 7.15 - 7.08 (d, J 
= 8.5 Hz, 2 H, ArH), 6.97 - 6.91 (m, 2 H, ArH), 6.86 ( m, 2 H, ArH), 6.51 - 6.42 (m, 2 H, 
ArH), 4.92 (s, 2 H, NCH2Ar), 1.33 (s, 9 H, COC(CH3)3); 
13C NMR (75.5 MHz, Acetone – 
d6) δ 177.5, 151.8, 146.5, 134.0, 128.4, 128.2, 123.4, 119.4, 115.3, 113.5, 48.9, 40.0, 27.7; 
I.R (thinfilm) ν max (cm-1): 1749.27 (C=O); HRMS (FTMS-NSI): m/z calculated for 
C24H21Br2NO3 requires 529.9961 for [M+H]















A solution of 4-((3,7-dibromo-10H-phenoxazin-10-yl)methyl)phenyl pivalate (1.60 g, 3.01 
mmol) in PhMe (100 mL) was cooled to 0 
oC before the dropwise addition of DIBAL – 1 M 
in Heptane (9.03 mL).  The reaction was stirred at 0 oC for 1 hr before being allowed to 
warm to rt. The reaction mixture was stirred for another 1 h before being quenched with 
saturated NH4Cl (50 mL). EtOAc (100 mL) was then added and the organic layer was 
washed with H2O (3 x 100 mL), brine (100 mL) and dried (MgSO4) and concentrated in-
vacuo to afford the title compound as a pink oil (0.9 g, 2.00 mmol, 67 %). 1H NMR (300 
MHz, Acetone – d6) δ 7.16 - 7.08 (d, J = 8.7 Hz, 2 H, ArH), 6.91 (dd, J = 2.3, 8.7 Hz, 2 H, 
ArH), 6.86 - 6.77 (m, 4 H, ArH), 6.48 - 6.40 (d, J = 8.5 Hz, 2 H, ArH), 4.77 (s, 2 H, NCH2Ar); 
13C NMR (75.5 MHz, CDCl3) δ 154.91, 145.36, 144.11, 132.68, 127.67, 127.01, 126.72, 
118.59, 115.99, 113.33, 112.84, 48.65; HRMS (TOF ASAP+): m/z calculated for 
C19H13Br2NO2 requires 444.9313 for [M]















4-((3,7-dibromo-10H-phenoxazin-10-yl)methyl)phenol (0.9 g, 2.00 mmol), bis(pinacolato) 
diboron (1.53 g, 6.00 mmol), potassium acetate (1.2 g, 11.94 mmol) and Pd(dppf)Cl2.DCM 
(0.145 g, 0.2 mmol) was dissolved in anhydrous DMF (10 mL) and refluxed under argon for 
2 hrs. The reaction was cooled to rt and partitioned with EtOAc (50 mL) and H2O (50 mL). 
The organic layer was washed with H2O (3 x 50 mL), brine (50 mL), dried (MgSO4) and 
concentrated in-vacuo to afford the crude product. The title compound was purified via 
column chromatography 20:80 to 50:50 (EtOAc/Pet Ether) to afford a white solid (0.90 g, 
1.66 mmol, 83 %). M.p. 230-233 oC; 1H NMR (300 MHz, Acetone - d6) δ 8.34 (s, 1 H, O-
H), 7.16 (m, 4 H, ArH), 6.97 (s, 2 H, ArH), 6.82 (d, J = 8.5 Hz, 2 H, ArH), 6.54 (d, J = 7.9 
Hz, 2 H, ArH), 4.85 (s, 2 H, NCH2Ar), 1.30 (s, 24 H, BPin); 
13C NMR (75 MHz, Acetone – 
d6) δ 157.9, 145.6, 137.3, 132.4, 128.6, 127.5, 121.7, 116.9, 116.8, 113.5, 84.7, 48.4, 25.5; 
I.R (thinfilm) ν max (cm-1): 3328.93 (O-H); HRMS (FTMS-NSI): m/z calculated for 
C31H37B2NO6 requires 540.2952 for [M+H]













132 (0.10 g, 0.185 mmol) was dissolved in DCM (2 mL) and NEt3 (0.075 µl, 0.55 mmol) 
was added. The solution was cooled to 0 oC before the addition of AcCl (0.040 µl, 0.55 
mmol). The reaction mixture was allowed to warm to rt and was stirred for 17 h. The reaction 
mixture was partitioned with H2O (20 mL) and the organic layer was washed with H2O (3 x 
20 mL), Brine (1 x 20 mL), dried (MgSO4) and concentrated in vacuo to afford the title 
compound as a pale yellow solid, no purification was required (0.077 g, 0.13 mmol, 71 %). 
M.p. 153-155 oC. 1H NMR (300 MHz, Acetone) δ 7.39 - 7.30 (d, J = 8.5 Hz, 2 H, ArH), 7.15 
(m, 4 H, ArH), 6.99 (d, J = 1.3 Hz, 2 H, ArH), 6.59 - 6.48 (d, J = 7.9 Hz, 2 H, ArH), 4.95 (s, 
2 H, ArCH2OAc), 2.24 (s, 3 H, OAc), 1.29 (s, 24 H, BPin); 
13C NMR (75 MHz, Acetone) δ 
170.1, 151.4, 145.6, 137.1, 134.6, 132.5, 128.4, 123.5, 121.9, 113.4, 84.7, 48.4, 25.6, 21.4; 
I.R (thinfilm) ν max (cm-1): 1766.00 (C=O); HRMS (FTMS-NSI): m/z calculated for 
C33H39B2NO7 requires 584.2985 for [M+H]














To a solution of 132 (0.10 g, 0.15 mmol) in DMF (100 mL), tert-butyldimethylsilylchloride 
(0.096 g, 0.6 mmol) and imidazole (0.040 g, 0.6 mmol) was added and the reaction was left 
to stir overnight. Tert-butyldimethylsilylchloride (0.096 g, 0.6 mmol) and imidazole (0.040 
g, 0.6 mmol) was then again added and the reaction was stirred for 3 d. H2O (100 mL) and 
EtOAc (100 mL) was added and the organic layer was washed with H2O (3 x 100 mL), brine 
(100 mL), dried (MgSO4) and concentrated in-vacuo to afford the crude material. The title 
compound was purified via column chromatography 0:100 to 5:95 (EtOAc/Pet ether) to 
afford a brown oil (0.011 g, 0.017 mmol, 11 %). 1H NMR (300 MHz, Acetone – d6) δ 7.21 
(d, J = 8.5 Hz, 2 H, ArH), 7.14 (dd, J = 1.3, 7.9 Hz, 2 H, ArH), 6.97 (d, J = 1.3 Hz, 2 H, 
ArH), 6.86 (d, J = 8.7 Hz, 2 H, ArH), 6.53 (d, J = 8.1 Hz, 2 H, ArH), 4.88 (s, 2 H, NCH2Ar), 
1.29 (s, 24 H, BPin), 0.97 (s, 9 H, OSi(CH3)2(CCH3)3), 0.19 (s, 6 H, OSi(CH3)2(CCH3)3); 
13C NMR (75.5 MHz, Acetone-d6) δ 156.0, 145.6, 137.3, 132.4, 129.8, 128.7, 121.8, 121.5, 
113.4, 84.7, 48.3, 26.4, 25.5, 19.1, -3.9; I.R (thinfilm) ν max (cm-1): 2977.24 (C-H, Sp3); 














132 (0.10 g, 0.185 mmol) was dissolved in DCM (2 mL) and NEt3 (0.040 µl, 0.28 mmol) 
was added. The solution was cooled to 0 oC before the addition of 2,4-dinitrobenzenesulfonyl 
chloride (0.053 g, 0.20 mmol). The reaction mixture was allowed to warm to rt and was 
stirred for 17 h. The reaction mixture was partitioned with H2O (20 mL) and the organic 
layer was washed with H2O (3 x 20 mL), Brine (1 x 20 mL), dried (MgSO4) and concentrated 
in vacuo to afford the crude compound. The title compound was purified via column 
chromatography 10:90 to 40:60 (EtOAc:Pet ether) to afford a purple foam (0.063 g, 0.082 
mmol, 44 %).1H NMR (300 MHz, Acetone) δ 8.95 (d, J = 2.3 Hz, 1 H), 8.68 (dd, J = 2.3, 
8.7 Hz, 1 H), 8.31 (d, J = 8.7 Hz, 1 H), 7.42 (d, J = 8.7 Hz, 2 H), 7.26 (s, 2 H), 7.14 (dd, J = 
1.3, 7.9 Hz, 2 H), 6.98 (d, J = 1.3 Hz, 2 H), 6.48 (d, J = 7.9 Hz, 2 H), 4.98 (s, 2 H), 1.30 (s, 
24 H); 13C NMR (75 MHz, Acetone-d6) δ 153.0, 149.4, 145.6, 137.8, 136.9, 135.2, 133.5, 
132.4, 129.5, 128.4, 123.8, 122.1, 121.9, 113.3, 84.8, 79.6, 48.2, 25.6; I.R (thinfilm) ν max 
(cm-1): 1738.78 (S=O); HRMS (FTMS-NSI): m/z calculated for C37H39B2N3O12S requires 











A solution of methyl 5-bromovalerate (1.47 mL, 10.25 mmol) and NaN3 (5.33 g, 82 mmol) 
in acetone (15 mL) and H2O (5 mL) was refluxed for 16 h. The reaction mixture was cooled 
to rt before the addition of H2O (50 mL) and DCM (50 mL). The organic layer was washed 
with H2O (3 x 50 mL), Brine and dried (MgSO4) and concentrated in-vacuo to afford the 
title compound as a yellow oil (1.60 g, 10.18 mmol, 99 %). 1H NMR (300 MHz, CDCl3) δ 
3.66 (s, 3 H, COOMe), 3.28 (t, J = 6.6 Hz, 2 H, MeOOCCH2), 2.40 - 2.28 (t, J = 6.97 Hz, 2 
H, CH2N3), 1.77 - 1.53 (m, 4 H, CH2CH2CH2CH2N3); 
13C NMR (75.5 MHz, CDCl3) δ 173.6, 
51.6, 51.0, 33.4, 28.3, 22.1; I.R (thinfilm) ν max (cm-1): 2091. 27 (N3), 1734.33 (C=O); 




















KOH (1.14 g, 20.36 mmol) was added portionwise to a solution of methyl 5-azidopentanoate 
(1.60 g, 10.18 mmol) in MeOH (25 mL) and H2O (20 mL) at 0 
oC. The reaction mixture was 
allow to warm to rt and it was stirred for 16 h. The MeOH was removed under reduced 
pressure and the pH was adjusted to 1. EtOAc (100 mL) was added and the aqueous layer 
was extracted with EtOAc (3 x 50 mL). The combined organics were dried (MgSO4) and 
concentrated in-vacuo to afford the title compound as a yellow oil (quant yield). 1H NMR 
(300 MHz, CDCl3) δ 11.48 (br. s., 1 H, COOH), 3.31 (t, J = 6.4 Hz, 2 H), 2.52 - 2.32 (m, 2 
H), 1.85 - 1.53 (m, 4 H); 13C NMR (75.5 MHz, CDCl3) δ 179.8, 51.0, 33.5, 28.2, 21.8; I.R 
(thinfilm) ν max (cm-1): 2090.49 (N3), 1702. 72 (C=O); HRMS (FTMS-NSI): m/z calculated 
for C5H9N3O2 requires 166.0587 for [M+Na]




















132 (0.15 g, 0.28 mmol) and 5-azidopentanoic acid (0.045 g, 0.31 mmol) was dissolved in 
DCM (4 mL) and cool to 0 oC. DCC (0.062 g, 0.31 mmol) was added and the reaction 
mixture was left to stir for 12 h. A further 1 equivalent of 5-azidopentanoic acid was added, 
followed by the addition of DMAP (2 mg, 0.014 mmol). The reaction mixture was stirred 
for another 12 h before the solvent was removed in-vacuo. The crude material was purified 
via column chromatography 20:80 (EtOAc/ Pet Ether) and trituration (MeOH) to afford the 
title compound as a brown foam (0.074, 0.11 mmol, 39 %); 1H NMR (300MHz, Acetone-
d6) δ 7.41 - 7.32 (d, J = 8.5 Hz, 2 H), 7.20 - 7.08 (m, 4 H), 6.99 (d, J = 1.3 Hz, 2 H), 6.57 - 
6.51 (d, J = 7.9 Hz, 2 H), 4.96 (s, 2 H), 3.41 (t, J = 6.5 Hz, 2 H), 2.68 - 2.58 (t, J = 7.16 Hz, 
2 H), 1.85 - 1.67 (m, 5 H), 1.30 (s, 24 H, BPin); 13C NMR (75.5 MHz, Acetone-d6) δ 172.6, 
151.4, 145.6, 137.1, 134.6, 132.5, 128.5, 123.5, 121.8, 113.4, 84.7, 52.0, 48.4, 34.4, 25.6, 















Phenoxazine (1.5 g, 8.18mmol) was dissolved in DMF (50 mL) and cooled to 0 °C. NaH – 
60 % in mineral oil (0.654 g, 16.37 mmol) was added portionwise and stirred for 10 min. 4-
nitrobenzyl bromide (3.54 g, 16.37 mmol) was then added. The solution was allowed to 
warm to rt and stir for 4 h. The mixture was quenched with H2O and the aqueous layer was 
extracted with EtOAc (2 x 50 mL). The combined organic layers were washed with H2O (3 
x 50 mL), and brine (1 x 50 mL), dried over MgSO4, filtered and concentrated in-vacuo to 
afford the crude material. The crude material was then carried forward on to the next step 
without purification. 1.55 g of the crude material was dissolved in CHCl3 and NBS (1.74 g, 
9.74 mmol) was added portionwise. The reaction mixture was stirred for 1 h before the 
addition of H2O (100 mL) and the organic layer was washed with H2O (3 x 100 mL), brine 
(100 mL) and dried (MgSO4) and concentrated in-vacuo to afford the dibrominated crude 
product. This was then taken on to the next step without any further purification. Crude 
dibromo (1.75 g, 3.68 mmol), bis(pinacolato) diboron (2.8 g, 11.03 mmol), potassium acetate 
(2.2 g, 22.08 mmol) and Pd(dppf)Cl2.DCM (0.269 g, 0.368 mmol) was dissolved in 
anhydrous DMF (15 mL) and refluxed under argon for 2 hrs. The reaction was cooled to rt 
and partitioned with EtOAc (50 mL) and H2O (50 mL). The organic layer was washed with 
H2O (3 x 50 mL), brine (50 mL), dried (MgSO4) and concentrated in-vacuo to afford the 
crude product. The title compound was purified via column chromatography 10:90 
(EtOAc/Pet Ether) and triturated (Pet ether) to afford a golden orange foam (0.47 g, 0.82 
mmol, 10 % - overall yield). 1H NMR (300MHz, CDCl3) δ 8.25 - 8.16 (d, J = 8.9 Hz, 2 H, 
ArH), 7.52 - 7.45 (d, J = 8.9 Hz, 2 H, ArH), 7.17 (d, J = 6.6 Hz, 2 H, ArH), 7.11 (s, 2 H, 
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ArH), 6.23 (d, J = 7.9 Hz, 2 H, ArH), 4.89 (s, 2 H, CH2Ar), 1.32 (s, 24 H, BPin); 
13C NMR 
(75.5 MHz, CDCl3) δ 147.4, 144.7, 143.8, 135.3, 131.0, 127.0, 124.3, 121.4, 111.3, 83.7, 
48.4, 24.8; HRMS (TOF MS ASAP+): m/z calculated for C31H36B2N2O7: requires 571.2798 






A solution of 10-(4-bromobenzyl)-10H-phenoxazine (1.60 g, 3.54 mmol) in AcOH (35 mL) 
was cooled to 0 oC before the dropwise addition of fuming HNO3 (0.67 mL). The reaction 
was kept at 0 oC for 1 h and then allowed to warm to rt. The reaction mixture was stirred for 
another 1 h with a bright red solid precipitating. The solution was filtered and the red solid 
was washed with MeOH. The title compound was isolated as a red solid (1.37 g, 2.80 mmol, 
62 %); M.p. 270-274 oC. 1H NMR (300 MHz, DMSO-d6) δ 7.74 (dd, J = 2.6, 9.0 Hz, 2 H), 
7.58 (d, J = 8.5 Hz, 2 H), 7.48 (d, J = 2.6 Hz, 2 H), 7.31 (d, J = 8.5 Hz, 2 H), 6.75 (d, J = 9.0 
Hz, 2 H), 5.07 (s, 2 H); 13C NMR (75. 5 MHz, DMSO-d6) δ 143.8, 142.2, 138.2, 134.1, 
132.2, 128.8, 121.8, 120.9, 113.4, 110.6, 48.9, 21.4; I.R (thinfilm) ν max (cm-1): 1488.96 
(NO2); HRMS (TOF ASAP+): m/z calculated for C19H12BrN3O5: requires 442.0039 for 











10-(4-bromobenzyl)-3,7-dinitro-10H-phenoxazine (1.40 g, 3.17 mmol), bis(pinacolato) 
diboron (1.61 g, 6.33 mmol), KOAc (1.9 g, 19.02 mmol) and Pd(dppf)Cl2 (0.232 g, 0.317 
mmol) was dissolved in anhydrous DMF (20 mL) and refluxed under argon overnight. The 
reaction was cooled to rt and the reaction mixture was partioned with EtOAc (50 mL) and 
H2O (50 mL). The aqueous layer was extracted with EtOAc (1 x 50 mL) and the combined 
organic layers were washed with H2O (50 mL), brine (50 mL) and dried (MgSO4). The 
solvent was removed in-vacuo to afford the crude material, which was purified via column 
chromatography 40:60 (EtOAc/ Pet Ether) to afford a crystalline orange solid (0.77 g, 1.57 
mmol, 50 %). M.p. 269-272 oC. 1H NMR (300 MHz, CDCl3) δ 7.93 - 7.78 (d, J = 8.1 Hz, 2 
H), 7.70 (dd, J = 2.5, 8.9 Hz, 2 H), 7.59 (d, J = 2.4 Hz, 2 H), 7.27 (d, J = 8.1 Hz, 2 H), 6.47 
- 6.36 (d, J = 8.9 Hz, 2 H), 4.92 (s, 2 H), 1.35 (s, 12 H); 13C NMR (75.5 MHz, CDCl3) δ 
144.2, 142.9, 138.0, 136.0, 124.9, 121.3, 112.2, 111.4, 84.1, 50.0, 24.9; I.R (thinfilm) ν max 
(cm-1): 2971.34 (C-H sp2), 1488.96 (NO2); HRMS (TOF ASAP+): m/z calculated for 
C25H24
10BN3O7: requires 489.18.16 for [M+H]















Crystal data and structure refinement for 132 
Identification code  e16tdj1 
Empirical formula  C32 H39 B2 Cl2 N O6 
Formula weight  626.16 
Temperature  150.00(10) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 21.0386(6) Å = 90°. 
 b = 12.0671(3) Å = 91.250(3)°. 
 c = 12.7442(4) Å  = 90°. 
Volume 3234.66(16) Å3 
Z 4 
Density (calculated) 1.286 Mg/m3 
Absorption coefficient 0.244 mm-1 
F(000) 1320 
Crystal size 0.500 x 0.400 x 0.150 mm3 
Theta range for data collection 3.361 to 30.348°. 
Index ranges -29<=h<=29, -17<=k<=16, -16<=l<=17 
Reflections collected 46742 
Independent reflections 8960 [R(int) = 0.0329] 
Completeness to theta = 25.242° 99.8 %  
Absorption correction Semi-empirical from equivalents 
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Max. and min. transmission 1.00000 and 0.85577 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8960 / 0 / 459 
Goodness-of-fit on F2 1.045 
Final R indices [I>2sigma(I)] R1 = 0.0652, wR2 = 0.1611 
R indices (all data) R1 = 0.0862, wR2 = 0.1737 
Extinction coefficient n/a 
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9.0 NMR  
 
 
Ethyl 3-bromo-4-methylbenzoate (65) (500 MHz, CDCl3) 
PROTON_01











































Ethyl 3-bromo-4-methylbenzoate (65) (125.75 MHz, CDCl3) 
 
CARBON_01










































































Ethyl 3-bromo-4-(hydroxymethyl)benzoate (68) (500 MHz, CDCl3) 
 
PROTON_01









































































Ethyl 3-bromo-4-(hydroxymethyl)benzoate (68) (125.5 MHz, CDCl3) 
CARBON_01


































































































































































Ethyl 3-bromo-4-(((tert-butyldimethylsilyl)oxy)methyl)benzoate (69) (125.75 MHz, 
CDCl3) 
CARBON_01



























































































(3-bromo-4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)methanol (70) (500 MHz, 
CDCl3) 
PROTON_01




















































































































































3-bromo-4-(((tert-butyldimethylsilyl)oxy)methyl)benzaldehyde (71) (300 MHz, CDCl3) 
 
acs654.010.001.1r.esp































































































































































































































































































































































f][1,3,2]diazaborinin-10-yl)phenyl)methanol (73) (500 MHz, CDCl3) 
 
PROTON_01














































































f][1,3,2]diazaborinin-10-yl)phenyl)methanol (73) (125.75 MHz, CDCl3) 
 
CARBON_01











































































































f][1,3,2]diazaborinin-10-yl)benzaldehyde (74) (300 MHz, CDCl3) 
 
PROTON_01











































































f][1,3,2]diazaborinin-10-yl)benzaldehyde (74) (75.5 MHz, CDCl3) 
 
CARBON_01


































































































f][1,3,2]diazaborinin-10-yl)-2-formylphenyl)acrylate (63) (500 MHz, CDCl3) 
PROTON_01



























































































f][1,3,2]diazaborinin-10-yl)-2-formylphenyl)acrylate (63) (125.5 MHz, CDCl3) 
 
CARBON_01































































































































































f][1,3,2]diazaborinin-10-yl)-3-(2-methoxy-2-oxoethyl)-1H-isoindole 2-oxide (75) 
(125.75 MHz, CDCl3) 
CARBON_01


















































































































tert-Butyl ((tert-butoxycarbonyl)oxy)(prop-2-yn-1-yl)carbamate (148) (300 MHz, 
CDCl3) 
acs722.030.001.1r.esp






























N-(Prop-2-yn-1-yl)hydroxylammonium chloride (148) (300 MHz, CDCl3) 
 
acs725.010.001.1r.esp



































N-(Prop-2-yn-1-yl)hydroxylammonium chloride (149) (75.5 MHz, CDCl3) 
N-HydroxylamineAlkyne.011.001.1r.esp















































2-(benzo[d]thiazol-2-yl)aniline (85) (500 MHz, CDCl3) 
 
PROTON_01


































2-(benzo[d]thiazol-2-yl)aniline (85) (125.75 MHz, CDCl3) 
 
CARBON_01




























































































































































yl)benzyl)aniline (86) (125.75 MHz, CDCl3) 
 
CARBON_01




































































































































yl)benzyl)aniline (84) (500 MHz, CDCl3) 
 
PROTON_01



















































yl)benzyl)aniline (84) (125.75 MHz, CDCl3) 
 
CARBON_01
























































































































3-Hydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one (150) (300 MHz, DMSO-d6) 
 
acs731.060.001.1r.esp



































3-Hydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one (150) (125.75 MHz, DMSO-d6) 
 
CARBON_01























































































4H-chromen-4-one (89) (300 MHz, CDCl3) 
 
acs731-bpin.020.001.1r.esp










































4H-chromen-4-one (89) (75.5 MHz, CDCl3) 
 
acs731-bpin.021.001.1r.esp































































































































3-Hydroxy-2-(p-tolyl)-4H-chromen-4-one (151) (300 MHz, DMSO-d6) 
 
acs739.030.001.1r.esp


































3-Hydroxy-2-(p-tolyl)-4H-chromen-4-one (151) (75 MHz, DMSO-d6) 
 
acs739.031.001.1r.esp

















































































chromen-4-one (90) (500 MHz, CDCl3) 
 
PROTON_01














































chromen-4-one (90) (125 MHz, CDCl3) 
 
CARBON_01



































































































































3-Hydroxy-2-phenyl-4H-chromen-4-one (151) (300 MHz, DMSO-d6) 
Ph.030.001.1r.esp


































3-Hydroxy-2-phenyl-4H-chromen-4-one (151) (75.5 MHz, DMSO-d6) 
acs735.051.001.1r.esp


















































































4-one (91) (300 MHz, CDCl3) 
 
acs735b.010.001.1r.esp











































4-one (91)  (75 MHz, CDCl3) 
 
acs735.057.001.1r.esp



























































































































2-(3-cyano-4,5,5-trimethylfuran-2(5H)-ylidene)malononitrile (96) (500 MHz, CDCl3) 
 
PROTON_01



































2-(3-cyano-4,5,5-trimethylfuran-2(5H)-ylidene)malononitrile (96) (75.5 MHz, CDCl3)  
Carbon.001.1r.esp












































































(97) (300 MHz, CDCl3) 
TCFOH.010.001.1r.esp









































































(97) (75.5 MHz, CDCl3) 
 
TCFOH.011.001.1r.esp








































































































yl)benzyl)oxy)styryl)furan-2(5H)-ylidene)malononitrile (94) (500 MHz, CDCl3) 
PROTON_01




















































































yl)benzyl)oxy)styryl)furan-2(5H)-ylidene)malononitrile (94) (125.5 MHz, CDCl3) 
 
CARBON_01





































































































































yl)styryl)furan-2(5H)-ylidene)malononitrile (95) (300 MHz, CDCl3) 
TCFB2.040.001.1r.esp










































































yl)styryl)furan-2(5H)-ylidene)malononitrile (95) (75.5 MHz, CDCl3) 
TCFB2.041.001.1r.esp











































































































































trifluoromethanesulfonate (109) (300 MHz, DMSO-d6) 
 
acs752.030.001.1r.esp





















































trifluoromethanesulfonate (109) (75.5 MHz, DMSO-d6) 
 
acs752.031.001.1r.esp
























































































































1,9'-xanthen]-3-one (106) (500 MHz, CDCl3) 
 
PROTON_01















































1,9'-xanthen]-3-one (106) (125.75 MHz, CDCl3) 
 
CARBON_01










































































































































xanthen]-6'-yl 2,4-dinitrobenzenesulfonate (108) (500 MHz, CDCl3) 
PROTON_01



























































xanthen]-6'-yl 2,4-dinitrobenzenesulfonate (108) (125.75 MHz, CDCl3) 
CARBON_01






















































































































































10-benzyl-10H-phenoxazine (112) (300 MHz, CDCl3) 
 
acs349.010.001.1r.esp






















































































































10-benzyl-3,7-dibromo-10H-phenoxazine (113) (300 MHz, CDCl3) 
 
acs350.010.001.1r.esp

































10-benzyl-3,7-dibromo-10H-phenoxazine (113) (75.5 MHz, CDCl3) 
acs350.011.001.1r.esp



















































































(300 MHz, CDCl3) 
ACS352 data.020.001.1r.esp




































(75.5 MHz, CDCl3) 
ACS352 data.040.001.1r.esp






























































































3,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-phenoxazine (25) (500 MHz, 
Acetone-d6) 
PROTON_01
































3,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-phenoxazine (25) (125.75 
MHz, Acetone-d6) 
CARBON_01





































































10-(4-bromobenzyl)-10H-phenoxazine (115) (500 MHz, CDCl3) 
PROTON_01






























































10-(4-bromobenzyl)-10H-phenoxazine (115) (125.75 MHz, CDCl3) 
CARBON_01














































































3,7-Dibromo-10-(4-bromobenzyl)-10H-phenoxazine (116) (300 MHz, CDCl3) 
acs334.010.001.1r.esp



































3,7-Dibromo-10-(4-bromobenzyl)-10H-phenoxazine (116) (75.5 MHz, CDCl3) 
 
acs334.020.001.1r.esp














































































dioxaborolan-2-yl)benzyl)-10H-phenoxazine (117) (500 MHz, Acetone-d6) 
PROTON_01
























































dioxaborolan-2-yl)benzyl)-10H-phenoxazine (117) (75.5 MHz, CDCl3) 
acs338.021.001.1r.esp














































































































3,7-Dibromo-10H-phenothiazine (121) (300 MHz, CDCl3) 
acs577.010.001.1r.esp





















































3,7-Dibromo-10H-phenothiazine (121) (75. 5 MHz, CDCl3) 
 
acs577.021.001.1r.esp
































































3,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-phenothiazine (120) (500 
MHz, CDCl3) 
acs589.010.001.1r.esp







































3,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-phenothiazine (120) (125.5 
MHz, CDCl3) 
CARBON_01

































































10-(4-bromobenzyl)-10H-phenothiazine (122) (300 MHz, CDCl3) 
acs594.030.001.1r.esp



































10-(4-bromobenzyl)-10H-phenothiazine (122) (75.5 MHz, CDCl3) 
 
acs594.031.001.1r.esp























































































3,7-dibromo-10-(4-bromobenzyl)-10H-phenothiazine (123) (300 MHz, CDCl3) 
acs586.010.001.1r.esp



































3,7-dibromo-10-(4-bromobenzyl)-10H-phenothiazine (123) (75.5 MHz, CDCl3) 
 
acs586.011.001.1r.esp



















































































dioxaborolan-2-yl)benzyl)-10H-phenothiazine (124) (300 MHz, CDCl3) 
 
acs596.010.001.1r.esp




















































































































































4-((tert-butyldimethylsilyl)oxy)benzaldehyde (126) (300 MHz, CDCl3) 
 
acs455.010.001.1r.esp






























4-((tert-butyldimethylsilyl)oxy)benzaldehyde (126) (75.5 MHz, CDCl3) 
 
acs455.011.001.1r.esp












































































(4-((tert-butyldimethylsilyl)oxy)phenyl)methanol (127) (300 MHz, CDCl3) 
acs456.010.001.1r.esp


































(4-((tert-butyldimethylsilyl)oxy)phenyl)methanol (127) (75.5 MHz, CDCl3) 
acs456.011.001.1r.esp




































































(4-(bromomethyl)phenoxy)(tert-butyl)dimethylsilane (128) (300 MHz, CDCl3) 
acs460.020.001.1r.esp


































(4-(bromomethyl)phenoxy)(tert-butyl)dimethylsilane (128) (75.5 MHz, CDCl3) 
acs460.011.001.1r.esp































































4-((10H-phenoxazin-10-yl)methyl)phenol (129) (300 MHz, CDCl3) 
acs463.010.001.1r.esp



































4-((10H-phenoxazin-10-yl)methyl)phenol (129) (75.5 MHz, CDCl3) 
acs463.020.001.1r.esp










































































10-(4-((tert-butyldimethylsilyl)oxy)benzyl)-10H-phenoxazine (130) (300 MHz, CDCl3) 
acs467.020.001.1r.esp


































10-(4-((tert-butyldimethylsilyl)oxy)benzyl)-10H-phenoxazine (130) (75.5 MHz, CDCl3) 
 
ACS467.021.001.1r.esp






























































































3,7-dibromo-10-(4-((tert-butyldimethylsilyl)oxy)benzyl)-10H-phenoxazine (131) (300 
MHz, CDCl3) 
acs475.010.001.1r.esp




































3,7-dibromo-10-(4-((tert-butyldimethylsilyl)oxy)benzyl)-10H-phenoxazine (131) (75.5 
MHz, CDCl3) 
acs475.020.001.1r.esp
























































































4-(Hydroxymethyl)phenyl pivalate (133) (300 MHz, CDCl3) 
acs503.010.001.1r.esp



















































4-(Hydroxymethyl)phenyl pivalate (133) (75.5 MHz, CDCl3) 
acs503.011.001.1r.esp




































































4-(Bromomethyl)phenyl pivalate (134) (300 MHz, CDCl3) 
 
acs543.010.001.1r.esp




















































4-(bromomethyl)phenyl pivalate (134) (75.5 MHz, CDCl3) 
acs543.011.001.1r.esp









































































4-((10H-phenoxazin-10-yl)methyl)phenyl pivalate (135) (300 MHz, CDCl3) 
 
acs544.010.001.1r.esp


































































4-((10H-phenoxazin-10-yl)methyl)phenyl pivalate (135) (75.5 MHz, CDCl3) 
 
acs544.011.001.1r.esp






































































































4-((3,7-dibromo-10H-phenoxazin-10-yl)methyl)phenyl pivalate (136) (300 MHz, 
Acetone-d6) 
acs550.010.001.1r.esp








































































4-((3,7-Dibromo-10H-phenoxazin-10-yl)methyl)phenyl pivalate (136) (75.5 MHz, 
Acetone-d6) 
acs550.020.001.1r.esp
































































































4-((3,7-Dibromo-10H-phenoxazin-10-yl)methyl)phenol (137) (300 MHz, Acetone-d6) 
Proton.001.1r.esp






























































4-((3,7-Dibromo-10H-phenoxazin-10-yl)methyl)phenol (137) (75.5 MHz, CDCl3) 
mw1-024_c.030.001.1r.esp


















































































yl)methyl)phenol (132) (300 MHz, Acetone-d6) 
 
acs538.020.001.1r.esp



































































yl)methyl)phenol (132) (75.5 MHz, Acetone-d6) 
acs538.021.001.1r.esp




























































































yl)methyl)phenyl acetate (139) (300 MHz, Acetone-d6) 
 
acsesterase.010.001.1r.esp













































































yl)methyl)phenyl acetate (139) (75.5 MHz, Acetone-d6) 
acsesterase.011.001.1r.esp
















































































































dioxaborolan-2-yl)-10H-phenoxazine (125) (300 MHz, Acetone-d6) 
acstbs.030.001.1r.esp














































dioxaborolan-2-yl)-10H-phenoxazine (125) (75.5 MHz, Acetone-d6) 
 
acstbs.031.001.1r.esp































































































yl)methyl)phenyl 2,4-dinitrobenzenesulfonate (138) (300 MHz, Acetone-d6) 
 
acs567.020.001.1r.esp




















































yl)methyl)phenyl 2,4-dinitrobenzenesulfonate (138) (75.5 MHz, Acetone-d6) 
 
acs567.021.001.1r.esp






















































































































Methyl 5-azidopentanoate (141) (300 MHz, CDCl3) 
acs704.050.001.1r.esp





































Methyl 5-azidopentanoate (141) (75.5 MHz, CDCl3) 
acs704.051.001.1r.esp




























































5-Azidopentanoic acid (142) (300 MHz, CDCl3) 
acs710.020.001.1r.esp





































5-Azidopentanoic acid (142) (75.5 MHz, CDCl3) 
 
acs710.021.001.1r.esp

























































yl)methyl)phenyl 5-azidopentanoate (140) (300 MHz, Acetone-d6) 
acs713.040.001.1r.esp











































yl)methyl)phenyl 5-azidopentanoate (140) (75.5 MHz, Acetone-d6) 
acs713.041.001.1r.esp









































































































phenoxazine (143) (300 MHz, CDCl3) 
acs453.010.001.1r.esp






































































phenoxazine (143) (75.5 MHz, CDCl3) 
acs453.011.001.1r.esp






















































































10-(4-bromobenzyl)-3,7-dinitro-10H-phenoxazine (145) (300 MHz, CDCl3) 
acs646.040.001.1r.esp












































10-(4-bromobenzyl)-3,7-dinitro-10H-phenoxazine (145) (75.5 MHz, CDCl3) 
acs646.041.001.1r.esp
















































































































phenoxazine (146) (300 MHz, CDCl3) 
acs648.040.001.1r.esp















































phenoxazine (146) (75.5 MHz, CDCl3) 
acs648.041.001.1r.esp
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